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Abstract 
 The thesis investigates the effect of surface treatment with various reducing and 
oxidizing agents on the quantum yield (QY) of CdSe and CdS quantum dots (QDs). The 
QDs, as synthesized by the organometallic method, contained defect sites on their surface 
that trapped photons and prevented their radiative recombination, therefore resulting in a 
decreased QY. To passivate these defect sites and enhance the QY, the QDs were treated 
with various reducing and oxidizing agents, including: sodium borohydride (NaBH4), 
calcium hydride (CaH2), hydrazine (N2H4), benzoyl peroxide (C14H10O4), and tert-butyl 
hydroperoxide (C4H10O2). It was hypothesized that the reducing/oxidizing agents reduced 
the ligands on the QD surface, causing them to detach, thereby allowing oxygen from 
atmospheric air to bind to the exposed cadmium. This cadmium oxdide (CdO) layer 
around the QD surface satisfied the defect sites and resulted in an increased QY. To 
correlate what effect the reducing and oxidizing agents were having on the optical 
properties of the QDs, we investigated these treatments on the following factors: 
chalcogenide (Se vs. S), ligand (oleylamine vs. OA), coordinating solvent (ODE vs. 
TOA), and dispersant solvent (chloroform vs. toluene) on the overall optical properties of 
the QDs. The QY of each sample was calculated before and after the various surface 
treatments from ultra-violet visible spectroscopy (UV-Vis) and fluorescence spectroscopy 
data to determine if the treatment was successful. 
 From our results, we found that sodium borohydride was the most effective 
surface treatment, with 10 of the 12 treatments resulting in an increased QY. Hydrazine, 
on the other hand, was the least effective treatments, as it quenched the QD fluorescence 
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in every case. From these observations, we hypothesize that the effectiveness of the QD 
surface treatments was dependent on reaction rate. More specifically, when the surface 
treatment reaction happened too quickly, we hypothesize that the QDs began to 
aggregate, resulting in a quenched fluorescence. Furthermore, we believe that the reaction 
rate is dependent on concentration of the reducing/oxidizing agents, solubility of the 
agents in each solvent, and reactivity of the agents with water. The quantum yield of the 
QDs can therefore be maximized by slowing the reaction rate of each surface treatment to 
a rate that allows for the proper passivation of defect sites.  
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Chapter 1. Introduction 
Fluorescent quantum dots (QD) are semiconductor nanocrystals with dimensions 
on the order of a few nanometers. At the nano-scale, materials exhibit size-dependent 
absorbance and fluorescence emission properties that are not observed in macro-scale 
(bulk) semiconductors. The size, shape, and growth conditions of QDs can be tuned by 
varying reaction conditions, such as the reaction time, reaction temperature, and 
stabilizing ligands used. The ability to tune the size of QDs allows for their potential 
application in a number of photonic devices, including: emitters for color displays1, color 
modifiers for light emitting diodes (LEDs)2, optical fiber amplifiers3,4, low threshold 
lasers5, self-assembled photonic sphere arrays6, polymer-based photovoltaic cells7, 
optical temperature probes8, chemical sensors7, and high-speed signal-processing filters9. 
Quantum dots, specifically CdSe QDs, are also becoming an important tool in medical 
imaging. Regardless of application, QDs with a high quantum yield (QY) are critical to 
development of many future technologies. This thesis focuses on developing and 
understanding the effect of surface treatments to produce cadmium selenide (CdSe) and 
cadmium sulfide (CdS) QDs with a high QY. 
The preparation method for the synthesis of CdSe and CdS QDs utilized in this 
thesis involves the high temperature thermolysis of organometallic precursors via 
microwave heating. During this method, organic precursors are dissolved in a heated 
coordinating solvent and bound to unsaturated metal atoms on the QD surface to prevent 
the formation of bulk semiconductors.10 The nanoparticles are capped with a monolayer 
of organic ligands and are soluble only in non-polar hydrophobic solvents.10 Ligands play 
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at least four distinct roles in the overall electronic function of the QDs. First, they are 
present during the nucleation process and determine the reactivity and availability of the 
crystal precursors and ligands.11 Second, they control the rate of growth and final particle 
size distribution11 by keeping the particles isolated and facilitating homogenous growth 
during synthesis.12 Third, they provide colloidal stability, preventing aggregation and 
growth.11,13, 14 Lastly, they interact electronically with surface sites and may passivate 
defects on the surface of QDs.12  
Quantum dots have a high surface area to volume ratio resulting in a large fraction 
of atoms on the surface of the nanocrystals. Incomplete surface coverage can lead to the 
formation of inhomogeneous defect sites on the QD surface. These defect sites are 
capable of trapping electrons or holes, which in turn prevents radiative recombination and 
ultimately degrades their QY. For this reason, proper passivation of the nanocrystal 
surface is necessary to achieve a high QY. The goal of this thesis is to develop methods 
to effectively passivate these surface defect points via treatment with various reducing 
and oxidizing agents. It is expected that treatment with reducing/oxidizing agents will 
lead to the formation of a cadmium oxide (CdO) layer around the QDs thereby 
passivating the defect sites and resulting in increased QY.16 The reducing agents that will 
be investigated include: sodium borohydride (NaBH4), calcium hydride (CaH2), and 
hydrazine (N2H4); while the oxidizing agents include: benzoyl peroxide (C14H10O4) and 
tert-butylhydroperoxide (C4H10O2). 
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To better understand the effect surface reactions of reducing and oxidizing agents 
have on the optical properties of the QDs, several variables were investigated more 
thoroughly. Specifically, the effect of cadmium precursor in the semiconductor (Se vs. S), 
stabilizing ligand (oleylamine vs. oleic acid (OA)), non-coordinating solvent 
(octadecence (ODE) vs. trioctylamine (TOA)), and dispersion solvent (chloroform vs. 
toluene) was studied. Untreated and treated QDs were subjected to ultra-violet visible 
(UV-Vis) spectroscopy, fluorescence spectroscopy, and thermogravimetric analysis 
(TGA) to provide information about the QD optical properties, size, and surface coverage 
of ligands. The QY of the QDs before and after treatment was used as a measure of 
success. 
This thesis is organized into 8 chapters. Chapter 2 is a literature review section 
that provides an overview of the applications and synthesis methods of QDs and serves as 
motivation for the work completed in this thesis. Chapter 3 outlines the experimental 
methods used to synthesize and treat the QDs with various reducing/oxidizing agents. 
Chapters 4, 5, and 6 present and discuss the results obtained from carrying out these 
procedures, and Chapter 7 provides general conclusions from these results. Lastly, 
recommendations for future work are summarized in Chapter 8.  
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Chapter 2. Background 
2.1 Quantum Dots versus Bulk Semiconductors 
A bulk semiconductor is a material that has an electrical conductivity between a 
metal and an insulator.1 Quantum dots behave similarly to bulk semiconductors but differ 
in two distinct ways: (1) the bandgap of QDs can be tuned; and (2) the energy levels of 
QDs are considered to be discrete rather than continuous. Electrons in a bulk 
semiconductor exhibit different energies and are therefore in different energy levels. The 
energy levels are continuous because there is virtually no energy difference between the 
levels.2 Some of the energy levels are ‘unavailable’ to electrons and are referred to as the 
bandgap.1-3 Electrons occupying levels below the bandgap are in the valence band while 
those above the bandgap are in the conduction band (see Figure 2.1 below).1,2,4  
 
Figure 2.1. Electron structure in a semiconductor material. 
 
In most bulk semiconductors, the valence band is occupied by electrons, while the 
conduction band is vacant.1,2,4,5 For electrons to move from the valence band to the 
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conduction band, they must acquire enough energy to cross the bandgap.1-3,5 To 
accomplish this, an external stimulus is required, such as heat, voltage, or photon flux.5 
The electrons transferred from the valence band to the conduction band are called ‘free’ 
electrons because they have been ‘freed’ from the confines of the valence band.1 The 
minimum amount of energy a bulk semiconductor absorbs to raise an electron from the 
valence band to the conduction band corresponds to the energy of the bandgap (Eg).2,3 For 
bulk semiconductors, the bandgap energy is fixed and is dependent on the semiconductor 
material. The temporary valence location vacated when an electron moves to the 
conduction band is a positively charged ‘hole’.1,3-5  A material rich in holes (or lacking 
electrons) is a p-type material whereas an electron-rich material is n-type.1,2 
The promoted electrons in the conduction band remain there momentarily before 
returning to the valence band. As the electron returns to the valence band, it passes 
through the bandgap. Electromagnetic radiation with a wavelength corresponding to the 
energy it loses in the transition is emitted.2,3 Typically, electrons fall from the bottom of 
the conduction band to the top of the valence band. In other words, they travel from one 
edge of the bandgap to the other. Thus, because the bandgap is fixed in bulk 
semiconductors, this emission wavelength is also fixed. Often this emitted light is not in 
the visible spectrum; instead it is in the infrared (IR) or ultra violet (UV) region.2 The 
process of an electron returning to the valence band is known as radiative 
recombination.2,3  
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Quantum dots are different from bulk semiconductors because their bandgap can 
be tuned to emit light at a particular wavelength. The size of the bandgap is dictated by 
the size of the particle. More specifically, the nanocrystal bandgap increases with 
decreasing size as 1/r2 (where r refers to the QD radius).6 As a result, quantum dots of the 
same material can vary in color and optical properties depending on the QD size. The size 
may be precisely controlled by the reaction time, temperature, and choice of ligand used 
during their synthesis, which will be discussed in detail below. CdSe QDs, for instance, 
can be tuned to emit radiation across most of the visible and some of the IR spectrum 
(4500 to 6500 Å).6 Experimental observations of CdSe QDs have shown that as the 
average radius increases from 0.6 nm to 4.15 nm, the emitted color changes from blue 
(centered at 450 nm7) to red (centered at 650 nm7) (see Figure 2.2 below), and the photon 
energy of the first absorbance peak decreases from 3.02 eV to 1.88 eV 8and eventually 
approaches the bandgap energy of bulk CdSe (Eg = 1.7 eV).9 The electrons of QDs that 
are considered ‘blue shifted’ must travel a greater distance in terms of energy and 
therefore produce radiation at a shorter, ‘bluer’ wavelength. Because this thesis focuses 
on both CdSe and cadmium sulfide (CdS) QD cores, it is important to note that the 
bandgap of CdS is higher than that of CdSe (Eg = 2.5 eV9). 
 
 
Figure 2.2. Schematic of QD particle size and color emitted. 
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Another difference between QDs and bulk semiconductors is that the distance 
between the electron and ‘hole’ pair (called an exciton) in the bulk material is much 
smaller than the dimensions of the semiconductor crystal. With QDs, the exciton is about 
the same size as the dimensions of the particle and as a result, their energy levels are 
discrete rather than continuous.6 In this context, discrete refers to the finite separation 
between energy levels (also referred to as quantum confinement). The separation between 
energy levels increases as the particle size decreases. Quantum confinement occurs when 
the nanocrystal radius becomes comparable to the bulk exciton Bohr radius (~56 Ǻ for 
CdSe).6 Under these conditions, the absorptive and emissive behavior of the 
semiconductor is changed because the addition or subtraction of just a few atoms can 
alter the boundaries of the bandgap.6  
 
2.2 Applications for Quantum Dots 
The ability to tune the size of quantum dots allows for their potential application 
in a number of photonic devices, including: emitters for color displays10, color modifiers 
for light emitting diodes (LEDs)11, optical fiber amplifiers12,13, low threshold lasers14, 
self-assembled photonic sphere arrays15, polymer-based photovoltaic cells16, optical 
temperature probes17, chemical sensors16, and high-speed signal-processing filters18. 
Quantum dots, specifically CdSe, are also often applied to the medical field. Due to the 
known toxicity of Cd and Se to cells, however, in vitro biomedical applications of CdSe 
QDs are currently practiced, whereas in vivo applications are still in the research stage. 
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Examples of in vitro applications include: laboratory blood tests, urine analysis, tissue 
slide staining, and cell culture monitoring.19 Future work of this thesis focuses on the 
potential use of QDs in various in vivo applications which are described in detail below. 
A primary application of QDs in the medical field involves bioconjugation, or the 
coupling of a QD to a small biomolecule, including oligonucleotides, peptides, proteins, 
and DNA. In fact, multiple biomolecules can be attached to the surface of a single QD 
due to the large surface area of the nanocrystals.20 It has been estimated that two to five 
protein molecules and 50 or more small molecules (such as oligonucleotides or peptides) 
can be conjugated to a single 4 nm QD.20 These bioconjugations are being used for the 
assembly of new materials, for developing homogeneous bioassays, and as multicolor 
fluorescent labels for detection and imaging.20 One specific example involves the 
attachment of antibodies that have the ability to bind many target proteins to QDs in 
order to form new luminescent tags which can help detect the presence of selected 
diseased tissues or illuminate the structure of diseased areas.20  
A further application of QDs is the multiplexed optical encoding and high-
throughput analysis of genes and proteins. This involves embedding polystyrene beads 
with multicolor CdSe QDs at various color and intensity combinations.20 It is estimated 
that the use of six colors and 10 intensity levels can encode one million protein or nucleic 
acid sequences.20 Specific capturing molecules (such as peptides, proteins, and 
oligonucleotides) are then covalently linked to the beads and encoded by the bead’s 
spectroscopic signature.20 To read all of the QD-encoded beads, a single light source is all 
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that is required.20 To then determine whether an unknown analyte is captured or not, 
conventional assay methodologies are applied.20 This so-called ‘bar-coding’ technology 
can be used for gene profiling and high-throughput drug and disease screening. These 
‘bar-coding’ technologies offer significant advantages over planar chip devices, including 
improved kinetic binding and dynamic range.20 
Quantum dots can also help read DNA sequences.20,21 Recent research has found 
that by attaching QDs and antibodies to polymer microspheres, the prevalence of targeted 
DNA sequences can be read by a standard flow cytometer.21 The surface of each 
microsphere could also be covered with specific antibodies that would bind to particular 
protein sequences.21 This method has significant potential as it is currently being 
compared to immuno-assay fluorescence arrays.21  
Quantum dots can further be used to accurately identify specific types of cancer. 
To diagnose a specific cancer type, slides are made from tumor tissue samples and 
selective chemical stains highlight one specific feature at a time, such as nuclei or aster 
cells.19 Quantum dots can allow for the simultaneous marking of numerous features with 
different colors, thus improving the amount and speed of information received by 
oncologists.19 
Oncologists are also exploring the use of quantum dots to guide cancer surgery. 
The intensity of scattered luminescence can guide a surgeon to selectively remove only 
tagged diseased tissue beyond the primary tumor.19,22 Traditionally, a radioactive blue 
dye is used to track the flow of cancer cells through the lymph system.23 However, 
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ionizing radiation is hazardous to both the patient and medical caregivers.23 As a 
potentially safer alternative, near-infrared (λ is approximately 850 nm) QDs are being 
explored to mark cancerous lymph nodes for surgical removal from mice and pigs.23  
 
2.3 Optical Properties 
Despite the large number of potential QD applications in the medical field, the 
future work of this thesis focuses on the specific use of QDs in bio-imaging. Quantum 
dots are an emerging alternative to traditional organic dyes for solar cells and bio-
imaging primarily because of their (1) small size, (2) ability to tailor the chemistry of the 
QD surface, (3) high quantum efficiency, (4) narrow spectral linewidth, (5) broad 
absorption tail, (6) stable emission, and (7) long fluorescence lifetime. The ability to 
tailor the QD chemistry is beneficial because varying the size, shape, and composition of 
QDs allows for the production of materials with specific emissive, absorptive, and light-
scattering properties. This flexibility allows for the production of QDs whose emissive 
properties range across the entire visible spectrum from the same material. 
The terms quantum yield, quantum efficiency, and photoluminescence are used 
interchangeably throughout this thesis to represent the brightness of the QDs. The 
quantum yield refers to the existence of nonradiative transition of electrons and holes 
between energy levels. In other words, it is the ratio of emitted photons to absorbed 
photons.1,25 The quantum yield of QDs is significantly higher than organic dyes causing 
them to be advantageous for bio-imaging applications.26 This is because the molar 
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extinction coefficients of QDs are about 10-50 times larger than those for organic dyes 
(5-10 X 104 M-1cm-1).26 This causes the QD absorption rates to be 10-50 times faster at 
the same excitation photon flux than organic dyes.26 Due to this increased rate of light 
emission, individual QDs appear to be 10-20 times brighter than dyes.26 
One major disadvantage of organic dyes involves their broad, overlapping 
emission spectra that prevent their use in multicolor detection applications20,27 without 
the use of complex mathematical analysis of the data. Multicolor detection is used to 
track multiple molecular targets simultaneously using different colors and intensities, and 
is therefore a very important feature. For example, most complex human diseases such as 
cancer and atherosclerosis involve a large number of genes and proteins and would 
therefore require this type of detection.26 Quantum dots exhibit a narrow spectral 
linewidth6,28, typically one third that of a conventional organic dye, therefore making 
them very attractive for these types of applications (see Figure 2.3).29 A narrow spectral 
linewidth means that the QDs can only be excited within a narrow window of 
wavelengths.30 Consequently, QDs of different sizes and colors can be excited by a single 
wavelength shorter than their emission wavelengths, with minimum signal overlap.  
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Figure 2.3. Excitation (dotted line) and fluorescence (solid line) spectra of fluorescein (top) and a typical 
water-soluble QD (bottom).30 
 
The fluorescence peak of traditional organic dyes is very close to their absorption 
peak.19 This causes each dye to require its own expensive, carefully-tuned, sharp-cutoff 
filter to block the excitation background from the imaging camera.19 In contrast, QDs 
have a broad absorption tail over wavelengths shorter than the peak emission 
wavelength.19 A single common long pass filter and a single excitation source are 
therefore all that is required for QDs that emit in several distinct wavelength ranges.31  
QDs offer another advantage over organic dyes because their emission 
wavelengths can be continuously tuned by varying the particle size and chemical 
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composition. Additionally, QDs are about 100 times more stable against photobleaching 
(also called fading) than organic dyes.28,30 Moreover, QDs show long-term stability 
against photochemical and current-induced degradation.6 This extreme stability reflects 
the strong chemical bonding found in QDs and makes them very attractive for the 
imaging of thick masses over long periods of time.30 It also allows for the acquisition of 
real-time20 images that are bright and well contrasted.32 
Another interesting characteristic of QDs is their long fluorescence lifetime on the 
order of several to tens of nanoseconds.29 This allows time-delayed fluorescence 
measurements, which can be used to suppress the autofluorescence of biological 
matricies.29 Additionally, the long fluorescence lifetime facilitates the use of time-gated 
detection to separate their signal from that of shorted lived species.32 More specifically, 
time-gated detection provides a technique to separate the QD fluorescence from 
background fluorescence.  
 
2.4 Synthesis 
2.4.1 Synthetic Methods  
Since QD emission is size dependent, the synthesis process must be carefully 
controlled to achieve the targeted radius with a narrow size distribution. There are two 
main approaches for the synthesis of QD cores depending on the nature of the solvent: (1) 
the wet chemistry method, and (2) high temperature thermolysis of organometallic 
precursors.6,19,20,33,34 The wet-chemistry method uses low-temperature polar solvents such 
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as water or methanol, whereas the organometallic synthesis method uses high 
temperature, non-polar solvents such as trioctylphosphine oxide (TOPO). Typically, the 
wet chemistry method produces lower quality QDs with smaller and wider emission 
peaks as compared to those produced by the organometallic method.19,35 The QDs 
produced in this thesis were synthesized via the latter method. 
 
2.4.1.1 Wet Chemistry Method  
The wet chemistry method involves the deposition of a precursor material with a 
surfactant in a coordinating organic solvent.36 As the QDs grow, the organic solvent is 
naturally coordinated to the surface of the QDs and acts as a dispersant.36 Accordingly, 
the organic solvent allows the initial nucleus to grow to the level of nanometers.36 The 
wet chemistry method allows for the control of QD core size by varying the organic 
solvents used, reaction temperature, and reaction time.36,37  
The type of organic solvent used in the wet chemistry method is of the utmost 
importance. The ideal solvent should: (1) have the ability to be coordinated to the surface 
of the QD36, (2) be sufficiently bulky to the extent that it can control the growth rate of 
the cores36, (3) be stable at the crystal growth temperature36, and (4) be able to disperse 
the QDs in a state where the solvent is coordinated to the surface of the core.36 For 
example, in a study by Masala et al.35, two different solvents were investigated: 
ethylenediamine and pyridine. The QDs produced in the presence of ethylenediamine 
were small and uniform (approximately 4 nm – 6 nm in diameter), whereas QDs with 
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poor crystallinity and low yield resulted in the presence of pyridine.35 From these results, 
ethylenediamine was recommended as the organic solvent of choice for this QD synthesis 
method. 
Unfortunately, the synthesis temperature is limited by the boiling point of the 
organic solvent.35 When grown at a low temperature, QDs often have a poor degree of 
crystallinity35 as well as a high defect concentration19 leading to a low quantum 
efficiency. It is therefore necessary to choose a solvent with a higher boiling point to 
ensure that a high enough reaction temperature can be used to produce high quality QDs.  
The particle size distribution of QDs synthesized from the wet chemistry method 
is usually so wide that size-selective precipitation is required to separate a distribution 
into sections with narrow emission peaks.19,35 Additionally, this method typically yields 
QDs with very poor crystallinity35 and low quantum yield. For these reasons, the wet 
chemistry method was not investigated in this thesis. 
 
2.4.1.2 Thermoylsis of Organometallic Precursors 
The decomposition of molecular precursors at high temperatures in a coordinating 
solvent is one of the most successful and popular routes to prepare high-quality QDs.35 
This approach was first developed in 1993 by Bawendi et al. who prepared CdE QDs 
(E = Se, S, and Te) through separate, rapid injections of a solution of cadmiumdimethyl 
(CdMe2) in trioctylamine (TOA) and a solution of trioctylphosphine (TOP) and the 
corresponding chalcogenide (Se, S, or Te) into tri-n-octylphosphine oxide (TOPO) at 
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high temperatures (200 °C to 300 °C).7,8,35,38 The capping agent allowed particle stability 
in organic solvents, prevented particle aggregation, and electronically passivated the 
semiconductor surface.35  
This method, although successful at producing high-quality QDs, is hindered by 
the toxicity of the starting materials as well as the high temperature required by the 
reaction. In particular, the alkyl metal (CdMe2) is pyrophoric, explosive at high 
temperatures, and emits highly toxic gases of metal oxide.35 It was later found that 
cadmium oxide (CdO) and cadmium salts with an anion of a weak acid, such as cadmium 
acetate (Cd(Ac)2) and cadmium carbonate (CdCO3A), proved to be adequate 
substitutes.35,38-40 Compared to the highly unstable CdMe2, the cadmium salt substitutes 
offer several advantages, including: (1) the injection temperature can be much lower 
(220 °C to 300 °C), (2) both nucleation and growth are almost independent of injection 
therefore guaranteeing great reproducibility, and (3) the slow nucleation implies that the 
injection can be completed within a longer time, therefore allowing large amounts of 
stock solutions to be added to the reaction vessel, making the process more feasible for 
scale-up productions.35 
Today, a typical reaction involves the dissolution of the cadmium salt in a mixture 
of TOPO and another solvent (for example, amines such as n-dodecylamine, or fatty 
acids such as stearic acid) at 300 °C or below, followed by the addition of a solution of 
the chalcogenide (Se, S, or Te) in tri-n-octylphosphine (TOP).35,40 The chalcogenide and 
cadmium precursor combine to form stable nuclei that subsequently grow as the reaction 
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proceeds.40 At the growth temperature, surfactant molecules adsorb and desorb rapidly 
from the QD surface, enabling the addition (as well as removal) of atoms from the 
nanocrystal, while aggregation is suppressed by the presence of one monolayer of 
surfactant at the nanocrystal surface.41 The QDs resulting from this method are typically 
monodisperse, with sizes ranging from 2 nm to 25 nm and quantum efficiencies of up to 
85%.35 
Tri-n-octylphosphine is used as both a surfactant and selenium-delivery solvent 
when in the form of a trioctylphosphine selenium (TOPSe) solution during QD 
synthesis.42 During the synthesis process, TOP (a cationic precursor) coordinates to the 
chalcogenide (Se or S) ion.42 The phosphine then undergoes nucleophilic attack from 
either the carboxylic acid/phosphonic acid counter ion or excess TOP in solution, 
cleaving the P=Se bond.42 In this thesis, the cadmium precursor used was cadmium 
acetate (Cd(Ac)2) therefore the carboxylic acid provided the counter ion. The presence of 
a ligand during synthesis (especially oleic acid (OA)) induces P=Se cleavage.42 The 
presence of TOP on selenium rich surfaces has also been shown to be the source of 
enhanced fluorescence.42  
The organometallic synthesis method was developed8 to produce superior 
crystallinity and higher quantum yield43,44 from higher temperature reactions, and to 
provide better size control and surface passivation44,45 than other synthesis methods. At 
these higher temperatures, there is more thermal energy to help each add-atom find more 
energetically favorable bonding positions in the crystal lattice, therefore reducing defects 
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by annealing during growth, leading to increased overall quantum efficiency.19 Another 
advantage associated with the organometallic method is that a narrower size distribution 
of QDs may be achieved compared to other techniques because effective separation of 
the two synthesis stages (nucleation and growth) is achieved by the ‘hot injection 
technique.’34 The ‘hot injection technique’ involves the rapid injection of organometallic 
reagents into a hot coordinating solvent causing nucleation to immediately take place and 
continue until the temperature and ligand concentration drop below a critical 
threshold.8,46 The depletion of reagents through nucleation and the sudden temperature 
drop associated with the introduction of room temperature reagents prevents further 
nucleation8, thus yielding particles of one size.46 It is estimated that the diameter of CdSe 
QDs immediately after nucleation is about 1.75 nm and the fluorescence peak is around 
500 nm.47 The subsequent growth of the QD, however, resulted in the red shift of the 
fluorescence peak to green, yellow, and red as the size of the QD continued to 
increase.47,38 The ‘hot injection technique’ was utilized in this thesis. 
 
2.4.2 Impact of Reaction Parameters on the Synthesis of QDs 
For any method, experimental conditions are of the utmost importance when 
trying to produce QDs with consistent shape, crystal structure, and size. Alisvisatos et al. 
explored the CdSe system extensively to demonstrate that parameters such as 
temperature, ligand concentration, and growth rate significantly influence QD size and 
morphology.35,41,46 The size of the QDs can easily be tuned by controlling the reaction 
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temperature, with larger particles forming at higher temperatures.35 Spherical QDs were 
found to form at high ligand concentrations and slow growth rates, whereas rod-, 
teardrop-, and tetrapod-like shaped QDs formed at lower ligand concentrations and 
increased growth rates.35 It is most desirable to produce spherical QDs because they can 
achieve the highest quantum efficiency (85% for CdSe QDs7) as compared to 
significantly lower quantum efficiencies for the other morphologies (for example, rod-
shaped CdSe QDs can achieve a quantum efficiency as low as 1%41).  
As mentioned above, the temperature necessary to maintain steady growth 
increases with increasing QD size. More specifically, as the size distribution narrows, the 
reaction temperature must be raised to maintain steady growth.8 At these higher 
temperatures, the CdSe cores begin to grow via Ostwald ripening, and their size 
distribution deteriorates, leading to broader spectral line widths.33 In Ostwald ripening, 
the higher surface free energy of small QDs makes them less stable to dissolution in a 
solvent than larger QDs.8,20 This difference in stability results in the sacrifice of small 
particles to larger particles.8 In other words, larger particles grow and smaller particles 
dissolve, thus widening particle size distributions. When the size distribution begins to 
broaden, the temperature necessary for slow, steady growth drops.8 These lower 
temperatures can lead to the incomplete decomposition of the precursors or to reduced 
crystallinity of the surface monolayer of ligands.33 It is therefore necessary to determine 
the ideal growth temperature individually for each CdSe core size to ensure that the size 
distribution of the cores remains constant and that surface ligand layers with a high 
degree of crystallinity are formed.33  
21 
 
 
 
Ligand concentration also affects both the shape and size distribution of QDs. For 
diffusion-controlled growth, the distribution of incoming diffusion flux toward each 
nanocrystal depends strongly on the ligand concentration in the bulk solution.48 At high 
ligand concentrations, the chemical potential of the bulk solution is equally as high as the 
overall chemical potential of the entire crystal.48 In this type of environment, there is no 
net diffusion flux between the bulk solution and the diffusion sphere. To minimize the 
total surface energy of the nanocrystal, the ligands on each nanocrystal surface adjust 
their position which means a rod-shaped crystal will turn into a dot-shaped one.48 Ligand 
concentration also affects the size distribution of QDs. At higher ligand concentrations, 
the smaller particles grow faster than the larger ones, resulting in a nearly monodisperse 
size distribution.41 If the ligand concentration drops below a critical threshold, small QDs 
are depleted as larger ones grow and the distribution broadens41 similar to Ostwald 
ripening. Thus, the preparation of nearly monodisperse spherical QDs is best achieved at 
a high ligand concentration. 
Manipulation of the growth kinetics can offer further control over the shape of 
QDs. This is possible because the growth of CdSe QDs is highly anisotropic when the 
system is kinetically over-driven by a high ligand concentration.41 In addition to being 
anisotropic, CdSe has a unique c-axis which leads to faster growth along this axis when 
the overall growth rate is fast.41 When the growth rate is slow, a nearly spherical shape 
that minimizes surface area is favored.41 A slow reaction rate is preferred because it 
forms the thermodynamically favored sphere rather than the kinetically favored rod. 
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In addition to the experimental conditions discussed above, the precursor ratio 
(amount of Cd compared to amount of Se) plays a significant role in determining the 
emission properties of the synthesized QDs. In a study by Qu and Peng, Cd:Se ratios 
were varied between 2:1 and 1:10 to determine effect of initial precursor concentrations.7  
From their study it was concluded that the highest quantum yields resulted when there 
was an excess of one of the precursors.7 When either one of the precursors was initially in 
excess, the concentration of the reacting species in the solution was considered constant 
after the growth reaction proceeded for a short period of time.7 This provided a desirable 
condition for the construction of the most favorable surface structure/reconstruction for 
the QDs in solution.7 Thus, an excess of one of the precursors, either Cd or Se, is required 
to produce QDs with high quantum efficiency.  
 
2.4.3 Effect of Ligands on the Synthesis of QDs 
The quality of QD cores produced is also dependent on the molecule that binds to 
the central metal atom of the QD core by some attractive interaction, (chemisorption, 
electrostatic attraction, or hydrophobic interaction).31 This molecule is called a ligand. 
Typical CdSe QDs have a diameter between 2 nm to 5 nm, with approximately 100 to 
1600 CdSe ion pairs, and approximately 40 to 250 capping ligands on the QDs surface.49 
Ligands play at least four distinct roles in the overall electronic function of the QDs. 
First, they are present during the nucleation process and determine the reactivity and 
availability of the crystal precursors and ligands.50 Second, they control the rate of 
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growth and final particle size distribution50 by keeping the particles isolated and 
facilitating homogenous growth during synthesis.19 Third, they provide colloidal stability, 
preventing aggregation and growth.31,50,51 Lastly, they interact electronically with surface 
sites and may passivate defects on the surface of QDs.19  
Defects exist on the surface of QDs due to the large surface-to-volume ratio of 
QDs45,52,53 which causes the formation of dangling bonds from some of the surface 
atoms.7 Ligands serve to donate electrons to, or accept electrons from, these dangling 
bonds of incompletely coordinated metal ions (Cd2+ sites are electron acceptors, and Se2- 
are electron donors) in order to preserve the core character of the QD.53,54 The surface 
defects often act as nonradiative recombination sites for electron-hole pairs produced by 
incident excitation light, thereby reducing the quantum efficiency of the QDs.7,55 In CdSe 
QDs, these nonradiative traps are positioned above the valence band.45 Ligands passivate 
varying amounts of these surface defects to influence the quantum efficiency of the QDs. 
If the surface ligand provides good passivation of surface defects, high quantum 
efficiency is expected.   
The nature and density of the surface trapping sites depends strongly on the 
surface structure and shape of the QD, along with the nature of the defect sites on the QD 
surface.7,31 Furthermore, the atomic configuration of the QD surface significantly affects 
the degree of passivation provided by the ligands.7 This can be visualized by considering 
the steric effect of the surface configuration of the QDs on the packing of the surface 
ligands.7 Thus, the surface structure of QDs also plays a role in determining quantum 
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yield. The shape of the QD dictates the number of atoms on the QD surface and therefore 
the number of potential surface trapping sites. Figure 2.4 below illustrates the fraction of 
surface atoms on a CdSe QD for different shapes. Spherical QDs have the smallest 
number of total surface atoms and are thermodynamically the most stable.56 It is 
estimated that approximately 56% of the atoms in a 3 nm spherical QD are at the 
surface.54 On the other hand, elongated structures, such as rods and wires, maintain a 
larger fraction of their constituent atoms on their surfaces. Thus, spherical particles have 
the least amount of potential defect sites on their surface causing them to have the highest 
quantum yield potential and therefore be the most desirable.  
 
Figure 2.4. Fractions of atoms on the CdSe QD surface plotted against the total number of atoms. The wires 
(purple) are 1 μm in length, the disks (green) are 20 nm in length, and the spheres (blue) and rods (red) are 
4 nm in diameter.56 
 
Because ligands play such a vital role on the overall quality of QDs, numerous 
efforts have been made to synthesize high quality spherical CdSe QDs using different 
capping ligands. Although there are several different types of ligands, this thesis 
25 
 
 
 
investigates the effect of two, oleic acid (OA) and oleylamine, which are discussed in 
further detail below. 
 
2.4.3.1 Oleic Acid (OA) 
As described above, a popular method of producing QD cores via the 
organometallic method involves the use of tri-n-octylphosphine oxide (TOPO) as the 
ligand of choice. Although nearly monodisperse QDs with high quantum yield were 
obtained with TOPO, it is expensive, hazardous, and toxic.57 Additionally, due to varying 
amounts of impurities in commercially obtained TOPO, it is difficult to consistently 
produce high-quality QDs using various TOPO batches. Oleic acid (OA) was chosen 
instead of TOPO as one of the ligands investigated in this thesis as it is an 
environmentally friendly, cheaper, and a safer capping ligand.57 
Research has shown that OA can yield much more stable QDs than other 
saturated fatty acids.58,59 This higher stability is attributed to the amorphous structure of 
the ligand layer which is less permeable to oxygen than a crystalline ligand layer.58 More 
specifically, crystalline packing of the hydrocarbon chains of the ligand creates gaps 
between each crystalline domain.58 These gaps act as the diffusion channels for oxygen 
molecules, consequently making the QDs less stable if they are coated with ligands with 
a saturated hydrocarbon chain.58 The stability of OA is also attributed to the double bond 
and associated ‘kink’ in its alkyl chain which serves to impart colloidal stability.42 Oleic 
acid further provides better protection against oxidation and emission loss than other 
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ligands with 18 carbons, including stearic acid and octadecylamine (ODA).19 This higher 
stability of QDs capped with OA was attributed to the amorphous structure of the OA 
ligand layer.19 
  
2.4.3.2 Oleylamine  
In a study conducted by Talapin et al. it was found that smaller QDs with better 
size distributions were achieved when amines (such as oleylamine) were used as 
stabilizing and size-regulating ligands than the commonly used TOPO.45 Additionally, 
amines provided much better passivation of the defects on the surface of QDs leading to 
non-radiative recombination.45 Research has consistently shown that for both CdS and 
CdSe QDs, direct interaction between the QD surface and amine ligand effectively 
passivates the QD surface and blocks the trapping of electrons at the defect sites therefore 
leading to high quantum efficiecy.60 The use of amines as capping ligands on CdSe QDs 
has also been shown to result in a surface reconstruction, specifically a lattice contraction 
during growth, which also may contribute to the elevated quantum efficiency.42  
The proper choice of amine is important in producing high quality QDs. In 
general, less sterically hindered amines create higher capping densities, which leads to 
improved surface capping and, hence, better passivation of traps.45 The boiling point of 
the chosen amine is also of importance as it can potentially limit its use. For example, the 
relatively low boiling point (~175 °C) of octylamine prevents its use in CdSe QD 
reactions, as they require a temperature of approximately 300 °C.45 Octylamine was 
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further ruled out as a capping ligand because QDs were found to have a tendency to 
partially precipitate from solution during heating.45 The use of secondary amines 
(including dioctylamine) was also found to be inadequate for QD synthesis because they 
resulted in a very weak stabilization and poorly controlled growth of the QDs.45 For this 
thesis, the amine ligand of choice was oleylamine because it has been shown to produce 
high quality QDs, is cost effective, and safe to handle. 
During the synthesis of QDs, the trioctylphosphine (TOP) and chalcogenide 
(either Se or S) solution is rapidly injected into the ligand and cadmium precursor 
solution to begin the growth process of the QD core. After this injection, the solution 
color may change based on ligand stability. For example, the TOPSe/TOPS solution is 
very stable in oleylamine due to hydrogen bonding, therefore the color is not expected to 
change.61 Because oleylamine is a very stable ligand, the growth rate of the QDs is much 
slower, resulting in spherical nanoparticles with a uniform size distribution.61 FTIR 
spectra on oleylamine-capped CdSe QDs suggested that oleylamine binds through 
donation of the lone pair of electrons from the nitrogen atom to both cadmium and 
selenium surface sites.42 Amines are expected to bind to selenium sites preferentially over 
cadmium sites due to the higher binding energy for selenium terminated sites over 
cadmium terminated sites, 1.05 eV compared to 0.91 eV, respectively.42 
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2.4.4 Effect of Solvent 
2.4.4.1 Non-Coordinating Solvent 
 The non-coordinating solvent mixture strongly affects nucleation, which in turn 
affects QD growth. This thesis investigates the effect of the coordinating properties of 
two different solvents when coupled with oleic acid: non-coordinating octadecene 
(ODE), and weakly-coordinating trioctylamine (TOA).  
Octadecene is a non-coordinating solvent that provides an environment for 
particle nucleation and growth.40,62 ODE has a relatively low melting point (below 
20 °C), relatively high boiling point (about 320 °C), low cost, low toxicity, low reactivity 
to precursors, and excellent solvation power for many compounds at elevated 
temperatures.62,63 Each of these factors makes ODE an ideal solvent for the growth of 
high-quality QDs. Research has shown that nucleation of CdSe QDs from ODE is very 
fast and stops almost immediately after precursor injection.40,62 It is estimated that when 
ODE is used, nucleation and growth is completed within the first 100 s of the reaction.40 
Because nucleation and growth happen so fast, QDs with a very narrow size distribution 
are formed in the presence of ODE. Additionally, it has been found that QDs prepared in 
ODE had a spherical shape.61 
In a study where CdS QDs were formed in the presence of OA coupled with 
ODE, the amount of nuclei formed during the reaction could be controlled.42 When too 
many nuclei were formed, the size distribution of QDs was defocused due to Ostwald 
ripening.42 Conversely, when there were too few nuclei, particle growth was too fast to 
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reach the required size distribution.42 The balance between these two extremes was able 
to be achieved by altering the concentration of the capping ligand (OA) and thus the 
amount of metal complex available for the reaction through control of the amount of 
ODE.42  Using ODE as a solvent also allows control over particle size, making it further 
advantageous.42 
 Unlike ODE, TOA is a weakly-coordinating solvent61, therefore it contains some 
coordinating groups. Similar to ODE, research has shown that in the presence of TOA, 
spherical QDs formed.61 Although little literature exists on TOA, this thesis sets out to 
compare the quantum yield of QDs prepared in the presence of TOA to those prepared in 
ODE. 
 
2.4.4.2 Dispersion Solvent 
Depending on the application, QDs may need to be suspended in a particular 
solvent. For example, biomedical applications typically require aqueous environments. 
Quantum dots synthesized from the wet chemistry method are soluble in water and other 
polar solvents. Those made from the organometallic synthesis, on the other hand, are 
soluble in a variety of volatile non-polar organic solvents because of the residual non-
polar organic ligands bonded to the QD surface.19 The QDs studied in this thesis were 
synthesized via the organometallic method, therefore the focus of this section will be on 
non-polar solvents, specifically chloroform and toluene. 
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 The dispersion solvent has an effect on the optical properties of the QDs. In a 
study conducted by Bullen et al., it was observed that chloroform yielded greater 
photoluminescence intensity than toluene.50 This difference in photoluminescence may be 
due to changes in the dissolved oxygen concentration in the different solvents.50 Oxygen 
is more soluble in chloroform than toluene.50 The concentration of oxygen at 20 °C is 
8.63 mM in toluene and 11.6 mM in chloroform.50 This suggests that the primary effect 
of solvent changes is to alter the degree of adsorption of passivating ligands on the QD 
surfaces.50 When the solvent in which the QDs are dissolved is altered, the adsorption 
isotherm adjusts.50 If the ligand is more soluble in the new medium, desorption occurs.50 
If the ligand is less soluble, it will tend to adsorb from solution and may enhance the 
luminescence even further.50 The as synthesized QDs with OA and oleylamine as the 
capping ligands are non-polar.  Consequently, QDs are more soluble in nonpolar solvents 
such as toluene, hardly soluble in chloroform, and insoluble in n-butanol and water.64,65 
In other words, because the QDs are less soluble in chloroform than toluene, it is 
expected that they will exhibit higher quantum efficiency when dissolved in chloroform. 
Quantum dot concentration in a dispersion solvent affects quantum efficiency. In 
general, the more concentrated the QD concentration, the higher the quantum efficiency. 
This trend is explained by the effect of dilution on the surface chemistry of the QD. 
Assuming a simple reversible equilibrium exists between ligands adsorbed to the QD 
surface and free ligands in solution, a proposed reaction is66: 
 [Cd–L]  [Cd] + [L]          (1) 
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where [Cd–L] is the concentration of Cd sites bound to ligand in solution, [Cd] is the 
concentration of empty binding sites, and [L] is the concentration of free ligand in 
solution.66 Because the proposed reaction is reversible, after dilution in a solvent the QDs 
and ligands should re-establish equilibrium and the fraction of bound surface sites should 
decrease.66 For this reason, decreased quantum efficiency is expected with decreasing QD 
concentration.66 
 
2.4.5 Separation of Cores from Reaction Solution 
 After synthesis, it is possible to precipitate QDs of a specific size from solution 
through the addition of methanol. The addition of methanol increases the average polarity 
of the solvent and reduces the energetic barrier to flocculation.8 Flocculation differs from 
precipitation because the colloids are suspended in a liquid prior to separation rather than 
actually dissolved in the solution. The largest particles in a dispersion experience the 
greatest attractive forces and therefore have a higher probability of overcoming the 
reduced barrier.8 For this reason, the large particles are enriched in the flocculate 
produced and it is possible to remove a specific subset of particles from the solution.8 In 
this thesis, methanol was used to precipitate cores of a specific size distribution. 
 
2.5 Surface Treatment  
As previously explained, the surface of QDs is coated with passivating ligands 
that stabilize the growing particle, sustain their dispersion in solution, and minimize the 
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number of surface atoms with reduced coordination number.67 Often, the surface 
coverage is incomplete and the unbound surface atoms constitute a distribution of 
localized sites that carry slight positive or negative charge.67 These sites act as 
inhomogeneous defects and are capable of trapping electrons or holes, preventing their 
radiative recombination32 and lowering the quantum efficiency.67,68 In addition to proper 
choice of ligand, these defect sites can be passivated through the addition of a reducing or 
oxidizing agent. 
In a specific instance, Jang treated cadmium sulfide (CdS) QDs with sodium 
borohydride (NaBH4). Sodium borohydide is a widely used reducing agent that is both 
inexpensive and safe with regards to storage and handling.69 The quantum efficiency of 
the CdS QDs increased from 1.4 % to 78 % after treatment, which is a 54 fold 
improvement.70 Additionally, they found that the shape and size of the QDs did not 
change after treatment, according to transmission electron microscopy (TEM) images.70 
Figure 2.5 illustrates these findings. Jang and coworkers concluded that treatment of the 
QDs with NaBH4 caused oxidation of the QD surfaces. The NaBH4 reduced the oleic acid 
surfactants to the corresponding alcohols or sodium salts which caused the ligands to lose 
their coordinating properties and detach from the nanocrystal surface.70 Oxygen (from 
atmospheric air) then diffused to the exposed cadmium on the QD surface to form a 
cadmium oxide (CdO) layer around the CdS QD surface.70 This CdO layer effectively 
passivated the surface defects, resulting in a nanocrystal with an enhanced quantum 
yield.70 They further concluded that because the treatment was independent of reaction 
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conditions and reagents, it would have similar effects for other II-VI QDs (including 
CdSe).70  
 
Figure 2.5. UV absorbance spectra and photoluminescence spectra of the original and NaBH4 treated CdS 
QDs excited at 365 nm. Inset: photos taken under a 365 nm UV lamp (left, original; right, treated with 
NaBH4) and HR-TEM images (left, original; right, treated with NaBH4) of the QDs in toluene.70 
 
Jang et al. expanded on their work to include cadmium telluride (CdTe) QDs 
produced via the wet-chemistry method. Ma et al. found that after NaBH4 surface 
treatment, the photostability of the QDs as well as the quantum efficiency were 
improved.71 These results successfully demonstrated that the NaBH4 treatment can be 
extended to water-soluble QDs because NaBH4 is also water-soluble.71 With their data, 
they generated an XPS spectrum which confirmed that a CdO layer formed around the 
QD surface, as proposed by Jang.71 Due to the formation of this CdO layer, the surface 
defects were effectively passivated and the quantum efficiency of the treated cores was 
double that of the untreated cores.71 This increased quantum efficiency was justified due 
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to the fact that CdO has a valence binding energy of 5.4 eV, which is higher than the 
CdTe bandgap energy (Eg = 1.44 eV), therefore resulting in effective surface 
passivation.71 Surface treatment did not change the size of the QDs (and therefore color 
emitted), however, as confirmed by the consistency of the peak wavelength (585 nm) and 
bandwith (40 nm) of the treated and untreated cores.71  
The CdO layer formed on the QD surface was also shown to shield the oxygen 
molecules from interacting with the QD core and preventing photo-oxidation.71 A total 
internal reflection fluorescence microscope (TIRFM) quantitatively illustrated that the 
original QDs were notably photobleached, while those treated with NaBH4 were much 
more photostable.71 The decay times were estimated to be 5.4 s and 32.7 s, for untreated 
and treated QDs, respectively, providing further evidence of the photostability of QDs by 
surface treatment.71 Good photostability of QDs is required for their application as 
fluorescent probes to label targets in biological systems, specifically for experiments with 
long-term imaging.71 
In the surface treatment of QDs, the amount of NaBH4 added as well as the 
reaction time is very important. An excess amount of NaBH4 and/or prolonged reaction 
time can result in the detachment of ligands from the QD core, resulting in the 
aggregation and precipitation of QDs.71 Because of this strong dependence, these two 
reaction parameters will be explored in this thesis. Additionally, this thesis will evaluate 
the effect of other reducing agents (including calcium hydride (CaH2) and hydrazine 
(N2H4)), as well as two oxidizing agents (including benzoyl peroxide (C14H10O4) and tert-
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butyl hydroperoxide (C4H10O2)) to develop more robust methods to alter the surface 
chemistry of CdSe and CdS QDs.  
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Chapter 3. Materials and Methods 
Chapter 3 will summarize the materials used and experimental methods practiced 
to complete the experimental work of this thesis. Specifically, this chapter is divided into 
several sections that will present the procedures used to synthesize CdSe and CdS QDs 
from two different ligands (oleylamine and oleic acid) as well as two non-coordinating 
solvents (octadecence (ODE) and trioctylamine (TOA)). Methods used to treat the 
surface of the as-synthesized QDs with various reducing/oxidizing agents will then be 
presented followed by the characterization techniques applied to evaluate the effect of 
each surface treatment. Lastly, the methods which quantum yield and bandgap energy 
(Eg) were calculated are presented. 
 
3.1 Materials 
3.1.1 Quantum Dot Core Synthesis with Oleylamine 
 The materials used to synthesize quantum dot cores include a glass vial (5 mL), 
plastic cap for the vial, a 50 mL round-bottom flask, a 50 mL centrifuge tube, 5 mL 
Norm-Ject® disposable syringes, syringe needles (21 G x 1½ in from Becton-Dickinson), 
stir bars, selenium (Acros Organics, 99.5+%), sulfur (E.M. Science), dihydrate cadmium 
acetate (Sigma-Aldrich, reagent grade, 98%), trioctylphosphine (TOP) (Sigma-Aldrich, 
90%), oleylamine (Aldrich Chemical Company), and methanol (Aldrich Chemical 
Company, 99+%). A CEM microwave (Discover System Model, 908005) was used to 
heat the solution and facilitate the reaction. A Thermo Electron Corporation centrifuge 
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(Centra CL5R) and centrifuge tubes were used to separate the cores from solution, an 
Entela ultraviolet light (UVGL) was used to provide a long-wave (365 nm) ultraviolet 
light to test sample fluorescence, and a Shel Lab vacuum oven was used to dry the 
sample. 
 
3.1.2 Quantum Dot Core Synthesis with Oleic Acid and ODE 
 The materials used to synthesize quantum dot cores include a glass vial (5 mL), 
plastic cap for the vial, a 50 mL round-bottom flask, a 50 mL centrifuge tube, 5 mL 
Norm-Ject® disposable syringes, syringe needles (21 G x 1½ in from Becton-Dickinson), 
stir bars, selenium (Acros Organics, 99.5+%), sulfur (E.M. Science), dihydrate cadmium 
acetate (Sigma-Aldrich, reagent grade, 98%), trioctylphosphine (TOP) (Sigma-Aldrich, 
90%), oleic acid (Aldrich Chemical Company), octadecene (ODE) (Sigma-Aldrich, 
technical grade, 90%), and methanol (Aldrich Chemical Company, 99+%). A CEM 
microwave (Discover System Model, 908005) was used to heat the solution and facilitate 
the reaction. A Thermo Electron Corporation centrifuge (Centra CL5R) and centrifuge 
tubes were used to separate the cores from solution, an Entela ultraviolet light (UVGL) 
was used to provide a long-wave (365 nm) ultraviolet light to test sample fluorescence, 
and a Shel Lab vacuum oven was used to dry the sample. 
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3.1.3 Quantum Dot Core Synthesis with Oleic Acid and TOA 
 The materials used to synthesize quantum dot cores include a glass vial (5 mL), 
plastic cap for the vial, a 50 mL round-bottom flask, a 50 mL centrifuge tube, 5 mL 
Norm-Ject® disposable syringes, syringe needles (21 G x 1½ in from Becton-Dickinson), 
stir bars, selenium (Acros Organics, 99.5+%), sulfur (E.M. Science), dihydrate cadmium 
acetate (Sigma-Aldrich, reagent grade, 98%), trioctylphosphine (TOP) (Sigma-Aldrich, 
90%), oleic acid (Aldrich Chemical Company), trioctylamine (TOA) (Aldrich, 98%), and 
methanol (Aldrich Chemical Company, 99+%). A CEM microwave (Discover System 
Model, 908005) was used to heat the solution and facilitate the reaction. A Thermo 
Electron Corporation centrifuge (Centra CL5R) and centrifuge tubes were used to 
separate the cores from solution, an Entela ultraviolet light (UVGL) was used to provide 
a long-wave (365 nm) ultraviolet light to test sample fluorescence, and a Shel Lab 
vacuum oven was used to dry the sample. 
 
3.1.4 Surface Treatment with Reducing/Oxidizing Agents 
 The materials used to treat the QD cores with various reducing and oxidizing 
agents include 7 mL glass vials, a 1,000 µL Eppendorf pipette, pipette tips, spectroscopic 
grade toluene (J.T. Baker), and spectrophotometric grade chloroform (Sigma-Aldrich, 
99.8%). The reducing agents used include sodium borohydride (NaBH4) (Sigma-Aldrich, 
98.5%), benzoyl peroxide (C14H10O4) (Aldrich, 97%), calcium hydride (CaH2) (Sigma-
Aldrich, 90-95%), tert-butyl hydroperoxide (C4H10O2) (Aldrich, 70 wt% in water), and 
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hydrazine (N2H4) (Sigma-Aldrich, 98%). Ultra-violet visible spectroscopy (UV-Vis) and 
fluorescence spectroscopy were performed using a Spectramax M5 Multi-Mode 
Microplate Reader (Molecular Devices) to measure sample absorbance and fluorescence, 
respectively. A Rotovapor R-210 (Buchi) was used to remove various solvents to isolate 
the cores. Lastly, a Entela ultraviolet light (UVGL) was used to provide a long-wave 
(365 nm) ultraviolet light to test sample fluorescence. 
 
3.2 Methods 
3.2.1 CdSe Quantum Dot Core Synthesis with Oleylamine 
The first step in the synthesis of CdSe quantum dot cores with oleylamine 
involves carrying out two reactions in parallel. The first reaction is between selenium and 
trioctylphosphine (TOP); the second is cadmium acetate with oleylamine (Figure 3.1).  
 
Figure 3.1. Synthetic scheme for the synthesis of CdSe quantum dot cores with oleylamine. 
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The Se/TOP reaction was carried out in a flame-dried 5 mL glass vial while the 
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were 
capped to ensure that the environment was rid of oxygen and water. The liquids were 
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject® 
disposable syringes and syringe needles. The quantity of reactants used in the reactions 
was dependent on the batch size (see Table 3.1 below).  
Table 3.1. Quantity of reactants required for various batch sizes. 
Batch Size 
Selenium TOP Cadmium Acetate Oleylamine 
g mol x 104 mL mol x 104 g mol x 104 mL mol x 102 
1X 0.008 1.06 0.04 0.897 0.025 0.94 1.50 0.46 
2X 0.015 1.87 0.70 15.7 0.050 1.88 3.30 1.00 
5X 0.039 4.88 2.00 44.8 0.125 4.69 7.50 2.28 
10X 0.077 9.75 4.00 89.7 0.250 9.38 15.0 4.56 
 
The solids in both solutions were dissolved by gently swirling with heating. It was 
important not to boil the solution during this step. Once the solids completely dissolved, a 
stir bar was added to the vial containing the Se/TOP mixture and placed in the CEM 
microwave at the settings summarized below. The settings of the CEM microwave were 
controlled by Synergy software.  
a. Temperature: 120 °C 
b. Power: 300 Watts 
c. Ramp Time: 2 min 
d. Hold Time: 30 s 
e. Stirring: High 
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Once the reaction was complete, the vial was removed from the microwave. A stir 
bar was added to the round-bottom flask containing the oleylamine and cadmium acetate 
mixture and placed in the microwave. As with reactant quantities, the microwave settings 
were adjusted with batch size (see Table 3.2). During the reaction, the round-bottom flask 
was purged with dry nitrogen. 
Table 3.2. Microwave settings for various batch sizes. 
Batch Size Step Power (W) Temperature (°C) Ramp (min) Hold (min) 
1X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
2X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
5X 1 300 100 3:00 0:10 
 2 300 150 2:00 1:30 
10X 1 300 100 3:00 0:10 
 2 300 150 2:00 1:30 
 
When the temperature of the reaction reached 120 °C during the second heating step, the 
microwave was paused and the pre-heated Se/TOP mixture was injected into the round-
bottom flask using a disposable syringe and needle. After the reaction was complete and 
the round-bottom flask cooled to room temperature, the solution was examined under the 
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the 
above table, the cores will fluoresce a yellow or reddish color.  
The excess oleylamine and unreacted cadmium precursor were separated from the 
QDs by extraction of the reaction solution with a volume of methanol equivalent to 4 
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times the reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The 
centrifuge tube was gently shaken to start this precipitation before being placed in the 
Thermo Electron Corporation centrifuge. A centrifuge tube containing water of an equal 
volume was placed opposite the solution in the blue centrifuge tube holder. The 
centrifuge was run for 5 min at a 25 °C and a speed of 4500 relative centrifugal force 
(RCF). Once the separation was complete, the QD cores were visibly separated from the 
methanol. The methanol was then poured from the tube and disposed. Finally, the newly 
synthesized cadmium selenide cores were dried over night under vacuum (4000 Pa) at 
room temperature. 
 
3.2.2 CdS Quantum Dot Core Synthesis with Oleylamine 
The first step in the synthesis of CdS quantum dot cores with oleylamine involves 
carrying out two reactions in parallel. The first reaction is between sulfur and 
trioctylphosphine (TOP); the second is cadmium acetate with oleylamine (see Figure 
3.2). 
 
Figure 3.2. Synthetic scheme for the synthesis of CdS quantum dot cores with oleylamine. 
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The S/TOP reaction was carried out in a flame-dried 5 mL glass vial while the 
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were 
capped to ensure that the environment was rid of oxygen and water. The liquids were 
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject® 
disposable syringes and syringe needles. The quantity of reactants used in the reactions 
was dependent on the batch size (see Table 3.3 below).  
Table 3.3. Quantity of reactants required for various batch sizes. 
Batch Size 
Sulfur TOP Cadmium Acetate Oleylamine 
g mol x 104 mL mol x 104 g mol x 104 mL mol x 102 
1X 0.008 2.62 0.040 0.897 0.025 0.94 1.50 0.456 
2X 0.015 4.61 0.700 15.7 0.050 1.88 3.30 1.00 
5X 0.039 12.0 2.00 44.8 0.125 4.69 2.00 0.608 
10X 0.077 24.0 4.00 89.7 0.250 9.38 15.0 4.56 
 
The solids in both solutions were dissolved by gently swirling with heating. It was 
important not to boil the solution during this step. Once the solids completely dissolved, a 
stir bar was added to the vial containing the S/TOP mixture and placed in the CEM 
microwave at the settings summarized below. The settings of the CEM microwave were 
controlled by Synergy software.  
a. Temperature: 120 °C 
b. Power: 300 Watts 
c. Ramp Time: 2 min 
d. Hold Time: 30 s 
e. Stirring: High 
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Once the reaction was complete, the vial was removed from the microwave. A stir 
bar was added to the round-bottom flask containing the oleylamine and cadmium acetate 
mixture and placed in the microwave. As with reactant quantities, the microwave settings 
were adjusted with batch size (see Table 3.4). During the reaction, the round-bottom flask 
was purged with dry nitrogen. 
Table 3.4. Microwave settings for various batch sizes. 
Batch Size Step Power (W) Temperature (°C) Ramp (min) Hold (min) 
1X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
2X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
5X 1 300 100 3:00 0:10 
 2 300 175 2:00 1:30 
10X 1 300 100 3:00 0:10 
 2 300 200 2:00 1:30 
 
When the temperature of the reaction reached 120 °C during the second heating step, the 
microwave was paused and the pre-heated S/TOP mixture was injected into the round-
bottom flask using a disposable syringe and needle. After the reaction was complete and 
the round-bottom flask cooled to room temperature, the solution was examined under the 
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the 
above table, the cores will fluoresce a yellow color.  
The excess oleylamine and unreacted cadmium precursor were separated from the 
QDs by extraction of the reaction solution with a volume of methanol equivalent to 4 
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times the reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The 
centrifuge tube was gently shaken to start this precipitation before being placed in the 
Thermo Electron Corporation centrifuge. A centrifuge tube containing water of an equal 
volume was next placed opposite the solution in the blue centrifuge tube holder. The 
centrifuge was run for 5 min at a 25 °C and a speed of 4500 relative centrifugal force 
(RCF). Once the separation was complete, the QD cores were visibly separated from the 
methanol. The methanol was then poured from the tube and disposed. Finally, the newly 
synthesized CdS cores were dried over night under vacuum (4000 Pa) at room 
temperature. 
 
3.2.3 CdSe Quantum Dot Core Synthesis with Oleic Acid and Octadecene 
The first step in the synthesis of CdSe quantum dot cores with oleic acid (OA) 
and octadecene (ODE) involves carrying out two reactions in parallel. The first reaction 
is between selenium and trioctylphosphine (TOP); the second is cadmium acetate, OA, 
and ODE (see Figure 3.3). 
 
Figure 3.3. Synthetic scheme for the synthesis of CdSe quantum dot cores with OA and ODE. 
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The Se/TOP reaction was carried out in a flame-dried 5 mL glass vial while the 
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were 
capped to ensure that the environment was rid of oxygen and water. The liquids were 
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject® 
disposable syringes and syringe needles. The quantity of reactants used in the reactions 
was dependent on the batch size (see Table 3.5 below).  
Table 3.5. Quantity of reactants required for various batch sizes. 
Batch 
Size 
Selenium TOP Cadmium Acetate OA ODE 
g mol  x 104 mL 
mol 
x 104 g 
mol 
x 104 mL 
mol 
x 102 mL 
mol 
x 103 
1X 0.008 1.06 0.04 0.897 0.025 0.938 1.00 0.317 0.50 1.56 
2X 0.015 1.87 0.70 15.7 0.050 1.88 2.00 0.634 1.00 3.13 
5X 0.039 4.88 2.00 44.8 0.125 4.69 5.00 1.58 2.50 7.81 
10X 0.077 9.75 4.00 89.7 0.250 9.38 10.0 3.15 5.00 15.6 
 
The solids in both solutions were dissolved by gently heating. It was important 
not to boil the solution during this step. Once the solids completely dissolved, a stir bar 
was added to the vial containing the Se/TOP mixture and placed in the CEM microwave 
at the settings summarized below. The settings of the CEM microwave were controlled 
by Synergy software.  
a. Temperature: 120 °C 
b. Power: 300 Watts 
c. Ramp Time: 2 min 
d. Hold Time: 30 s 
e. Stirring: High 
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Once the reaction was complete, the vial was removed from the microwave. A stir 
bar was added to the round-bottom flask containing the OA, ODE, and cadmium acetate 
mixture and placed in the microwave. As with reactant quantities, the microwave settings 
were adjusted with batch size (see Table 3.6). During the reaction, the round-bottom flask 
was purged with nitrogen. 
Table 3.6. Microwave settings for various batch sizes. 
Batch Size Step Power (W) Temperature (°C) Ramp (min) Hold (min) 
1X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
2X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
5X 1 300 100 3:00 0:10 
 2 300 150 2:00 1:30 
10X 1 300 100 3:00 0:10 
 2 300 150 2:00 1:30 
 
When the temperature of the reaction reached 120 °C, the microwave was paused and the 
pre-heated Se/TOP mixture was injected into the round-bottom flask using a disposable 
syringe and needle. After the reaction was complete and the round-bottom flask cooled to 
room temperature, the solution was examined under the UV long-wave light to ensure 
that it fluoresced. Based on the settings specified in the above table, the cores will 
fluoresce a yellowish color.  
The excess OA and unreacted cadmium precursor were separated from the QDs 
by extraction of the reaction solution with a volume of methanol equivalent to 4 times the 
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reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The centrifuge 
tube was gently shaken to start the precipitation, the cap was removed from the tube, and 
the solution was left until it separated into two distinct layers. The top layer composed of 
methanol and excess unreacted ligand was removed from the centrifuge tube and 
discarded using a pipette. Following the same procedure, the QD cores were washed a 
second time with methanol. Finally, the newly synthesized CdSe cores were dried over 
night under vacuum (4000 Pa) at room temperature. 
 
3.2.4 CdS Quantum Dot Core Synthesis with Oleic Acid and Octadecene 
The first step in the synthesis of CdS quantum dot cores with oleic acid (OA) and 
octadecene (ODE) involves carrying out two reactions in parallel. The first reaction is 
between sulfur and trioctylphosphine (TOP); the second is cadmium acetate, OA, and 
ODE (see Figure 3.4). 
 
Figure 3.4. Synthetic scheme for the synthesis of CdS quantum dot cores with OA and ODE. 
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The S/TOP reaction was carried out in a flame-dried 5 mL glass vial while the 
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were 
capped to ensure that the environment was rid of oxygen and water. The liquids were 
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject® 
disposable syringes and syringe needles. The quantity of reactants used in the reactions 
was dependent on the batch size (see Table 3.7 below).  
Table 3.7. Quantity of reactants required for various batch sizes. 
Batch 
Size 
Sulfur TOP Cadmium Acetate OA ODE 
g mol x 104 mL 
mol 
x 104 g 
mol 
x 104 mL 
mol 
x 102 mL 
mol 
x 103 
1X 0.008 2.62 0.04 0.897 0.025 0.938 1.00 0.317 0.50 1.56 
2X 0.015 4.61 0.70 15.7 0.050 1.88 2.00 0.634 1.00 3.13 
5X 0.039 12.0 2.00 44.8 0.125 4.69 5.00 1.58 2.50 7.81 
10X 0.077 24.0 4.00 89.7 0.250 9.38 10.0 3.15 5.00 15.6 
 
The solids in both solutions were dissolved by gently swirling with heating. It was 
important not to boil the solution during this step. Once the solids completely dissolved, a 
stir bar was added to the vial containing the S/TOP mixture and placed in the CEM 
microwave at the settings summarized below. The settings of the CEM microwave were 
controlled by Synergy software.  
a. Temperature: 120 °C 
b. Power: 300 Watts 
c. Ramp Time: 2 min 
d. Hold Time: 30 s 
e. Stirring: High 
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Once the reaction was complete, the vial was removed from the microwave. A stir 
bar was added to the round-bottom flask containing the OA, ODE, and cadmium acetate 
mixture and placed in the microwave. As with reactant quantities, the microwave settings 
were adjusted with batch size (see Table 3.8). During the reaction, the round-bottom flask 
was purged with nitrogen. 
Table 3.8. Microwave settings for various batch sizes. 
Batch Size Step Power (W) Temperature (°C) Ramp (min) Hold (min) 
1X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
2X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
5X 1 300 100 3:00 0:10 
 2 300 185 2:00 1:30 
10X 1 300 100 3:00 0:10 
 2 300 190 2:00 1:30 
 
When the temperature of the reaction reached 120 °C during the second heating step, the 
microwave was paused and the pre-heated S/TOP mixture was injected into the round-
bottom flask using a disposable syringe and needle. After the reaction was complete and 
the round-bottom flask cooled to room temperature, the solution was examined under the 
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the 
above table, the cores will fluoresce a yellowish color.  
The excess OA and unreacted cadmium precursor were separated from the QDs 
by extraction of the reaction solution with a volume of methanol equivalent to 4 times the 
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reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The centrifuge 
tube was gently shaken to start the precipitation, the cap was removed from the tube, and 
the solution was left until it separated into two distinct layers. The top layer composed of 
methanol and excess unreacted ligand was removed from the centrifuge tube using a 
pipette and discarded. Following the same procedure, the QD cores were washed a 
second time with methanol. Finally, the newly synthesized cadmium sulfide cores were 
dried over night under vacuum (4000 Pa) at room temperature. 
 
3.2.5 CdSe Quantum Dot Core Synthesis with Oleic Acid and Trioctylamine 
The first step in the synthesis of CdSe QD cores with oleic acid (OA) and 
trioctylamine (TOA) involves carrying out two reactions in parallel. The first reaction is 
between selenium and trioctylphosphine (TOP); while the second is cadmium acetate, 
OA, and TOA (see Figure 3.5). 
 
Figure 3.5. Synthetic scheme for the synthesis of CdSe quantum dot cores with OA and TOA. 
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The Se/TOP reaction was carried out in a flame-dried 5 mL glass vial while the 
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were 
capped to ensure that the environment was rid of oxygen and water. The liquids were 
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject® 
disposable syringes and syringe needles. The quantity of reactants used in the reactions 
was dependent on the batch size (see Table 3.9 below). 
Table 3.9. Quantity of reactants required for various batch sizes. 
Batch 
Size 
Selenium TOP Cadmium Acetate OA TOA 
g mol  x 104 mL 
mol  
x 104 g 
mol  
x 104 mL 
mol  
x 102 mL 
mol 
x 103 
1X 0.008 1.06 0.04 0.897 0.025 0.938 1.00 0.317 0.50 1.14 
2X 0.015 1.87 0.70 15.7 0.050 1.88 2.00 0.634 1.00 2.29 
5X 0.039 4.88 2.00 44.8 0.125 4.69 5.00 1.58 2.50 5.72 
10X 0.077 9.75 4.00 89.7 0.250 9.38 10.0 3.15 5.00 11.4 
 
The solids in both solutions were dissolved by gently swirling with heating. It was 
important not to boil the solution during this step. Once the solids completely dissolved, a 
stir bar was added to the vial containing the Se/TOP mixture and placed in the CEM 
microwave at the settings summarized below. The settings of the CEM microwave were 
controlled by Synergy software.  
f. Temperature: 120 °C 
g. Power: 300 Watts 
h. Ramp Time: 2 min 
i. Hold Time: 30 s 
j. Stirring: High 
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Once the reaction was complete, the vial was removed from the microwave. A stir 
bar was added to the round-bottom flask containing the OA, TOA, and cadmium acetate 
mixture and placed in the microwave. As with reactant quantities, the microwave settings 
were adjusted with batch size (see Table 3.10). During the reaction, the round-bottom 
flask was purged with nitrogen. 
Table 3.10. Microwave settings for various batch sizes. 
Batch Size Step Power (W) Temperature (°C) Ramp (min) Hold (min) 
1X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
2X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
5X 1 300 100 3:00 0:10 
 2 300 150 2:00 1:30 
10X 1 300 100 3:00 0:10 
 2 300 150 2:00 1:30 
 
When the temperature of the reaction reached 120 °C during the second heating step, the 
microwave was paused and the pre-heated Se/TOP mixture was injected into the round-
bottom flask using a disposable syringe and needle. After the reaction was complete and 
the round-bottom flask cooled to room temperature, the solution was examined under the 
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the 
above table, the cores will fluoresce a reddish color.  
The excess OA and unreacted cadmium precursor were separated from the QDs 
by extraction of the reaction solution with a volume of methanol equivalent to 4 times the 
58 
 
 
 
reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The centrifuge 
tube was gently shaken to start the precipitation, the cap was removed from the tube, and 
the solution was left until it separated into two distinct layers. The top layer composed of 
methanol was then removed from the centrifuge tube and discarded using a pipette. 
Following the same procedure, the QD cores were washed a second time with methanol. 
To separate the washed QD cores from methanol, the Thermo Electron Corporation 
centrifuge was used. A centrifuge tube containing water of an equal volume was placed 
opposite the solution in the blue centrifuge tube holder. The centrifuge was run for 5 min 
at a 25 °C and a speed of 4500 relative centrifugal force (RCF). Once the separation was 
complete, the QD cores were visibly separated from the methanol. The methanol was 
then poured from the tube and disposed. Finally, the newly synthesized CdSe cores were 
dried over night under vacuum (4000 Pa) at room temperature. 
 
3.2.6 CdS Quantum Dot Core Synthesis with Oleic Acid and Trioctylamine 
The first step in the synthesis of CdS quantum dot cores with OA and 
trioctylamine (TOA) involves carrying out two reactions in parallel. The first reaction is 
between sulfur and trioctylphosphine (TOP); while the second is cadmium acetate, OA, 
and TOA (see Figure 3.6). 
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Figure 3.6. Synthetic scheme for the synthesis of CdS quantum dot cores with OA and TOA. 
 
The S/TOP reaction was carried out in a flame-dried 5 mL glass vial while the 
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were 
capped to ensure that the environment was rid of oxygen and water. The liquids were 
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject® 
disposable syringes and syringe needles. The quantity of reactants used in the reactions 
was dependent on the batch size (see Table 3.11 below).  
Table 3.11. Quantity of reactants required for various batch sizes. 
Batch 
Size 
Sulfur TOP Cadmium Acetate Oleic Acid TOA 
g mol  x 104 mL 
mol  
x 104 g 
mol  
x 104 mL 
mol  
x 102 mL 
mol 
x 103 
1X 0.0084 2.62 0.04 0.897 0.025 0.938 1.0 0.317 0.5 1.14 
2X 0.0148 4.61 0.70 15.7 0.050 1.88 2.0 0.634 1.0 2.29 
5X 0.0385 12.0 2.00 44.8 0.125 4.69 5.0 1.58 2.5 5.72 
10X 0.077 24.0 4.00 89.7 0.250 9.38 10.0 3.15 5.0 11.4 
 
The solids in both solutions were dissolved by gently swirling with heating. It was 
important not to boil the solution during this step. Once the solids completely dissolved, a 
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stir bar was added to the vial containing the S/TOP mixture and placed in the CEM 
microwave at the settings summarized below. The settings of the CEM microwave were 
controlled by Synergy software.  
f. Temperature: 120 °C 
g. Power: 300 Watts 
h. Ramp Time: 2 min 
i. Hold Time: 30 s 
j. Stirring: High 
 
Once the reaction was complete, the vial was removed from the microwave. A stir 
bar was added to the round-bottom flask containing the oleic acid, TOA, and cadmium 
acetate mixture and placed in the microwave. As with reactant quantities, the microwave 
settings were adjusted with batch size (see Table 3.12). During the reaction, the round-
bottom flask was purged with nitrogen.  
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Table 3.12. Microwave settings for various batch sizes. 
Batch Size Step Power (W) Temperature (°C) Ramp (min) Hold (min) 
1X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
2X 1 300 100 2:00 0:10 
 2 300 160 1:30 0:30 
5X 1 300 100 3:00 0:10 
 2 300 175 2:00 1:30 
10X 1 300 100 3:00 0:10 
 2 300 175 2:00 1:30 
 
When the temperature of the reaction reached 120 °C during the second heating step, the 
microwave was paused and the pre-heated S/TOP mixture was injected into the round-
bottom flask using a disposable syringe and needle. After the reaction was complete and 
the round-bottom flask cooled to room temperature, the solution was examined under the 
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the 
above table, the cores will fluoresce a yellowish color.  
The excess OA and unreacted cadmium precursor were separated from the QDs 
by extraction of the reaction solution with a volume of methanol equivalent to 4 times the 
reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The centrifuge 
tube was gently shaken to start the precipitation, the cap was removed from the tube, and 
the solution was left until it separated into two distinct layers. The top layer composed of 
methanol and unreacted ligand was then removed from the centrifuge tube using a pipette 
and discarded. Following the same procedure, the QD cores were washed a second time 
with methanol. To separate the washed QD cores from methanol, the Thermo Electron 
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Corporation centrifuge was used. A centrifuge tube containing water of an equal volume 
was placed opposite the solution in the blue centrifuge tube holder. The centrifuge was 
run for 5 min at a 25 °C and a speed of 4500 relative centrifugal force (RCF). Once the 
separation was complete, the QD cores were visibly separated from the methanol. The 
methanol was then poured from the tube and disposed. Finally, the newly synthesized 
CdS QDs were dried over night under vacuum (4000 Pa) at room temperature. 
 
3.2.7 Treatment with a Reducing/Oxidizing Agent 
 The CdSe and CdS cores were treated with various reducing/oxidizing agents to 
increase their quantum efficiency. This step was completed by dissolving the dried cores 
in spectrophotometric grade chloroform. It is important to note that regular grade 
chloroform resulted in negative fluorescence peaks, therefore spectrophotometric grade 
was required. The absorbance of the QD solution was measured via ultra-violet visible 
spectroscopy (UV-Vis) using a Spectramax M5 Multi-Mode Microplate Reader. For 
dilute solutions, the solution absorbance is linearly proportional to QD concentration. The 
lower the arbitrary units (a.u.), the more dilute the solution. A solution absorbance 
between 0.08 and 0.10 a.u. was desirable for this investigation, therefore the volume of 
chloroform added to each batch of QD cores was varied to adjust the absorbance to this 
range.  
 Once absorbance of the QD solution was between 0.08 and 0.10 a.u., the master 
batch was divided into 16 different sub-batches in 7 mL glass sample vials. The volume 
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of each sample was approximately 5 mL. This thesis investigates the effect of 5 different 
reducing/oxidizing agents: (1) sodium borohydride (NaBH4), (2) calcium hydride (CaH2), 
(3) hydrazine (N2H4), (4) benzoyl peroxide (C14H10O4), and (5) tert-butyl hydroperoxide 
(C4H10O2). To determine the optimal quantity of agent to be used for each batch, these 16 
prepared samples were used to test 3 different concentrations of each of the 5 agents. One 
additional sample was left untreated and used as a reference throughout the treatment 
process. For solid agents, the masses investigated were: 0.001 g, 0.003 g, and 0.006 g. 
For liquid agents, the volumes investigated were: 0.05 mL, 0.10 mL, and 0.15 mL. 
Preliminary results showed that QDs fluoresced brighter in chloroform than toluene, 
therefore, chloroform was used as the solvent when determining concentration. The 
optimum quantity of reducing/oxidizing agents for each of the batch types was defined as 
the quantity at which the highest quantum yield was achieved. These quantities are 
summarized in Table 3.13 below, while the plots and pictures supporting the chosen 
quantities can be found in Appendix A. 
Table 3.13. Optimal quantity of reducing/oxidizing agents. 
 CdSe CdS 
 Oleylamine OA/ODE OA/TOA Oleylamine OA/ODE OA/TOA 
NaBH4 
0.006 g 
0.159 mmol 
0.006 g 
0.159 mmol 
0.001 g 
0.026 mmol 
0.003 g 
0.079 mmol 
0.003 g 
0.079 mmol 
0.006 g 
0.159 mmol 
CaH2 
0.001 g 
0.024 mmol 
0.001 g 
0.024 mmol 
0.001 g 
0.024 mmol 
0.001 g 
0.024 mmol 
0.001 g 
0.024 mmol 
0.003 g 
0.071 mmol 
N2H4 
0.150 mL 
4.74   mmol 
0.050 mL  
1.58   mmol 
0.150 mL 
4.74   mmol 
0.150 mL 
4.74   mmol 
0.050 mL 
1.58   mmol 
0.050 mL 
1.58   mmol 
C14H10O4 
0.001 g 
0.004 mmol 
0.006 g 
0.025 mmol 
0.003 g 
0.012 mmol 
0.001 g 
0.004 mmol 
0.003 g 
0.012 mmol 
0.001 g 
0.004 mmol 
C4H10O2 
0.050 mL 
0.519 mmol 
0.150 mL 
1.56   mmol 
0.100 mL 
1.04   mmol 
0.150 mL 
1.56   mmol 
0.100 mL 
1.04   mmol 
0.100 mL 
1.04   mmol 
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After the concentration for each of the reducing/oxidizing agents was determined, 
6 additional 7 mL glass vials were filled with 5 mL aliquots of the QD solution. To 5 of 
these samples, the optimum amount of reducing/oxidizing agents as summarized in Table 
3.13 was added. The additional sample was left untreated and used as a reference 
throughout the treatment process. An absorbance and fluorescence spectrum of each of 
the 5 treated samples was measured 1 min, 1 d, 5 d, and 10 d after treatment. These 
spectra were compared to those of the untreated sample and used to evaluate the effect 
each reducing/oxidizing agent had on the quantum yield of the various QD batches. 
 The rotary evaporator was then used to evaporate the remaining chloroform from 
the QD solution. The isolated solid QD cores were then resuspended in photrex grade 
toluene. The volume of toluene added was varied until a solution absorbance between 
0.08 a.u. and 0.10 a.u. was achieved as measured by the SpectraMax M5. Similar to 
chloroform, photrex grade toluene was required to eliminate negative fluorescence peaks 
that appeared in fluorescence spectra of QDs dissolved in regular grade toluene. The QD 
and toluene solution was divided into 6, 5 mL samples. Following the same procedure as 
described above, these toluene samples were treated with each of the 5 
reducing/oxidizing agents and the absorbance and fluorescence of these samples was 
measured at the specified time intervals. Preliminary results showed that QDs fluoresced 
brighter in chloroform than toluene, therefore chloroform was used as the solvent when 
determining the optimum amount of reducing/oxidizing agents to be used. It was 
assumed that the optimum amount of agents was not dependent on solvent, therefore, 
Table 3.13 was applied to the toluene samples as well.  
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3.3 Characterization Techniques 
Following synthesis and treatment, QD samples were analyzed for absorbance, 
fluorescence, and ligand surface coverage using the techniques described in detail below. 
 
3.3.1 Ultra-Violet Visible (UV-Vis) Spectroscopy  
 Ultra-violet visible (UV-Vis) spectroscopy is a technique used to analyze 
compounds in the ultraviolet (UV) and visible (Vis) regions. UV-Vis measures electronic 
transitions and can be used to determine the wavelength and maximum absorbance of 
compounds. Spectra are produced when electrons in atoms or molecules move from one 
energy level to another higher energy level. In doing so, they absorb energy equal to the 
gap between the two energy levels. Compounds that absorb light in the visible region 
have color (such as QDs), while those that absorb only in the UV region are colorless.  
Inside a UV-Vis spectrophotometer, there are two light sources: one giving off 
UV light and one giving off visible light. Typically, a tungsten light bulb is used as the 
visible light source while a deuterium light is used for UV light. The light sources 
produce white light that includes energies of all wavelengths (or colors) of light. A mirror 
directs this light into the diffraction grating which splits the colors into their constituent 
wavelengths. The instrument scans through the spectrum, sending different wavelengths 
of light through the sample in sequence. The single beam of light passing through the 
sample is then directed to a detector by mirrors. This detector compares the sample’s 
intensity to the reference intensity and sends a signal proportional to their ratio to the 
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computer that controls the instrument. The logarithm of this ratio gives the absorbance of 
the sample. Absorbance is a measure of how much light is being absorbed by the sample 
at a particular wavelength. 
 In this thesis, UV-Vis was used to measure the absorbance of the QD solution 
samples using a Spectramax M5 Multi-Mode Microplate Reader (Molecular Devices). 
SoftMax Pro software was used to collect the absorbance data from 350 nm to 750 nm 
and generate plots of absorbance units (a.u.) versus wavelength (nm).  As previously 
mentioned, sample absorbance is proportional to the QD concentration. The lower the 
a.u., the more dilute the sample. Absorbance data was therefore used as a measure of 
sample concentration. Additionally, the intensity of the absorbance peak at 365 nm was 
used in calculating the quantum yield of each sample as described in detail in the 
following section.  Lastly, the absorbance value corresponding to 365 nm was used to 
normalize the fluorescence data, as described in detail below.  
 
3.3.2 Fluorescence Spectroscopy 
Fluorescence spectroscopy is a type of electromagnetic spectroscopy used to 
analyze the fluorescence from a sample. This technique involves using a beam of 
ultraviolet light to excite the electrons in molecules of certain compounds and causes 
them to emit light of a lower energy. In this thesis, fluorescence spectroscopy was used to 
measure the fluorescence of the QD samples using a Spectramax M5 Multi-Mode 
Microplate Reader (Molecular Devices). The optimum excitation wavelength is defined 
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as the excitation wavelength that yields an emission wavelength that is separated from the 
excitation peak wavelength by more than 80 nm.1 As seen in Figure 3.7 below, an 
excitation wavelength of 365 nm resulted in an approximate 200 nm separation between 
the emission wavelength (560 nm) and the excitation peak wavelength (365 nm). The 
optimum excitation wavelength was therefore found to be 365 nm for all samples in this 
thesis. 
 
Figure 3.7. Sample fluorescence spectrum with excitation wavelength of 365 nm and no cutoff. 
 
As seen in Figure 3.7 above, the intensity of the excitation light peak (at 365 nm) 
is significantly greater than that of the emitted light peak (at 560 nm). This difference in 
intensity is caused by interference due to scattered or stray light and background 
interference.1,2 Sources of background include stray excitation light, sample constituents, 
and solvents.1 To restrict these interferences, a long-pass emission cutoff filter is 
necessary.1 The optimum emission cutoff filter should block as much of the residual 
excitation light as possible without reducing the fluorescence signal.1 The cutoff 
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wavelength value should be between the excitation wavelength and the maximum 
emission wavelength.1 For this thesis, the cutoff wavelength was chosen to be 420 nm. 
Figure 3.8 below illustrates the effect of using an emission cutoff filter. This figure 
includes a fluorescence spectrum of the same sample as shown in Figure 3.7 excited at 
365 nm with a cutoff filter at 420 nm. 
 
Figure 3.8. Sample fluorescence spectrum with excitation wavelength of 365 nm and cutoff at 420 nm. 
 
Solutions of QDs were loaded into quartz cuvettes for fluorescence 
measurements. The cuvettes were made of quartz to allow passage of the UV excitation 
radiation, and were transparent on all four sides. It was necessary that the sides be 
transparent, since the fluorescence emission is detected in a direction perpendicular to the 
direction of the incident excitation radiation.3 SoftMax Pro software was used to collect 
the fluorescence data of the reference solution (which in this case was the blank solvent) 
as well the fluorescence of the QD solutions from 350 nm to 750 nm and generate plots 
of relative fluorescence units (RFU) versus wavelength (nm). The reference fluorescence 
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data was subtracted from the QD fluorescence data to correct for the solvent effect. To 
normalize this fluorescence data to absorbance data, the fluorescence values 
corresponding to a specific sample were divided by the absorbance of the same sample at 
the excitation wavelength of 365 nm. The area of the normalized fluorescence peak was 
used in calculating the quantum yield of each sample as described in detail in the 
following section. 
 
3.3.3 Thermogravimetric Analysis (TGA)  
Thermogravimetric analysis (TGA) measures the weight change of a sample as it 
is heated to the temperature at which it degrades. A thermal degradation profile of a 
sample can be determined by plotting the residual mass versus temperature. In this thesis, 
TGA was utilized to measure the ligand surface coverage of the QDs. TGA was 
performed using a TA Instruments SDT-Q600, which employs two cantilever balances in 
a furnace purged with nitrogen. An aliquot of a QD sample solution was placed in an 
alumina ceramic pan and placed in an oven at a temperature of 70 °C until the solvent 
evaporated. This step was repeated until the bottom of the ceramic pan was covered with 
a layer of the QD powder. The alumina ceramic pan filled with this QD powder was 
placed on one cantilever. A second, empty ceramic pan was placed on the other cantilever 
as a reference. The sample was then heated from 30 °C to 600 °C at a constant rate of 
10 °C/min. The mass remaining after heating to the set temperature was believed to be 
that of the metal core without organic ligands. The mass lost due to heating was therefore 
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assumed to be that of the ligands, thereby allowing for the estimation of ligand surface 
coverage. 
 
3.4 Calculating Quantum Yield 
 The quantum yield (QY) of a compound is defined as the fraction of molecules 
that emit a photon after direct excitation by the source. This value is of importance as it is 
a measure of the extent of interferences and therefore is a quantitative measure of a 
compound’s brightness. The QY of untreated QD cores and those treated with a 
reducing/oxidizing agent was calculated by comparison with a known reference. In this 
thesis, Rhodamine 6G (Rh6G) was chosen as the reference because its QY is known 
(0.95), and it emits a photon at a similar wavelength as the QDs synthesized in this thesis 
(~ 530 nm) when excited at 365 nm. Reference solutions were made by dissolving Rh6G 
in water until the absorbance of each solution was between 0.08 a.u. and 0.10 a.u., as 
measured using the SpectraMax M5. A solution absorbance within this range was desired 
so that the concentration of the reference solution was comparable to the concentration of 
the QD sample solutions. The fluorescence of the reference solutions was also measured 
using the SpectraMax and peaks were generated. A custom MATLAB script was 
developed to calculate the area under each measured fluorescence peak. The QY of each 
QD sample was calculated using the following relation: 
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Where GRhQY 6  is the quantum yield of the reference solution, Rh6G (0.95); QDsFL  and
GRhFL 6 are the areas under the fluorescence peaks of the quantum dot and reference 
(Rh6G) solutions, respectively; QDsAB  and GRhAB 6  are the intensities of the absorbance 
peaks of the quantum dot and reference (Rh6G) solutions at 365 nm, respectively; solη  is 
the refractive index of the solvent ( 497.1=tolueneη  and )446.1=chloroformη ; and OH2η  is 
the refractive index of water ( )333.1
2
=OHη . 
 
3.5 Calculating Band Gap Energy (Eg) 
 The bandgap energy (Eg) is the energy between the valence and conduction band 
in a semiconductor. As described in the background section, the Eg is the minimum 
amount of energy required to promote an electron from the valence band to the 
conduction band. When the electron returns to the valence band, energy corresponding to 
the energy of the bandgap is emitted. This value is of importance when referring to QDs 
because, unlike in bulk semiconductors, the Eg can be tuned to emit light of a particular 
wavelength. In other words, QDs of the same material can emit light at an array of 
wavelengths. The size of the bandgap is dictated by the size of the particle. For this 
reason, the Eg will be used throughout this thesis to quantitatively account for changes in 
QD size after surface treatment with various reducing and oxidizing agents.  
 To calculate Eg, the absorbance data for each sample was plotted versus energy. 
The bandgap energy was defined as the minimum energy required for radiative 
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recombination from the valence band to the conduction band and was simply read off 
each graph (see Figure 3.9).4 To convert wavelength to energy, the following relation was 
used: 
λ
hcE =
 
    (2) 
Where E is energy in eV (1 eV = 1.602 x 10-19 J); h is Planck’s constant (6.63 x 10-34 J•s); 
c is the speed of light (3.00 x 108 m/s); and λ is wavelength in m. 
 
Figure 3.9. Typical absorbance spectra used to estimate the bandgap energy (Eg).4 
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Chapter 4. Results and Discussion: CdSe 
 Chapter 4 will present and discuss the results of the experimental work performed 
on CdSe QDs. This chapter will be divided into three sections: (1) CdSe QDs synthesized 
with oleylamine, (2) CdSe QDs synthesized with oleic acid (OA) and octadecene (ODE), 
and (3) CdSe QDs synthesized with OA and trioctylamine (TOA). Each section will 
summarize the effect of treating the surface of the various QD batches with three 
reducing and two oxidizing agents. More specifically, the effect of each treatment on the 
quantum yield (QY) of the QDs will be investigated. The QY refers to the nonradiative 
transition of electrons and holes between energy levels, and is therefore a measure of 
brightness. The QY reported for each treatment was calculated following the procedures 
presented in Chapter 3 of this thesis. Rhodamine 6G (Rh6G) was chosen as the reference 
in the QY calculation because its QY is known (0.95), and it emits a photon at a similar 
wavelength as the QDs synthesized in this thesis (~ 530 nm) when excited at 365 nm.  
It is important to note that the calculated QY is representative of the entire QD 
mixture, not just the QDs because the QD solution was not purified after treatment. For 
this reason, a major limitiation of this study is that the measured absorbance and 
fluorescence spectra of each sample were of the mixture, not the pure components. For 
example, the absorbance of the mixture (Amixture) can be represented by the following 
equation: 
                   𝐴𝑚𝑖𝑥𝑡𝑢𝑟𝑒 = 𝐴𝑄𝐷𝑠 + 𝐴𝑙𝑖𝑔𝑎𝑛𝑑 + 𝐴𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 + 𝐴𝑠𝑜𝑙𝑣𝑒𝑛𝑡             (3) 
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Where Amixture is the intensity of the absorbance peak of the QD mixture at 365 nm; AQDs 
is of the QDs; Aligand is of the ligand; Atreatment is of the reducing/oxidizing agents; and 
Asolvent is of the solvent.  
When performing UV-Vis on the reaction mixture, the blank solvent was used as 
the reference and subtracted from the total absorbance, therefore the absorbance of the 
solvent can be neglected in the equation 3 (Asolvent = 0). Furthermore, UV-Vis was 
performed on a mixture containing each ligand and solvent combination. Again, the blank 
solvent was used as the reference, therefore the measured absorbance was representative 
of only the ligand. Figure 4.1 below contains the absorbance spectra of a sample QD 
mixture (CdSe QDs capped with oleylamine in chloroform) represented by the solid line 
and a solution of ligand (oleylamine) and chloroform represented by the dashed line.  
 
Figure 4.1. Absorbance spectra of a CdSe (oleylamine) QDs dissolved in chloroform (solid) and a solution 
of oleylamine and chloroform (dashed). 
 
Absorbance is directly related to concentration via Beer’s Law:  
365  
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     𝐴 = 𝜀𝐶𝐿                       (4) 
Where A is the intensity of the absorbance peak; ε is the molar absorbtivity (L/mol·cm) C 
is the molar concentration (mol/L) of the component in solution; and L is the path length 
(cm) of the radiation beam used for measuring the absorbance spectrum. As seen in 
equation 3, the absorbance of the QD mixture (Amixture) is the sum of the intensities of the 
absorbance peaks at 365 nm of each component. The absorbance of the ligand is 
significantly less than that of the QD mixture at 365 nm (see Figure 4.1), therefore we 
can conclude that there is a small concentration of ligand in the QD mixture. 
Furthermore, even though the intensity of the absorbance peaks in Figure 4.1 were both 
approximately 0.06, indicating that the concentration of the components in the solutions 
were approximately the same, there were more components in the QD mixture solution 
than the solution comprised of only ligand and solvent. For this reason, we can conclude 
that the concentration of ligand in the QD mixture was orders of magnitude less than that 
in the solution only composed of ligand and solvent. The absorbance of the ligand 
(Aligand) in equation 3 can therefore be assumed to be negligible (Aligand = 0). The 
absorbance measured for each QD mixture as summarized in the following sections is 
therefore representative of the mixture of the absorbance of the QDs and that of the 
treatment, or: 
 𝐴𝑚𝑖𝑥𝑡𝑢𝑟𝑒 = 𝐴𝑄𝐷𝑠 + 𝐴𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡                   (5) 
The measured fluorescence spectra included in this study are also representative 
of the QD mixture rather than just the QDs. For this reason, when the fluorescence of the 
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QDs was quenched, we were unable to conclude what caused this quenching. For 
example, if the quenching was caused by excess free ligand in the QD solution, it may be 
possible to restore the fluorescence by purifying the QDs after treatment and removing 
this residual ligand. In a study by Tansakul et al. it was found that the quenched QD 
fluorescence could be restored, therefore proving that quenching may be reversible.24 It is 
recommended that future work performed on this study explore whether the quenching is 
reversible by purifying the QDs after treatment.  
In addition to comparing the QY of the QDs before and after surface treatment, a 
change in QD size distribution was also investigated. In a study by Zezza et al., it was 
concluded that the sharpness of the absorbance peak is indicative of the particle size 
distribution.1 Specifically, the sharper the absorbance peak, the narrower the size 
distribution.1 Furthermore, Bullen et al. found that a high full-width half-maximum 
(FWHM) value indicates the onset of Ostwald ripening which causes a slow “defocusing” 
of the size distribution.2 It can therefore be concluded that a sharp absorbance peak and 
low FWHM value is indicative of a narrow size distribution.   
Lastly, the bandgap energy (Eg) was calculated before and after each surface 
treatment following the procedure provided in Chapter 3. The bandgap energy is the 
minimum amount of energy a QD absorbs to raise an electron from the valence band to 
the conduction band. The electron remains in the conduction band momentarily before 
returning through the bandgap to the valence band at which time it emits electromagnetic 
radiation with a wavelength corresponding to the bandgap.3,4 The size of the bandgap is 
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therefore dictated by the size of the QD. Specifically, Eg increases with decreasing 
particle size.5 Furthermore, QD size is representative of the color emitted, with smaller 
QDs emitting blue and large QDs emitting red.  
The reducing agents to be investigated include: sodium borohydride (NaBH4), 
calcium hydride (CaH2), and hydrazine (N2H4), while the oxidizing agents include: 
benzoyl peroxide (C14H10O4) and tert-butyl hydroperoxide (C4H10O2). Three different 
concentrations of each reducing/oxidizing agent were investigated prior to 
experimentation to determine which concentration yielded the highest calculated QY for 
each batch of QDs (see Appendix A). This concentration was defined as the optimum 
concentration and was used to treat each batch of QDs, as described in the following 
sections.  
 
4.1 CdSe (Oleylamine) Quantum Dot Cores  
4.1.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform 
 Figure 4.2 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 
1.99 x 10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Figure 
4.2 below. From these values, it can be seen that the QY of the QDs increased slightly 
after treatment with NaBH4 and reached a maximum 1 d after treatment before 
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decreasing to below that of the untreated QY 10 d later. Figure 4.2e confirms this 
decrease in QY 10 d after treatment as the treated QDs (right) are less bright than the 
untreated QDs (left). Additionally, no notable change in the sharpness of the absorbance 
peak or FWHM value was observed therefore ruling out a significant broadening of the 
QD size distribution after treatment. Lastly, the Eg did not change after treatment 
indicating that there was no change in the size of the QDs. In conclusion, treatment of 
CdSe (oleylamine) QDs dissolved in chloroform with NaBH4 resulted in a 66.7 % 
increase in the QY of the QDs 1 d after treatment. 
 
Figure 4.2. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 
1 d (red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (1.99 x 10-5 molar ratio of QDs to 
NaBH4). Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light 
(c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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Table 4.1. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(oleylamine) QD and NaBH4 solution dissolved in chloroform at a 1.99 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.003 38.7 2.19 
Initial 0.003 40.3 2.19 
1 d 0.005 42.5 2.19 
5 d 0.004 45.7 2.19 
10 d 0.002 49.4 2.20 
 
4.1.2 Treatment with Sodium Borohydride (NaBH4) in Toluene 
 Figure 4.3 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a 
3.27 x 10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 
4.2 below. From these values, it can be seen that the QY of the QDs increased 
immediately after treatment with NaBH4 before decreasing to below that of the untreated 
QY 10 d later. The pictures in Figure 4.3 confirm these results as the treated sample 
(right) is brighter than the untreated sample (left) 1 d after treatment (c) and less bright 10 
d after treatment (e). Additionally, the absorption edge continued to become less sharp 
and the FWHM continued to increase with time, indicating a broadening of the QD size 
distribution after treatment. Lastly, the Eg did not change after treatment indicating that 
there was no change in the size of the QDs. In conclusion, treatment of CdSe 
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(oleylamine) QDs dissolved in toluene with NaBH4 resulted in a 64.0 % increase in the 
QY of the QDs immediately after treatment. 
 
Figure 4.3. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (3.27 x 10-5 molar ratio of QDs to NaBH4). 
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 4.2. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(oleylamine) QD and NaBH4 solution dissolved in toluene at a 3.27 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.050 39.3 2.15 
Initial 0.082 39.7 2.16 
1 d 0.025 39.3 2.15 
5 d 0.046 46.2 2.17 
10 d 0.029 47.5 2.18 
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4.1.3 Treatment with Calcium Hydride (CaH2) in Chloroform 
Figure 4.4 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 1.33 x 
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.3 
below. From these values, it can be seen that the QY of the QDs decreased after treatment 
with CaH2. Additionally, the spectra in Figure 4.4 illustrate that the fluorescence peak 
flattened and the absorbance increased after treatment. In a study by Mandal et al., an 
increase in absorbance was found to be indicative of aggregation because absorbance 
measurements are sensitive to scattering from colloidal suspensions that form as QD 
aggregates grow in size.6 Furthermore, they found that a significant decrease in QD 
fluorescence also resulted from aggregation.6 It can therefore be concluded that the 
flattening of the fluorescence peak coupled with the significant increase in absorbance 
observed 10 d after treatment with CaH2, indicates that the QDs began to aggregate at this 
time. Furthermore, because the QDs were no longer fluorescent 10 d after treatment (see 
Figure 4.4e), it can be concluded that the QDs precipitated out of solution.7 Lastly, the Eg 
did not change after treatment indicating that there was no change in the size of the QDs.  
In conclusion, treatment of CdSe (oleylamine) QDs dissolved in chloroform with CaH2 
caused the QDs to stop fluorescing 10 d after treatment. 
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Figure 4.4. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 
d (red), 5 d (green), and 10 d (purple) after treatment with CaH2 (1.33 x 10-4 molar ratio of QDs to CaH2). 
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
 
Table 4.3. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of of a CdSe 
(oleylamine) QD and CaH2 solution dissolved in chloroform at a 1.33 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.003 40.0 2.19 
Initial 0.003 43.7 2.19 
1 d 0.003 40.6 2.19 
5 d 0.002 43.3 2.20 
10 d --- --- --- 
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4.1.4 Treatment with Calcium Hydride (CaH2) in Toluene 
Figure 4.5 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and calcium hydride (CaH2) solution dissolved in toluene at a 2.17 x  
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.4 
below. From these values, it can be seen that the QY of the QDs steadily decreased with 
time after treatment with CaH2. The pictures included in Figure 4.5 confirm this expected 
decrease in QY, as the treated sample (right) is less fluorescent than the untreated sample 
(left). Additionally, the absorption edge continued to become less sharp and the FWHM 
increased with time, indicating a broadening of the QD size distribution after treatment. 
Lastly, the Eg increased slightly after treatment indicating that there was a slight decrease 
in the size of the QDs. In conclusion, treatment of CdSe (oleylamine) QDs dissolved in 
toluene with CaH2 resulted in a quenching of the QDs fluorescence. 
85 
 
 
 
 
Figure 4.5. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with CaH2 (2.17 x 10-4 molar ratio of QDs to CaH2). 
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
 
Table 4.4. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(oleylamine) QD and CaH2 solution dissolved in toluene at a 2.17 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.057 39.1 2.15 
Initial 0.042 40.3 2.15 
1 d 0.026 39.9 2.15 
5 d 0.020 46.6 2.19 
10 d 0.023 53.6 2.23 
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4.1.5 Treatment with Hydrazine (N2H4) in Chloroform 
Figure 4.6 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and hydrazine (N2H4) solution dissolved in chloroform at a 6.74 x 10-7 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.5 
below. From these values, it can be seen that the QY of the QDs decreased after treatment 
with N2H4. A possible explanation for the observed decrease in QY involves the 
solubility of N2H4 in chloroform. Specifically, N2H4 is nearly insoluble in chloroform8 
and is a liquid at room temperature. Therefore, an emulsion formed immediately after the 
addition of N2H4 to the untreated QD solution, as seen in Figure 4.6c where N2H4 formed 
large droplets that were poorly dispersed in the continuous chloroform phase. We 
hypothesize that oleylamine was able to act as a surfactant and stabilize the hydrazine 
droplets, as its surface tension (31.4 mN/m9) is in between that of N2H4 (66.39 mN/m9) 
and chloroform (27.5 mN/m9). As mentioned above, N2H4 formed large, unevenly 
dispersed droplets in the chloroform which led to the assumption that oleylamine was a 
poor surfactant. This assumption was confirmed as the hydrophilic-lipophilic balance 
(HLB) of oleylamine was found to be approximately 1010, indicating that it is a 
hydrophilic surfactant.11 Chloroform is a hydrophobic solvent, therefore a hydrophobic 
surfactant with a low HLB value is required to yield a stable emulsion with small, evenly 
dispersed droplets of N2H4. 
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When the reducing/oxidizing agents were soluble in a given solvent, it was 
assumed that the reduction/oxidation of the QDs happened immediately. Because N2H4 is 
nearly insoluble in chloroform, an emulsion formed immediately after treatment. 
Immediately after addition, a small amount of soluble N2H4 reacted with the QDs and 
reduced their surface to etch and destroy the QDs thereby quenching the QD 
fluorescence. The remainder of the N2H4 formed large, unevenly dispersed N2H4 droplets 
stabilized by the residual oleylamine. The solution appeared blue-green when excited by 
a 365 nm UV lamp because the oleylamine emits light at 450 nm upon excitation (see 
Figure 4.7). After 10 d a visible layer forms at the top of the chloroform solution, 
presumably due to instability of the emulsion (see Figure 4.6e). In conclusion, CdSe 
(oleylamine) QDs dissolved in chloroform died immediately after the addition of N2H4.  
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Figure 4.6. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 
d (red), 5 d (green), and 10 d (purple) after treatment with N2H4 (6.74 x 10-7 molar ratio of QDs to N2H4). 
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
 
Table 4.5. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(oleylamine) QD and N2H4 solution dissolved in chloroform at a 6.74 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.006 39.5 2.19 
Initial 0.001 --- --- 
1 d 0.003 107 2.37 
5 d 0.004 107 2.40 
10 d 0.004 106 2.40 
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Figure 4.7. Normalized fluorescence spectrum of a solution composed of chloroform, oleylamine, and 
N2H4. 
 
4.1.6 Treatment with Hydrazine (N2H4) in Toluene 
Figure 4.8 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and hydrazine (N2H4) solution dissolved in toluene at a 1.10 x 10-6 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.6 
below. From these values, it can be seen that the QY of the QDs was quenched 
immediately after treatment with N2H4. This quenching of the fluorescence was 
confirmed by the flattening of the fluorescence spectrum and the pictures in Figure 4.8 
where the treated samples (right) no longer fluoresce. Hydrazine is soluble in toluene, 
therefore it was assumed that the reducing agent reacted with the QDs immediately after 
treatment and the concerns discussed in section 4.1.5 above were not applicable. In 
conclusion, treatment of CdSe (oleylamine) QDs dissolved in toluene with N2H4 caused 
the QDs to stop fluorescing immediately after treatment. 
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Figure 4.8. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with N2H4 (1.10 x 10-6 molar ratio of QDs to N2H4). 
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
 
Table 4.6. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(oleylamine) QD and N2H4 solution dissolved in toluene at a 1.04 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.041 39.6 2.15 
Initial 0.003 42.3 2.05 
1 d 0.001 70.9 --- 
5 d 0.001 --- --- 
10 d --- --- --- 
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4.1.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform 
Figure 4.9 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 
7.99 x 10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 
4.7 below. From these values, it can be seen that the QY of the QDs decreased after 
treatment with C14H10O4. Although the QY was calculated to be at a maximum 10 d after 
treatment, a decrease in fluorescence was actually observed (see Figure 4.9e).  
Similar to treatment with N2H4 (as described in section 4.1.5 above), the 
fluorescence peak centered at 560 nm in Figure 4.10 represents the true emission of the 
QDs. The peaks centered at 450 nm, on the other hand, are representative of the mixture 
of chloroform, oleylamine, and C14H10O4, not the QDs. Focusing on the peak 
representing the QDs, it can therefore be seen that the fluorescence of the QDs decreased 
immediately after treatment, decreased further and experienced a blue-shift 5 d after 
treatment, and was completely quenched 10 d after treatment. Figure 4.9e illustrates this 
quenching of the QD fluoescence 10 d after treatment, as the treated sample (right) is not 
fluorescent. Additionally, the absorption edge continued to become less sharp with time 
and the FWHM increased, indicating a broadening of the QD size distribution after 
treatment. Lastly, the Eg increased 5 d after treatment indicating that there was a slight 
decrease in the size of the QDs at this time. In conclusion, treatment of CdSe 
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(oleylamine) QDs dissolved in chloroform with C14H10O4 caused the QDs to stop 
fluorescing 10 d after treatment. 
 
Figure 4.9. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 
1 d (red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (7.99 x 10-4 molar ratio of QDs to 
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 4.7. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(oleylamine) QD and C14H10O4 solution dissolved in chloroform at a 6.39 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.005 39.3 2.19 
Initial 0.003 39.7 2.19 
1 d 0.002 39.3 2.19 
5 d 0.003 53.3 2.23 
10 d 0.007 102 2.40 
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Figure 4.10. Normalized fluorescence spectrum of a solution composed of chloroform, oleylamine, and 
benzoyl peroxide (C14H10O4). 
 
4.1.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene 
 Figure 4.11 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 1.30 
x 10-3 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.8 
below. From these values, it can be seen that the QY of the QDs increased 1 d after 
treatment with C14H10O4 before decreasing to below that of the untreated QY 5 d later. 
This increase in QY 1 d after treatment is illustrated in Figure 4.11c as the treated sample 
(right) is brighter than the untreated sample (left).  
 Similar to treatment with C14H10O4 in chloroform (as described in section 4.1.7 
above), the fluorescence peak centered at 550 nm in Figure 4.11 represents the emission 
of the QDs. The peaks measured 5 d (green) and 10 d (purple) after treatment, on the 
other hand, are centered at 450 nm and are therefore representative of the mixture of 
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toluene, oleylamine, and C14H10O4, not the QDs (see Figure 4.12 below).  Focusing on 
the peak representing the QDs, it can therefore be seen that the fluorescence of the QDs 
increased 1 d after treatment and was completely quenched 5 d after treatment. Figure 
4.11d and e confirm these observations as the treated sample (right) is not fluorescent 5 d 
and 10 d after treatment, respectively. Additionally, the absorption edge continued to 
become less sharp with time and the FWHM increased, indicating a broadening of the 
QD size distribution after treatment. In conclusion, treatment of CdSe (oleylamine) QDs 
dissolved in toluene with C14H10O4 resulted in a 22.9 % increase in the QY of the QDs 
1 d after treatment, however, the fluorescence of the QDs was quenched 5 d after 
treatment. 
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Figure 4.11. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.30 x 10-3 molar ratio of QDs to 
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 4.8. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(oleylamine) QD and C14H10O4 solution dissolved in toluene at a 1.30 x 10-3 molar ratio.  
 QY FWHM (nm) Eg (eV) 
Untreated 0.035 40.4 2.15 
Initial 0.013 39.5 2.15 
1 d 0.043 41.0 2.19 
5 d 0.028 84.5 2.35 
10 d 0.007 71.6 2.40 
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Figure 4.12. Normalized fluorescence spectrum of a solution composed of toluene, oleylamine, and 
C14H10O4. 
 
4.1.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform 
Figure 4.13 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and tert-Butyl Hydroperoxide (C4H10O2) solution dissolved in 
chloroform at a 6.14 x 10-6 molar ratio. From these spectra, quantum yield (QY), full-
width half-maximum (FWHM), and bandgap energy (Eg) were calculated before 
treatment, as well as immediately, 1 d, 5 d, and 10 d after treatment. These results are 
summarized in Table 4.9 below. From these values, it can be seen that the QY of the QDs 
decreased immediately after treatment with C4H10O2 before ceasing to fluoresce 1 d later. 
Figure 4.13c illustrates this quenching of the QD fluoescence 1 d after treatment, as the 
treated sample (right) is not fluorescent. 
Similar to treatment with C14H10O4 (as described in sections 4.1.7 and 4.1.8 
above), the fluorescence peak centered at 550 nm in Figure 4.10 represents the true 
emission of the QDs. The peaks measured after treatment, on the other hand, are centered 
at 450 nm and are therefore representative of the mixture of chloroform, oleylamine, and 
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C4H10O2, not the QDs. For this reason, the quenching of the fluorescence of the QDs 1 d 
after treatment was confirmed. In conclusion, treatment of CdSe (oleylamine) QDs 
dissolved in chloroform with C4H10O2 resulted in a quenching of the QD fluorescence 1 d 
after treatment. 
 
Figure 4.13. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 
d (red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (6.14 x 10-6 molar ratio of QDs to 
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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Table 4.9. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(oleylamine) QD and C4H10O2 solution dissolved in chloroform at a 6.14 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.002 44.0 2.19 
Initial 0.001 48.0 2.19 
1 d 0.001 32.8 2.40 
5 d 0.003 43.5 2.38 
10 d --- --- 2.35 
 
 
Figure 4.14. Normalized fluorescence spectrum of a solution composed of chloroform, oleylamine, and 
tert-butyl hydroperoxide (C4H10O2). 
 
4.1.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene 
Figure 4.15 displays the absorbance and fluorescence spectra of a CdSe 
(oleylamine) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at 
a 1.00 x 10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These values, as summarized in Table 
4.10, show that the QY of the QDs decreased immediately after treatment with C4H10O2. 
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This decrease in QY is illustrated in Figure 4.15c where the treated QDs (right) are less 
bright than the untreated QDs (left).  
Similar to treatment with C4H10O2 in chloroform (as described in section 4.1.9 
above), the fluorescence peak centered at 550 nm in Figure 4.15 represents the true 
emission of the QDs. The peak measured 5 d (green) and 10 d (purple) after treatment, on 
the other hand, is centered at 450 nm and is therefore representative of the mixture of 
toluene, oleylamine, and C4H10O2, not the QDs (see Figure 4.16 below). Focusing on the 
fluorescence peak representing the QDs, it can therefore be seen that the fluorescence 
was quenched 5 d after treatment. Figure 4.15d and e confirm this quenching of the QD 
fluoescence as the treated sample (right) is not fluorescent 5 d and 10 d after treatment, 
respectively. Additionally, the absorption edge continued to become less sharp with time 
and the FWHM increased, indicating a broadening of the QD size distribution after 
treatment.1,12 In conclusion, treatment of CdSe (oleylamine) QDs dissolved in toluene 
with C4H10O2 resulted in a quenching of the QD fluorescence 5 d after treatment.  
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Figure 4.15. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (1.00 x 10-5 molar ratio of QDs to 
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 4.10. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(oleylamine) QD and C4H10O2 solution dissolved in toluene at a 1.00 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.052 46.6 2.15 
Initial 0.002 --- 2.15 
1 d 0.021 52.4 2.23 
5 d 0.062 75.6 2.35 
10 d 0.097 76.9 2.39 
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Figure 4.16. Normalized fluorescence spectrum of a solution composed of toluene, oleylamine, and  
C4H10O2. 
 
4.1.11 Summary of CdSe/Oleylamine Treatments 
 Figure 4.17 compares the effect of treating CdSe (oleylamine) QDs with various 
reducing and oxidizing agents in chloroform versus toluene. From these photographs, it 
can be seen that the QDs dissolved in toluene were visibly brighter than those in 
chloroform. This observation was confirmed as the QY of the QDs before treatment in 
chloroform was approximately 0.004 while the QY in toluene was approximately 0.050. 
Because both sets of QDs came from the same master batch of cores, this difference in 
QY may be due to the solubility of the oleylamine in the various solvents. Thuy et al. 
have shown that the QY is higher when the capping ligand is less soluble in a given 
solvent.13 Because the QY was higher in toluene than chloroform, we therefore 
hypothesize that oleylamine is less soluble in toluene than chloroform. The Eg of the 
untreated QDs in chloroform and toluene were 2.19 eV and 2.15 eV, respectively, which 
suggests that the QD size and therefore color emitted is independent of solvent. 
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Figure 4.17. Photos of CdSe (oleylamine) QDs that are from left to right: untreated, treated with NaBH4, 
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were 
suspended and treated in chloroform while those in the right column were suspended and treated in toluene. 
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment. 
 
 The effect of reducing and oxidizing agents on the QY of CdSe (oleylamine) QDs 
was found to be independent of solvent for 4 of the 5 treatments. More specifically, it was 
found that the QY of the QDs declined after treatment with CaH2, N2H4, and C4H10O2 and 
improved after treatment with NaBH4 in both chloroform and toluene. Treatment with 
C14H10O4, on the other hand, increased the QY of the QDs when dissolved in toluene, but 
not in chloroform. The reason for this dependence on solvent is not known, however, a 
possible explanation focuses on the solubility of the oxidizing agent in the dispersion 
solvent, as explained in detail below.  
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 Treatment of QDs with a reducing/oxidizing agent is expected to reduce the 
surface ligands thereby causing them to lose their coordinating properties and detach 
from the QD surface.14 Oxygen from atmospheric air is then able to diffuse to the 
exposed cadmium on the QD surface to form a cadmium oxide (CdO) layer around the 
QDs.14This CdO layer serves to passivate defects on the QD surface, thereby enhancing 
the QY of the QDs.14 A possible explanation for the observed decrease of the QY after 
treatment with C14H10O4 in chloroform is that the oxidizing agent reacted with the QDs at 
a rate so fast that oxygen was not able to diffuse to the QD surface and form a CdO layer. 
Instead, C14H10O4 caused the oleylamine ligands to quickly detach from the QD surface 
and therefore caused aggregation in chloroform (as measured by the increase in 
absorbance), and resulted in a quenched QY.7 In toluene, however, the reaction rate was 
slowed down significantly because C14H10O4 is less soluble in toluene than chloroform.15 
Because the reaction rate was slowed, after the C14H10O4 reduced the oleylamine on the 
QD surface, oxygen was able to form the CdO layer and therefore passivate the defect 
sites on the QD surface. To confirm this theory, additional testing is required. A possible 
experiment involves treating the QDs with a lower concentration of C14H10O4 in 
chloroform to see if the reaction rate slows enough to allow for the formation of a CdO 
layer and therefore increased QY. 
 As mentioned above, treatment of CdSe (oleylamine) QDs with NaBH4 resulted 
in an enhanced QY, while treatment with CaH2 decreased the QY of the QDs. We 
hypothesize that this result can be explained by a difference in the reducing agents 
reactivity with water. Specifically, we hypothesize that the reducing agents react with the 
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residual water present in each of the solvents to form hydrogen. The hydrogen then reacts 
with the surface ligands, causing them to detach from the QD surface, and allowing 
oxygen from the atmospheric air to diffuse to the exposed cadmium. The resulting CdO 
layer around the QDs serves to passivate the defect sites located on the QD surface and 
therefore improves the QY of the QDs. If the reducing agent reacts too fast with the 
residual water, the QDs will aggregate and the QY will be quenched. In a study by Kong 
et al., the reaction rate of NaBH4 with water vapor was found to be ten times slower than 
that of CaH2.16 For this reason, it is hypothesized that CaH2 reacted very fast with the 
residual water present in the QD solution, causing the QDs to aggregate, and the QY to 
be quenched. This aggregation was confirmed by an increase in the measured absorbance. 
NaBH4, on the other hand, reacted with the water at a slow enough rate that the hydrogen 
produced was able to effectively detach ligands on the QD surface and allow for the 
formation of the CdO layer.  
 In each of the 10 preceding subsections, a fluorescence peak centered at 
approximately 450 nm was observed. To account for this peak, fluorescence spectroscopy 
was performed on solutions consisting of each oleylamine, solvent, and 
reducing/oxidizing agent combination. Several of these spectra are included in the above 
section. From these spectra, the peak at 450 nm was consistently found to represent the 
ligand, solvent, and reducing/oxidizing agent combination, not the QDs. In 8 of the 10 
cases summarized above, an increase in this peak centered at 450 nm was observed with 
time. A possible explanation for this increase is that the solvent evaporated over time, as 
seen by the decrease in solution volume in the pictures included in the figures above. As 
105 
 
 
 
the solvent evaporated, the concentration of the precursor solution increased, and an 
increase in fluorescence was therefore observed. 
 
4.2 CdSe (OA and ODE) Quantum Dot Cores  
4.2.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform 
 Figure 4.18 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 2.02 x 
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 
4.11 below. These values show that the QY of the QDs increased after treatment with 
NaBH4 and reached a maximum 5 d after treatment. Additionally, the Eg decreased 
slightly with time, indicating a minor increase in QD size and slight red-shift in emission 
color. Figure 4.18d illustrates this increase in QY and red-shift in emission color 5 d after 
treatment as the treated sample (right) is significantly brighter and slightly more red than 
the untreated sample (left). Lastly, the FWHM decreased significantly 5 d and 10 d after 
treatment, indicating a significant narrowing of the QD size distribution.  
A possible explanation for the observed red-shift in emission is explained by the 
measured increase in absorbance 10 d after treatment (see Figure 4.18a). Absorbance is 
related to the concentration of QDs in solution, therefore an increase in absorbance is 
indicative of a higher density of particles packed in the QD solution. When the space 
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between QDs is small, it is possible for the wave function of the electrons in an 
individual QD to ‘leak out’ and overlap with the wave function of a neighboring QD.7 
This formation of collective electronic states due to electron overlap interactions results 
in a spectral red-shift of QD emission.7 In conclusion, treatment of CdSe (OA & ODE) 
QDs dissolved in chloroform with NaBH4 resulted in a 170 % increase in the QY of the 
QDs and a red-shift in emission 5 d after treatment. 
 
Figure 4.18. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA 
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (2.02 x 10-5 molar ratio of QDs to NaBH4). 
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
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Table 4.11. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & ODE) QD and NaBH4 solution dissolved in chloroform at a 2.02 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.060 217 2.23 
Initial 0.061 217 2.23 
1 d 0.061 217 2.23 
5 d 0.162 172 2.18 
10 d 0.130 154 2.20 
 
4.2.2 Treatment with Sodium Borohydride (NaBH4) in Toluene 
Figure 4.19 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a 9.21 x 10-5 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 
4.12 below. These values show that the QY of the QDs increased slightly after treatment 
with NaBH4 before decreasing to below that of the untreated QDs 1 d later. Additionally, 
the Eg decreased slightly with time, indicating a minor increase in QD size and red-shift 
in emission color. The pictures included in Figure 4.19 illustrate this decrease in QY and 
red-shift, as the treated sample (right) is less fluorescent and more red than the untreated 
sample (left).  
Similar to the previous section, a possible explanation for the observed red-shift is 
explained by the measured increase in absorbance 5 d and 10 d after treatment (see 
Figure 4.19a). Absorbance is related to the concentration of QDs in solution, therefore an 
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increase in absorbance is indicative of a higher density of particles packed in the QD 
solution. When the space between QDs is small, it is possible for the wave function of the 
electrons in an individual QD to ‘leak out’ and overlap with the wave function of a 
neighboring QD.7 This formation of collective electronic states due to electron overlap 
interactions results in a spectral red-shift of QD emission.7 In conclusion, treatment of 
CdSe (OA & ODE) QDs dissolved in toluene with NaBH4 resulted in a 0.05 % increase 
in the QY of the QDs immediately after treatment as well as a red-shift in emission. 
 
Figure 4.19. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-6 M solution of CdSe (OA 
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with NaBH4 (9.21 x 10-5 molar ratio of QDs to NaBH4). 
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
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Table 4.12. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & ODE) QD and NaBH4 solution dissolved in toluene at a 9.21 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.204 157 2.52 
Initial 0.205 156 2.52 
1 d 0.165 155 2.52 
5 d 0.103 159 2.50 
10 d 0.066 166 2.49 
 
4.2.3 Treatment with Calcium Hydride (CaH2) in Chloroform 
Figure 4.20 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 1.34 x 10-4 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 
4.13. These values show that the QY of the QDs reached a maximum 5 d after treatment 
with CaH2 before decreasing to below that of the untreated QY 10 d later. Additionally, 
the absorbance value increased significantly between 5 d and 10 d after treatment. In a 
study by Mandal et al., an increase in absorbance was found to be indicative of 
aggregation because absorbance measurements are sensitive to scattering from colloidal 
suspensions that form as QD aggregates grow in size.6 Furthermore, they found that a 
decrease in QD fluorescence also resulted from aggregation.6 Similar to treatment of 
CdSe (oleylamine) QDs with CaH2 as described in section 4.1.3 above, the observed 
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increase in absorbance and flattening of the fluorescence peak (see Figure 4.20) indicates 
that the QDs began to aggregate 10 d after treatment.  
 
Figure 4.20. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA 
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with CaH2 (1.34 x 10-4 molar ratio of QDs to CaH2). 
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
Table 4.13. Quantum yield (QY) and full-width half-maximum (FWHM) of a CdSe (OA & ODE) QD and 
CaH2 solution dissolved in chloroform at a 1.34 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.070 156 2.23 
Initial 0.038 218 2.23 
1 d 0.071 163 2.24 
5 d 0.165 155 2.25 
10 d 0.040 163 2.21 
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From the above results, a slight red-shift in emission was also observed 10 d after 
treatment as confirmed by the slight red-shift of the fluorescence peak, minor decrease in 
Eg, and in Figure 4.20e where the treated QDs (right) appeared slightly more red than the 
untreated QDs (left). Several other research groups have reported observing a red-shift in 
conjunction with aggregation.7,17-19 This red-shift is attributed to the tight packing of the 
QDs contained in the aggregates. Similar to treatment with NaBH4 as described in the 
preceding sections, when QDs are tightly packed, the wave function of the electrons in an 
individual QD is believed to ‘leak out’ and overlap with the wave function of a 
neighboring QD.7 This formation of collective electronic states due to electron overlap 
interactions results in a spectral red shift of QD emission.7 In conclusion, treatment of 
CdSe (OA & ODE) QDs dissolved in chloroform with CaH2 resulted in a 136 % increase 
in the QY of the QDs 5 d after treatment and a red-shift due to aggregation 10 d after 
treatment. 
 
4.2.4 Treatment with Calcium Hydride (CaH2) in Toluene 
Figure 4.21 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and calcium hydride (CaH2) solution dissolved in toluene at a 6.10 x 10-4 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 
4.14 below. These values show that the QY of the QDs steadily decreased with time after 
treatment with CaH2. Furthermore, a significant increase in absorbance was observed 
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10 d after treatment (see Figure 4.21a). As explained in detail in section 4.2.3 above, an 
increase in absorbance was found to be indicative of aggregation because absorbance 
measurements are sensitive to scattering from colloidal suspensions that form as QD 
aggregates grow in size.6 Furthermore, aggregation also results in a decrease in QD 
fluorescence.6 It is therefore hypothesized that the observed increase in absorbance 
coupled with a decrease in fluorescence 10 d after treatment indicates that the QDs began 
to aggregate at this time. 
In Table 4.14 below, the FWHM was reported to increase and Eg to decrease 
slightly 5 d and 10 d after treatment, indicating a broadening of the size distribution and 
slight red-shift in emission color. This red-shift was confirmed in Figure 4.21 where the 
treated sample (right) is more red than the untreated sample (left) 5 d (d) and 10 d (e) 
after treatment. Similar to the preceding section, a possible explanation for the observed 
red-shift in emission is attributed to the tight packing of the QDs contained in the 
aggregates. When QDs are tightly packed, the wave function of the electrons in an 
individual QD is believed to ‘leak out’ and overlap with the wave function of a 
neighboring QD.7 This formation of collective electronic states due to electron overlap 
interactions results in a spectral red shift of QD emission.7 In conclusion, treatment of 
CdSe (OA & ODE) QDs dissolved in toluene with CaH2 resulted in a decline in the QY 
of the QDs and a red-shift in emission due to aggregation. 
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Figure 4.21. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-6 M solution of CdSe (OA 
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with CaH2 (6.10 x 10-4 molar ratio of QDs to CaH2). Photos of 
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 4.14. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & ODE) QD and CaH2 solution dissolved in chloroform at a 6.10 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.177 156 2.52 
Initial 0.119 154 2.53 
1 d 0.165 156 2.55 
5 d 0.068 173 2.51 
10 d 0.038 196 2.50 
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4.2.5 Treatment with Hydrazine (N2H4) in Chloroform 
Figure 4.22 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and hydrazine (N2H4) solution dissolved in chloroform at a 2.03 x 10-6 molar 
ratio. Because the fluorescence of the QDs was quenched immediately after treatment, it 
was not possible to calculate the quantum yield (QY), full-width half-maximum (FWHM) 
or bandgap energy (Eg) of the QDs. Similar to treatment of CdSe (oleylamine) QDs in 
chloroform (as described in section 4.1.5 above), the addition of N2H4 resulted in an 
emulsion. We hypothesize that OA was able to act as a surfactant and stabilize the 
hydrazine droplets, as its surface tension (32.5 mN/m9) was in between that of N2H4 
(66.39 mN/m9) and chloroform (27.5 mN/m9). The hydrophilic-lipophilic balance (HLB) 
of OA was found to be 120, indicating that it is a hydrophobic surfactant.11 Chloroform is 
a hydrophobic solvent, therefore OA was found to be a good surfactant that yielded a 
stable emulsion with small, evenly dispersed droplets of N2H4. 
Immediately after adding N2H4 to the chloroform, a small amount of soluble N2H4 
reacted with the QDs and reduced their surface to etch and destroy the QDs thereby 
quenching the QD fluorescence. The fluorescence spectrum included in Figure 4.22b 
confirms this quenching of the fluorescence as the peak completely flattened immediately 
after treatment. The residual OA in the solution then stabilized the remaining N2H4 into 
small, evenly dispersed N2H4 droplets. These droplets scattered the light, causing the 
solution to appear cloudy in visible light. When a 365 nm UV lamp was used as the 
incident light, the evenly dispersed droplets of N2H4 in the QD solution scattered the light 
causing the solution to appear purple (see pictures in Figure 4.22). In conclusion, 
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treatment of CdSe (OA & ODE) QDs dissolved in chloroform with N2H4 caused the QDs 
to stop fluorescing immediately after treatment. 
 
Figure 4.22. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA 
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with N2H4 (2.03 x 10-6 molar ratio of QDs to N2H4). 
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
 
Table 4.15. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & ODE) QD and N2H4 solution dissolved in toluene at a 2.03 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.069 159 2.23 
Initial --- --- --- 
1 d --- --- --- 
5 d --- --- --- 
10 d --- --- --- 
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4.2.6 Treatment with Hydrazine (N2H4) in Toluene 
Figure 4.23 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and hydrazine (N2H4) solution dissolved in toluene at a 9.27 x 10-6 molar ratio. 
From these spectra, quantum yield (QY), full-width half-maximum (FWHM), and 
bandgap energy (Eg) were calculated before treatment, as well as immediately, 1 d, 5 d, 
and 10 d after treatment. These results are summarized in Table 4.16 below. As 
illustrated in Figure 4.23b, immediately after treatment with N2H4, the fluorescence peak 
centered at 550 nm flattened completely and a peak centered at 460 nm was observed. 
This peak was found to be representative of the solution of toluene, OA, ODE, andN2H4, 
not the QDs (see Figure 4.24 below). We therefore hypothesize that immediately after 
treatment with N2H4 the fluorescence of the QD solution was quenched. The blue color 
observed in the pictures included in Figure 4.23 is therefore representative of the 
precursor solution, not the QDs. Because N2H4 is soluble in toluene, the issues explained 
in section 4.2.5 above are not applicable to this system. In conclusion, treatment of CdSe 
(OA & ODE) QDs dissolved in toluene with N2H4 resulted in the quenching of the QD 
fluorescence immediately after treatment. 
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Figure 4.23. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-6 M solution of CdSe (OA 
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with N2H4 (9.27 x 10-6 molar ratio of QDs to N2H4). Photos of 
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 4.16. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & ODE) QD and N2H4 solution dissolved in toluene at a 9.27 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.173 155 2.52 
Initial 0.004 133 2.71 
1 d 0.003 121 2.74 
5 d 0.008 121 2.74 
10 d 0.006 117 2.83 
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Figure 4.24. Normalized fluorescence spectrum of a solution composed of toluene, OA, ODE, and N2H4. 
 
4.2.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform 
Figure 4.25 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 1.29 x 
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, which are summarized in 
Table 4.17 below, show that the QY of the QDs increased significantly after treatment 
with C14H10O4 and reached a maximum 5 d after treatment before decreasing to slightly 
below that of the untreated QY 10 d later. Additionally, the FWHM was at a minimum 
5 d after treatment, indicating a narrowing of the size distribution. Lastly, the absorbance 
peak shifted to a slightly higher wavelength 5 d and 10 d after treatment (Figure 4.25a), 
the fluorescence peak red-shifted slightly (Figure 4.25b), and the Eg decreased slightly, 
indicating a slight red-shift in emission. Figure 4.25 illustrates this increase in QY and 
119 
 
 
 
red-shift, as the treated sample (right) is brighter and slightly more red than the untreated 
sample (left).  
Similar to treatment with CaH2 and NaBH4 as described in the preceding sections, 
a possible explanation for the observed red-shift in emission is explained by the measured 
increase in absorbance 10 d after treatment. Absorbance is related to the concentration of 
QDs in solution, therefore an increase in absorbance is indicative of a higher density of 
particles packed in the QD solution. When the space between QDs is small, it is possible 
for the wave function of the electrons in an individual QD to ‘leak out’ and overlap with 
the wave function of a neighboring QD.7 This formation of collective electronic states 
due to electron overlap interactions results in a spectral red-shift of QD emission.7 In 
conclusion, treatment of CdSe (OA & ODE) QDs dissolved in chloroform with C14H10O4 
resulted in an 81.5 % increase in the QY of the QDs 5 d after treatment as well as a red-
shift in emission. 
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Figure 4.25. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA 
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.29 x 10-4 molar ratio of QDs to 
C14H10O4). Photos of untreated QDs (left) and QDs treated with 0.025 mmol C14H10O4 (right) excited with 
365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 4.17. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & ODE) QD and C14H10O4 solution dissolved in chloroform at a 1.29 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.081 182 2.23 
Initial 0.116 176 2.25 
1 d 0.145 170 2.29 
5 d 0.147 156 2.20 
10 d 0.074 168 2.20 
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4.2.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene 
 Figure 4.26 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 5.86 x 10-4 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 
4.18 below. From these values, it can be seen that the QY of the QDs steadily decreased 
with time after treatment with C14H10O4. Additionally, the absorbance peak shifted to a 
higher wavelength 5 d and 10 d after treatment indicating the QDs grew and size and 
therefore a red-shift in emission is expected. Conversely, the fluorescence peak narrowed 
and centered at a lower wavelength 5 d and 10 d after treatment indicating a blue-shift in 
emission. Furthermore, Figure 4.26 illustrates that the QDs fluoresced pink 5 d and 10 d 
after treatment. An explanation for these conflicting results is not known and it is 
therefore recommended that this treatment be redone to ensure accuracy. In conclusion, 
treatment of CdSe (OA & ODE) QDs dissolved in toluene with C14H10O4 resulted in a 
decrease in the QY of the QDs. 
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Figure 4.26. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-7 M solution of CdSe (OA 
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with C14H10O4 (5.86 x 10-4 molar ratio of QDs to C14H10O4). 
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 4.18. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & ODE) QD and C14H10O4 solution dissolved in toluene at a 5.86 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.186 156 2.50 
Initial 0.185 156 2.50 
1 d 0.125 162 2.49 
5 d 0.034 84.6 2.66 
10 d 0.037 60.6 2.64 
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4.2.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform 
 Figure 4.27 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in chloroform at a 
2.06 x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 
4.19 below. From these values, it can be seen that the QY of the QDs decreased after 
treatment with C4H10O2. Despite this measured decrease in fluorescence, the solution 
appeared blue when excited by a 365 nm UV lamp (see pictures in Figure 4.27) because 
the mixture of residual OA, ODE, and C4H10O2  in solution emits light at 450 nm upon 
excitation (see Figure 4.28). Additionally, the broad fluorescence peak narrowed and 
centered at a lower wavelength, resulting in a decreased FWHM and increased Eg. In 
conclusion, treatment of CdSe (OA & ODE) QDs dissolved in chloroform with C4H10O2 
resulted in a decrease in the QY of the QDs. 
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Figure 4.27. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA 
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (2.06 x 10-6 molar ratio of QDs to 
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 4.19. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & ODE) QD and C4H10O2 solution dissolved in toluene at a 2.06 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.067 157 2.23 
Initial 0.012 198 --- 
1 d 0.013 158 2.31 
5 d 0.021 124 2.30 
10 d 0.007 --- 2.31 
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Figure 4.28. Normalized fluorescence spectrum of a solution composed of chloroform, OA, ODE, and 
C4H10O2. 
 
4.2.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene 
 Figure 4.29 displays the absorbance and fluorescence spectra of a CdSe (OA & 
ODE) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at a 9.39 
x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, which are summarized in 
Table 4.20 below, show that the QY of the QDs decreased after treatment with C4H10O2. 
This decrease in QY was confirmed by the significant decrease in the fluorescence peak 
(Figure 4.29b) as well from the pictures in Figure 4.29 where the treated QDs (right) are 
less bright than the untreated QDs (left). Additionally, the broad fluorescence peak 
narrowed and centered at a lower wavelength, resulting in a decreased FWHM and 
increased Eg. These observations suggest an expected blue-shift in emission which was 
confirmed in Figure 4.29 where the treated QD solution (right) is significantly bluer than 
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the untreated solution (left). In conclusion, treatment of CdSe (OA & ODE) QDs 
dissolved in toluene with C4H10O2 resulted in a decrease in the QY of the QDs. 
 
Figure 4.29. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-6 M solution of CdSe (OA 
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with C4H10O2 (9.39 x 10-6 molar ratio of QDs to C4H10O2). 
Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 4.20. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & ODE) QD and C4H10O2 solution dissolved in toluene at a 9.39 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.173 156 2.52 
Initial 0.002 198 --- 
1 d 0.007 119 2.64 
5 d 0.013 100 2.68 
10 d 0.012 110 2.67 
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4.2.11 Summary of CdSe/OA & ODE Treatments 
 Figure 4.30 compares the effect of treating CdSe (OA & ODE) QDs with various 
reducing and oxidizing agents in chloroform versus toluene. From these photographs, it 
can be seen that the QDs dissolved in toluene were visibly brighter than those in 
chloroform. This observation was confirmed as the QY of the QDs before treatment in 
chloroform was approximately 0.067 while the QY in toluene was approximately 0.170. 
Because both sets of QDs came from the same master batch of cores, this difference in 
QY may be due to the solubility of OA in the various solvents. Thuy et al. have shown 
that the QY is higher when the capping ligand is less soluble in a given solvent.13 From 
our results, we found that the QY of the QDs was higher in toluene than chloroform 
therefore implying that OA is less soluble in toluene than chloroform. The literature, 
however, states that OA is more souble in toluene than chloroform, therefore disproving 
this explanation. A possible explanation for this dependence on solvent may therefore be 
due to the solubility of oxygen in each of the solvents. The Eg of the untreated QDs in 
chloroform and toluene were 2.23 eV and 2.52 eV, respectively, which suggests that the 
solvent does have an effect on QD size and color emitted. An explanation for this 
phenomenon is not readily known, and will be explored via additional characterization 
methods in the future work of this thesis. 
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Figure 4.30. Photos of CdSe (OA & ODE) QDs that are from left to right: untreated, treated with NaBH4, 
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were 
suspended and treated in chloroform while those in the right column were suspended and treated in toluene. 
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment. 
 
The overall effect of reducing and oxidizing agents on the overall QY of CdSe 
(OA & ODE) QDs was found to be independent of solvent for 3 of the 5 treatments. 
More specifically, it was found that the QY of the QDs improved after treatment with 
NaBH4 and worsened after treatment with N2H4 and C4H10O2 in both chloroform and 
toluene. Treatment with CaH2 and C14H10O4, on the other hand, increased the QY of the 
QDs when dissolved in chloroform, but not in toluene. Even though the QY of the QDs 
increased after treatment with NaBH4 in both chloroform and toluene, the percent 
increase in QY in chloroform was significantly higher than in toluene, 170 % compared 
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to 0.05 %, respectively. These results clearly illustrate that the surface treatment of CdSe 
(OA & ODE) QDs was more effective in chloroform than toluene.  
 The reason for this dependence on solvent is not known, however, a possible 
explanation focuses on the solubility of the ligand (OA) in the dispersion solvent. In a 
study by Bullen et al., it was concluded that desorption of the surface ligands may occur 
if the ligand is more soluble in a given solvent, therefore resulting in decreased QY.21 
Oleic acid is more soluble in toluene than chloroform as confirmed by comparing 
Hildebrand solubility parameters. Specifically, the Hildebrand solubility parameter (δ) 
provides a good estimation of the solubility of two substances as it is a numerical 
estimate of the degree of interaction between materials. The closer the δ of two 
substances, the better the degree of solubility. Furthermore, δOA = 15.95, δtoluene = 17.8, 
and δchloroform = 19.0,22 therefore confirming that OA is more soluble in toluene than 
chloroform. For this reason, it can be hypothesized that OA ligands will desorb from the 
QD surface at a faster rate in toluene than chloroform, thereby explaining why surface 
treatment is more effective in chloroform than toluene. 
 A second possible explanation for the observed results focuses on the solubility of 
the reducing agent in the dispersion solvent. We hypothesize that when a 
reducing/oxidizing agent it highly soluble in a given solvent, it reacts with the QDs at a 
rate so fast desorption of the ligands and aggregation occur before forming a stable QD 
with a CdO layer.7 The net result is an increase in the UV absorbance and a quenching of 
the fluorescence resulting in a decrease in QY. As explained above, treatment of QDs 
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dispersed in toluene resulted in a decreased QY, while treatment in chloroform enhanced 
the QY. We therefore hypothesize that CaH2 is more soluble in toluene than chloroform, 
resulting in a faster reduction rate of the QDs when dissolved and treated in the former 
solvent. Unfortunately, information is not currently available regarding the solubility of 
CaH2 in toluene versus chloroform. For this reason, it is recommended that future work 
include a solubility study to determine the solubility of CaH2 in both chloroform and 
toluene to confirm this theory.   
 Treatment with C14H10O4 also resulted in an enhanced QY when the QDs were 
dispersed and treated in chloroform but not in toluene. This result is opposite of the 
results obtained in the treatment of CdSe (oleylamine) QDs as detailed in section 4.1.11 
above. When dissolved in toluene, treatment with C14H10O4 resulted in conflicting results. 
Specifically, the absorbance spectrum showed a red-shift in emission while the 
fluorescence spectrum showed a blue-shift in emission after treatment. An explanation 
for these conflicting results is not known and it was therefore recommended that this 
treatment be redone to ensure accuracy. It is expected that after retreating CdSe (OA & 
ODE) QDs dissolved in toluene with C14H10O4 , a greater increase in QY will result than 
the 81.5 % increase observed when the QDs were dissolved in chloroform. This 
expectation is supported by the fact that C14H10O4 is more soluble in chloroform than 
toluene, therefore the rate of reaction will be higher in chloroform than toluene. Because 
an increase in QY was observed in chloroform, it can therefore be hypothesized that an 
even greater increase in QY will be observed when the QDs are retreated in toluene.  
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In Figure 4.30, it can clearly be seen that treatment with N2H4 and C4H10O2 had a 
different effect in chloroform than toluene. Specifically, the QD solutions appeared very 
bright when dissolved in chloroform but did not fluoresce when in toluene. Although the 
QY was calculated to decrease after treatment in both solvents, the reason for the 
observed decrease was very different. In the case of N2H4, as explained in detail in the 
preceding sections, the reducing agent was nearly insoluble in chloroform and has poor 
solubility in toluene. For this reason, an emulsion formed when the QDs were treated in 
chloroform, causing the incident light to scatter, and the QD solution to appear purple. 
When the QDs were treated in toluene, however, the N2H4 was soluble in toluene 
therefore no emulsion formed. Instead, the QDs reacted with the reducing agent 
immediately after treatment resulting in a quenched fluorescence. In the case of C4H10O2, 
when added to QDs dispersed in chloroform, the solution appeared significantly brighter 
than when added to toluene, even though the QY was calculated to decrease in both 
cases. A reason for this decrease is not known, however, as explained above, the 
increased solubility of OA in toluene over chloroform may be a potential reason. 
In section 4.1.11 above, a fluorescence peak centered at approximately 450 nm 
was observed in every measured fluorescence spectra. This peak was not observed in any 
of the 10 preceding sections. Similar to the case of oleylamine, fluorescence spectroscopy 
was performed on solutions consisting of each OA, ODE, solvent, and reducing/oxidizing 
agent combination to account for the potential influence of the various reaction materials 
on QD fluorescence. In these spectra, a peak at 450 nm was measured and was therefore 
said to be representative of the reaction materials. Because this peak was not observed in 
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the above spectra, we hypothesize that there was no residual OA present in the solvents. 
In other words, if residual OA was present in the solution, we would expect to see a 
fluorescence peak representing its interaction with the solvent it is dispersed in and added 
reducing/oxidizing agent.  
 
4.3 CdSe (OA and TOA) Quantum Dot Cores  
4.3.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform 
 Figure 4.31 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 5.54 x 
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
4.21 below, show that the QY of the QDs steadily increased after treatment with NaBH4 
until reaching a maximum 10 d after treatment. Figure 4.31e illustrates this increase in 
QY 10 d after treatment, as the treated sample (right) is brighter than the untreated 
sample (left). Additionally, no notable change in FWHM or Eg was observed therefore 
ruling out a significant broadening of the QD size distribution or shift in QD emission 
after treatment. 
 In calculating QY for this sample, the fluorescence peak centered at 620 nm was 
determined to be representative of the QDs rather than the negative peak centered at 
430 nm because the QDs fluoresced red in color (see pictures in Figure 4.31) which 
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indicates a higher wavelength. To account for the potential influence of the various 
reaction materials on the negative fluorescence peak, fluorescence spectroscopy was 
performed on a solution of chloroform, OA, TOA and NaBH4. The normalized 
fluorescence spectrum of this solution is included in Figure 4.32. From this spectrum it 
can be seen that a significant fluorescence peak centered at 450 nm resulted, however, no 
negative peak was measured. An explanation for this negative peak is therefore not 
known and will be explored further in future work. In conclusion, treatment of CdSe (OA 
& TOA) QDs dissolved in chloroform with NaBH4 resulted in a 133 % increase in the 
QY of the QDs 10 d after treatment. 
 
Figure 4.31. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (5.54 x 10-5 molar ratio of QDs to NaBH4). 
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
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Table 4.21. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and NaBH4 solution dissolved in chloroform at a 5.54 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.003 53.5 1.92 
Initial 0.005 56.4 1.91 
1 d 0.005 53.0 1.91 
5 d 0.004 50.6 1.92 
10 d 0.007 53.3 1.93 
 
 
Figure 4.32. Normalized fluorescence spectrum of a solution composed of chloroform, OA, TOA and 
NaBH4. 
 
4.3.2 Treatment with Sodium Borohydride (NaBH4) in Toluene 
Figure 4.33 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a 5.83 x 10-5 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
4.22 below, show that the QY of the QDs steadily decreased with time after treatment 
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with NaBH4. From the pictures in Figure 4.33, however, an increase in the QY was 
observed as the treated QDs (right) appeared more bright than the untreated QDs (left). In 
fact, the untreated QD solution appeared to decrease in brightness with time. This result 
leads to the hypothesis that CdSe (OA & TOA) QDs are not stable with time. 
Furthermore, this decrease in the QY of the untreated QDs over time may explain why 
the QY calculated after treatment with NaBH4 decreased with time even though an 
increase in brightness was observed. Lastly, no noticeable change in FWHM or Eg was 
observed, therefore ruling out a significant change in the size distribution or size of the 
QDs. In conclusion, treatment of CdSe (OA & TOA) QDs dissolved in toluene with 
NaBH4 resulted in an increase in the QY of the QDs. 
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Figure 4.33. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with NaBH4 (5.83 x 10-5 molar ratio of QDs to NaBH4). 
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 4.22. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and NaBH4 solution dissolved in toluene at a 5.83 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.073 61.1 1.92 
Initial 0.072 60.7 1.92 
1 d 0.040 55.2 1.93 
5 d 0.040 56.1 1.93 
10 d 0.038 56.7 1.93 
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4.3.3 Treatment with Calcium Hydride (CaH2) in Chloroform 
Figure 4.34 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 6.00 x 10-5 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
4.23 below, show that the QY of the QDs decreased immediately after treatment with 
CaH2 and the QDs stopped fluorescing 5 d after treatment. Additionally, the absorbance 
value increased after treatment. In a study by Mandal et al., an increase in absorbance 
was found to be indicative of aggregation because absorbance measurements are sensitive 
to scattering from colloidal suspensions that form as QD aggregates grow in size.6 
Furthermore, they found that a decrease in QD fluorescence also resulted from 
aggregation.6 Similar to treatment of CdSe (OA & ODE) QDs with CaH2 as described in 
section 4.2.3 above, the observed increase in absorbance and flattening of the 
fluorescence peak (see Figure 4.34) therefore indicate that the QDs began to aggregate 
5 d after treatment. In Figure 4.34d, a decrease in the QY was observed as the treated 
QDs (right) are less bright than the untreated QDs (left).  
The absorbance continued to increase 10 d after treatment (see purple line in 
Figure 4.34a) which indicates that the QD aggregates continued to grow between 5 d and 
10 d after treatment. Furthermore, because in Figure 4.34e the fluorescence of the treated 
QDs solution is quenched, it can be hypothesized that the aggregates grew large enough 
that the QDs precipitated out of solution at this time.7 Lastly, as explained in section 
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4.3.1, a reason for the observed negative peak centered at 430 nm is not readily known 
and will be explored further in future work. In conclusion, treatment of CdSe (OA & 
TOA) QDs dissolved in chloroform with CaH2 resulted in a quenching of the QD 
fluorescence 10 d after treatment due to aggregation. 
 
Figure 4.34. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with CaH2 (6.00 x 10-5 molar ratio of QDs to CaH2). 
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
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Table 4.23. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and CaH2 solution dissolved in chloroform at a 6.00 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.003 53.5 1.92 
Initial 0.002 56.7 1.90 
1 d 0.002 54.0 1.91 
5 d --- --- --- 
10 d --- --- --- 
 
4.3.4 Treatment with Calcium Hydride (CaH2) in Toluene 
Figure 4.35 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and calcium hydride (CaH2) solution dissolved in toluene at a 6.31 x 10-5 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
4.24 below, show that the QY of the QDs steadily decreased with time after treatment 
with CaH2. This decrease in QY after treatment was confirmed by both the flattening of 
the fluorescence peak and pictures included in Figure 4.35 where the treated QDs (right) 
appeared less bright than the untreated QDs (left). Additionally, a slightly broader 
fluorescence peak, increased FWHM, and less refined absorption peak indicate 
broadening of the QD size distribution after treatment. In conclusion, treatment of CdSe 
(OA & TOA) QDs dissolved in toluene with CaH2 resulted in a decrease in the QY of the 
QDs. 
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Figure 4.35. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with CaH2 (6.31 x 10-5 molar ratio of QDs to CaH2). Photos of 
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 4.24. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and CaH2 solution dissolved in toluene at a 6.31 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.047 61.8 1.92 
Initial 0.034 64.7 1.91 
1 d 0.038 64.2 1.92 
5 d 0.012 74.2 1.90 
10 d 0.002 75.3 1.88 
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4.3.5 Treatment with Hydrazine (N2H4) in Chloroform 
Figure 4.36 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and hydrazine (N2H4) solution dissolved in chloroform at a 3.04 x 10-7 molar 
ratio. From these spectra, quantum yield (QY), full-width half-maximum (FWHM), and 
bandgap energy (Eg) were calculated before treatment, as well as immediately, 1 d, 5 d, 
and 10 d after treatment. These results are summarized in Table 4.25 below. Similar to 
treatment of CdSe (OA & ODE) QDs in chloroform (as described in section 4.2.5 above), 
treatment of CdSe (OA & TOA) QDs with N2H4 resulted in an emulsion due to the near 
insolubility of N2H4 in chloroform. Although it was previously concluded that OA was a 
good surfactant in chloroform due to its low HLB value, large, poorly dispersed droplets 
of N2H4 formed in the treatment of CdSe (OA & TOA) QDs in chloroform (see pictures 
in Figure 4.36).  
Octadecene does not have surfactant-like properties because it does not contain 
both polar and non-polar groups, therefore it was not a factor in the emulsion described in 
section 4.2.5. Tricoctylamine, on the other hand, does contain polar and non-polar groups 
and was therefore a factor in the emulsion. More specifically, the nitrogen in TOA forms 
three bonds, leaving a single lone pair of electrons. We hypothesize that this lone pair of 
electrons is repelled by the lone pair of electrons of N2H4, preventing all of the reducing 
agent from reacting with the QDs. Instead, immediately after adding N2H4 to the 
chloroform, a small amount of soluble N2H4 reacted with the QDs and reduced their 
surface to etch and destroy the QDs thereby quenching the QD fluorescence. The 
fluorescence spectrum included in Figure 4.36b confirms this quenching of the 
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fluorescence as the peak completely flattened immediately after treatment. The remainder 
of the N2H4 formed large, unevenly dispersed N2H4 droplets stabilized by the residual OA 
and TOA. The solution appeared blue-green when excited by a 365 nm UV lamp because 
the mixture of chloroform, OA, and TOA emits light at 450 nm upon excitation (see 
Figure 4.37). After 10 d a visible layer formed at the top of the chloroform solution, 
presumably due to instability of the emulsion (see Figure 4.36e). This result is consistent 
with the result of treating CdSe (oleylamine) QDs in chloroform with N2H4 as explained 
in section 4.1.5 above. 
 
Figure 4.36. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with N2H4 (3.04 x 10-7 molar ratio of QDs to N2H4). 
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
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Table 4.25. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and N2H4 solution dissolved in chloroform at a 3.04 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.003 53.5 1.92 
Initial --- --- --- 
1 d 0.004 103 --- 
5 d 0.074 101 2.33 
10 d --- --- --- 
 
 
Figure 4.37. Normalized fluorescence spectrum of a solution composed of chloroform, OA, TOA, and 
N2H4. 
 
It is unclear why the fluorescence spectrum of the QDs 5 d after treatment is not 
similar to that of the 10 d spectrum. A possible explanation is that the cuvette in which 
the fluorescence was measured was contaminated. Lastly, as explained in section 4.3.1, a 
reason for the observed negative peak centered at 430 nm is not readily known and will 
be explored further in future work. Figure 4.36b shows a second negative peak centered 
at 650 nm that appeared 10 d after treatment. This too will be explored in future work. In 
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conclusion, treatment of CdSe (OA & TOA) QDs dissolved in chloroform with N2H4 
resulted in a quenching of the QD fluorescence. 
 
4.3.6 Treatment with Hydrazine (N2H4) in Toluene 
Figure 4.38 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and hydrazine (N2H4) solution dissolved in toluene at a 3.20 x 10-7 molar ratio. 
From these spectra, quantum yield (QY), full-width half-maximum (FWHM), and 
bandgap energy (Eg) were calculated before treatment, as well as immediately, 1 d, 5 d, 
and 10 d after treatment. These results, as summarized in Table 4.26 below, show that the 
QY of the QDs decreased immediately after treatment with N2H4. Although N2H4 is 
soluble in toluene, residual TOA in the QD solution prevented all of the reducing agent 
from reacting with the QDs, similar to treatment in chloroform as described in section 
4.2.5 above. Instead, immediately after adding N2H4 to the toluene, a small amount of 
N2H4 reacted with the QDs and reduced their surface to etch and destroy the QDs thereby 
quenching the QD fluorescence. The fluorescence spectrum included in Figure 4.38b 
confirms this quenching of the fluorescence as the peak completely flattened immediately 
after treatment. The remainder of the N2H4 formed large, unevenly dispersed N2H4 
droplets stabilized by the residual OA and TOA. The solution appeared blue-green when 
excited by a 365 nm UV lamp because the mixture of toluene, OA, and TOA emits light 
at 450 nm upon excitation (see Figure 4.39). After 10 d, unreacted N2H4 would visibly be 
seen in the toluene solution (see Figure 4.38e). A distinct N2H4 layer did not form in this 
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case because N2H4 is more dense than toluene. In conclusion, treatment of CdSe (OA & 
TOA) QDs dissolved in toluene with N2H4 resulted in a quenching of the QD 
fluorescence. 
 
Figure 4.38. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with N2H4 (3.20 x 10-7 molar ratio of QDs to N2H4). Photos of 
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
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Table 4.26. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and N2H4 solution dissolved in toluene at a 3.20 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.054 61.2 1.92 
Initial 0.007 164 2.43 
1 d 0.001 137 --- 
5 d 0.005 116 2.43 
10 d 0.005 151 2.43 
 
 
Figure 4.39. Normalized fluorescence spectrum of a solution composed of toluene, OA, TOA, and N2H4. 
 
4.3.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform 
Figure 4.40 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 1.20 x 
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
4.27 below, show that the QY of the QDs increased slightly 1 d after treatment with 
C14H10O4 before decreasing to below that of the untreated QY 10 d later. Additionally, no 
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notable change in FWHM or Eg was observed therefore ruling out a significant 
broadening of the QD size distribution or change in QD size after treatment. Furthermore, 
as explained in section 4.3.1, a reason for the observed negative peak centered at 430 nm 
is not readily known and will be explored further in future work. In conclusion, treatment 
of CdSe (OA & TOA) QDs dissolved in chloroform with C14H10O4 resulted in a 66.7 % 
increase in the QY of the QDs 1 d after treatment. 
 
Figure 4.40. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.20 x 10-4 molar ratio of QDs to 
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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Table 4.27. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and C14H10O4 solution dissolved in chloroform at a 1.20 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.003 53.5 1.92 
Initial 0.003 54.3 1.93 
1 d 0.005 52.8 1.93 
5 d 0.003 54.0 1.93 
10 d 0.002 54.7 1.95 
 
4.3.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene 
Figure 4.41 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 1.26 x 10-4 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
4.28 below, show that the QY of the QDs steadily decreased with time after treatment 
with C14H10O4. This decrease in QY after treatment was confirmed by the flattening of 
the fluorescence peak and by the pictures in Figure 4.41 where the treated QDs (right) 
were less bright than the untreated QDs (left). Additionally, no notable change in FWHM 
or Eg was observed therefore ruling out a significant broadening of the QD size 
distribution or change in QD size after treatment. In conclusion, treatment of CdSe (OA 
& TOA) QDs dissolved in toluene with C14H10O4 resulted in a decrease in the QY of the 
QDs. 
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Figure 4.41. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.26 x 10-4 molar ratio of QDs to C14H10O4). 
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 4.28. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and C14H10O4 solution dissolved in toluene at a 1.26 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.051 63.3 1.92 
Initial 0.050 63.0 1.92 
1 d 0.029 61.3 1.92 
5 d 0.004 67.7 1.93 
10 d 0.001 56.2 1.95 
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4.3.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform 
Figure 4.42 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and tert-Butyl Hydroperoxide (C4H10O2) solution dissolved in chloroform at a 
1.38 x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
4.29 below, show that the QY of the QDs decreased immediately after treatment with 
C4H10O2. In fact, the QDs stopped fluorescing 5 d after treatment as confirmed by both 
the flattening of the fluorescence spectrum and Figure 4.42 where the treated QDs (right) 
no longer fluoresced. Furthermore, as seen in the fluorescence spectra of each of the 
treatments completed in chloroform, a negative peak centered at 430 nm was measured. 
A second negative peak centered at 650 nm was also measured 10 d after treatment with 
N2H4 as mentioned in section 4.3.5 above. As seen in Figure 4.42b below, both of these 
negative peaks were observed after treatment with C4H10O2. An explanation for these 
negative peaks is not readily known and will be explored further in future work. In 
conclusion, treatment of CdSe (OA & TOA) QDs dissolved in chloroform with C4H10O2 
resulted in a quenching of the QD fluorescence. 
151 
 
 
 
 
Figure 4.42. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (1.38 x 10-6 molar ratio of QDs to 
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 4.29. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and C4H10O2 solution dissolved in chloroform at a 1.38 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.003 53.5 1.92 
Initial 0.001 56.1 1.92 
1 d 0.001 65.0 --- 
5 d --- --- --- 
10 d --- --- --- 
 
 
152 
 
 
 
4.3.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene 
Figure 4.43 displays the absorbance and fluorescence spectra of a CdSe (OA & 
TOA) QD and tert-Butyl Hydroperoxide (C4H10O2) solution dissolved in toluene at a 1.46 
x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
4.30 below, show that the QY of the QDs decreased immediately after treatment with 
C4H10O2. A significant increase in absorbance was also observed immediately after 
treatment (see orange line in Figure 4.43a). In a study by Mandal et al., an increase in 
absorbance was found to be indicative of aggregation because absorbance measurements 
are sensitive to scattering from colloidal suspensions that form as QD aggregates grow in 
size.6 Furthermore, they found that a significant decrease in QD fluorescence also 
resulted from aggregation.6 It can therefore be concluded that the flattening of the 
fluorescence peak coupled with the significant increase in absorbance observed 
immediately after treatment with C4H10O2, indicates that the QDs began to aggregate at 
this time. Eventually, the aggregates grew to a size that allowed them to be clearly visible 
in the solution, causing the solution to appear cloudy in visible light. When excited with a 
365 nm UV light, as seen in the pictures in Figure 4.43, the aggregates scattered the 
incident light and caused the solution to appear pink. As time progressed, the aggregates 
continued to grow until the QDs precipitated out of solution 5 d after treatment as seen by 
the quenching of the QD fluorescence in Figure 4.43d. 
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Figure 4.43. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA 
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with C4H10O2 (1.46 x 10-6 molar ratio of QDs to C4H10O2). 
Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 4.30. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe 
(OA & TOA) QD and C4H10O2 solution dissolved in toluene at a 1.46 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.029 64.1 1.92 
Initial --- --- --- 
1 d 0.002 62.4 1.90 
5 d 0.002 71.5 2.46 
10 d 0.010 69.5 2.44 
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Similar to treatment of CdSe (oleylamine) QDs with C4H10O2 in chloroform (as 
described in section 4.1.9 above), the fluorescence peak centered at 600 nm in Figure 
4.43 represents the emission of the QDs. The peak measured 10 d (purple) after 
treatment, on the other hand, is centered at 450 nm and is therefore representative of the 
mixture of toluene, OA, TOA, and C4H10O2, not the QDs (see Figure 4.44 below). For 
this reason, it can be confirmed that the fluorescence of the QDs died 5 d after treatment. 
In conclusion, treatment of CdSe (OA & TOA) QDs dissolved in toluene with C4H10O2 
resulted in a decrease in the QY of the QDs due to aggregation.  
 
Figure 4.44. Normalized fluorescence spectrum of a solution composed of toluene, OA, TOA, and  
C4H10O2. 
 
4.3.11 Summary of CdSe/OA & TOA Treatments 
 Figure 4.45 compares the effect of treating CdSe (OA & TOA) QDs with various 
reducing and oxidizing agents in chloroform versus toluene. The quality of this batch of 
QDs was significantly less than that of the previous 2 batches described above, as seen 
from these photographs. The QY of the QDs before treatment in chloroform was 
approximately 0.003 while the QY in toluene was approximately 0.049. Because both 
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sets of QDs came from the same master batch of cores, this difference in QY may be due 
to the solubility of OA in the various solvents. Thuy et al. have shown that the QY is 
higher when the capping ligand is less soluble in a given solvent.13 From our results, we 
found that the QY of the QDs was higher in toluene than chloroform therefore implying 
that OA is less soluble in toluene than chloroform. The literature, however, states that OA 
is more soluble in toluene than chloroform, therefore disproving this explanation. A 
possible explanation for this dependence on solvent may therefore be due to the solubility 
of oxygen in each of the solvents. This hypothesis is consistent with the results 
summarized in section 4.2.11. The Eg of the untreated QDs in chloroform and toluene 
were both 1.92 eV, which suggests that the solvent does not have an effect on QD size 
and color emitted.  
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Figure 4.45. Photos of CdSe (OA & TOA) QDs that are from left to right: untreated, treated with NaBH4, 
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were 
suspended and treated in chloroform while those in the right column were suspended and treated in toluene. 
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment. 
 
The overall effect of reducing and oxidizing agents on the QY of CdSe (OA & 
TOA) QDs was found to be independent of solvent for 4 of the 5 treatments. More 
specifically, it was found that the quality of the QDs worsened after treatment with CaH2, 
N2H4, and C4H10O2 and improved after treatment with NaBH4 in both chloroform and 
toluene. Treatment with C14H10O4, on the other hand, increased the quality of the QDs 
when dissolved in chloroform, but not in toluene. Even though the QY of the QDs 
increased after treatment with NaBH4 in both chloroform and toluene, in chloroform a 
133 % increase was calculated whereas the increased QY was only qualitative in toluene. 
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Similar to treatment of CdSe (OA & ODE) QDs, as discussed in section 4.2.11 above, 
these results clearly illustrate that the surface treatment of CdSe (OA & ODE) QDs was 
more effective in chloroform than toluene.  
 The reason for this dependence on solvent is not known, however, the two 
possible explanations discussed in detail in section 4.2.11 above can be applied to this 
system because the capping ligand is still OA. The first explanation focuses on the 
solubility of the ligand (OA) in the dispersion solvent. Specifically, it is hypothesized that 
because OA is more soluble in toluene than chloroform, OA ligands will desorb from the 
QD surface at a faster rate in toluene than chloroform. As the ligands continue to detach 
from the QD surface, the QDs are unable to remain dispersed in the solvent and the QY 
decreases. The second explanation focuses on the solubility of the reducing agent in the 
dispersion solvent. Specifically, if a given reducing/oxidizing agent is more soluble is a 
particular solvent, it will react at a much faster rate than when the treatment occurs in a 
solvent to which it is less soluble. If the reaction happens too fast, the ligands will detach 
from the QD surface before oxygen is able to diffuse to the QD surface to form a CdO 
layer and therefore will not be able to passivate the surface defect sites. To confirm either 
of these explanations, future work is required. 
 As mentioned above, treatment of CdS (OA & TOA) QDs with NaBH4 resulted in 
an enhanced QY, while treatment with CaH2 decreased the QY of the QDs. This same 
result was observed in the treatment of CdSe (oleylamine QDs). As explained in section 
4.1.11 above, we hypothesize that this result can be explained by a difference in the 
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reducing agents reactivity with water. Specifically, we hypothesize that the reducing 
agents react with the residual water present in each of the solvents to form hydrogen. The 
hydrogen then reacts with the surface ligands, causing them to detach from the QD 
surface, and allowing oxygen from the atmospheric air to diffuse to the exposed 
cadmium. The resulting CdO layer around the QDs serves to passivate the defect sites 
located on the QD surface and therefore improves the QY of the QDs. If the reducing 
agent reacts too fast with the residual water, the QDs will aggregate and the QY will be 
quenched. In a study by Kong et al., the reaction rate of NaBH4 with water vapor was 
found to be ten times slower than that of CaH2.16 For this reason, it is hypothesized that 
CaH2 reacted very fast with the residual water present in the QD solution, causing the 
QDs to aggregate, and the QY to be quenched. This aggregation was confirmed by an 
increase in the measured absorbance. NaBH4, on the other hand, reacted with the water at 
a slow enough rate that the hydrogen produced was able to effectively detach ligands on 
the QD surface and allow for the formation of the CdO layer.  
In the previous summary sections, the observation of a fluorescence peak centered 
at approximately 450 nm was discussed. Fluorescence spectroscopy was performed on 
solutions consisting of each ligand, solvent, and reducing/oxidizing agent combination to 
confirm that this peak was not representative of the QDs. In the case of CdSe 
(oleylamine) QDs, this peak was observed in each of the 10 treatments, however it was 
only observed in 2 of the 10 treatments in the case of CdSe (OA & ODE) QDs. 
Specifically, this peak was seen in the treatment of the QDs in toluene with N2H4 and 
C4H10O2. Although it is not clear why this peak was only measured for 2 of the 5 
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treatments performed in toluene, the trend was consistent with the theory provided above. 
In both of these cases, the peak increased with time which further supports that the 
reaction solution evaporated with time.  
From the spectra seen in the above 10 sections representing CdSe (OA & TOA) 
QDs, a negative peak centered at approximately 450 nm was measured when the QDs 
were dissolved in chloroform. Fluorescence spectroscopy was performed on solutions 
consisting of OA, TOA, chloroform, and each reducing/oxidizing agent to account for 
this negative peak, however, these combinations yielded positive fluorescence peaks 
centered at 450 nm, similar to those included in the previous sections. An explanation for 
this negative peak is therefore not known. Munro et al. reported that chloroform contains 
impurities23 which may explain this unusual result, however because it was not observed 
in all chloroform solutions, no conclusions can be made. It is therefore recommended that 
in future work of this thesis, additional batches of CdSe (OA & TOA) QDs dissolved in 
chloroform be tested to see if a negative fluorescence peak results. If the negative peak is 
observed in these new batches, it is recommended that further characterizations be 
performed to determine its cause. 
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Chapter 5. Results and Discussion: CdS 
Chapter 5 will present and discuss the results of the experimental work performed 
on CdS QDs. This chapter will be divided into three sections: (1) CdS QDs synthesized 
with oleylamine, (2) CdS QDs synthesized with oleic acid (OA) and octadecene (ODE), 
and (3) CdS QDs synthesized with OA and trioctylamine (TOA). Following the same 
model as Chapter 4, each section will summarize the effect of treating the surface of the 
various QD batches with three reducing and two oxidizing agents. More specifically, the 
effect of each treatment on the quantum yield (QY), size distribution, and bandgap 
energy (Eg) of the QDs will be evaluated. The reducing agents to be investigated include: 
sodium borohydride (NaBH4), calcium hydride (CaH2), and hydrazine (N2H4), while the 
oxidizing agents include: benzoyl peroxide (C14H10O4) and tert-butyl hydroperoxide 
(C4H10O2).  
 
5.1 CdS (Oleylamine) Quantum Dot Cores  
5.1.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform 
 Figure 5.1 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 
6.11 x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.1 below, show that the QY of the QDs reached a maximum 10 d after treatment with 
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NaBH4. Additionally, the Eg decreased and fluorescence peak shifted to a lower 
wavelength 5 d and 10 d after treatment indicating a blue-shift in emission. This increase 
in QY and blue-shift in emission are illustrated in Figure 5.1e as the treated solution 
(right) is brighter and more blue than the untreated solution (left). Lastly, the FWHM 
decreased slightly 5 d and 10 d after treatment, indicating a narrowing of the QD size 
distribution. In conclusion, treatment of CdS (oleylamine) QDs dissolved in chloroform 
with NaBH4 resulted in a 3.85 % increase in the QY of the QDs 10 d after treatment. 
 
Figure 5.1. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 
d (red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (6.11 x 10-6 molar ratio of QDs to 
NaBH4). Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light 
(c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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Table 5.1. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and NaBH4 solution dissolved in chloroform at a 6.11 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.078 194 2.42 
Initial 0.076 195 2.42 
1 d 0.076 194 2.42 
5 d 0.074 146 2.49 
10 d 0.081 134 2.50 
 
5.1.2 Treatment with Sodium Borohydride (NaBH4) in Toluene 
 Figure 5.2 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a 
4.18 x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.2 below, show that the QY of the QDs reached a maximum 5 d after treatment with 
NaBH4 before decreasing to below that of the untreated QY 10 d later. This increase in 
QY 5 d after treatment is illustrated in Figure 5.2d as the treated sample (right) is brighter 
than the untreated sample (left). In Figure 5.2e, however, the treated sample (right) is less 
bright than the untreated sample (left) confirming the QY calculations. Additionally, the 
FWHM decreased slightly 5 d and 10 d after treatment, indicating a narrowing of the QD 
size distribution. In conclusion, treatment of CdS (oleylamine) QDs dissolved in toluene 
with NaBH4 resulted in a 23.4 % increase in QY of the QDs 5 d after treatment. 
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Figure 5.2. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (4.18 x 10-6 molar ratio of QDs to NaBH4). 
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 5.2. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and NaBH4 solution dissolved in toluene at a 4.18 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.448 174 2.40 
Initial 0.440 175 2.40 
1 d 0.450 174 2.40 
5 d 0.553 158 2.48 
10 d 0.391 148 2.50 
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5.1.3 Treatment with Calcium Hydride (CaH2) in Chloroform 
Figure 5.3 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 2.01 x 
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 5.3 
below, show that the QY of the QDs decreased after treatment with CaH2. The spectra in 
Figure 5.3 illustrate that the fluorescence peak flattened and the absorbance increased 
immediately after treatment. In a study by Mandal et al., an increase in absorbance was 
found to be indicative of aggregation because absorbance measurements are sensitive to 
scattering from colloidal suspensions that form as QD aggregates grow in size.1 
Furthermore, they found that a significant decrease in QD fluorescence also resulted from 
aggregation.1 It can therefore be hypothesized that the flattening of the fluorescence peak 
coupled with the significant increase in absorbance observed immediately after treatment 
with CaH2, indicates that the QDs began to aggregate at this time.  
Figure 5.3d shows that 5 d after treatment, a slight red-shift was observed as the 
treated QDs (right) appear more red than the untreated QDs (left). This red-shift is 
attributed to the tight packing of the QDs contained in the aggregates. When the QDs are 
tightly packed, the wave function of the electrons in an individual QD is believed to ‘leak 
out’ and overlap with the wave function of a neighboring QD.2 This formation of 
collective electronic states due to electron overlap interactions results in a spectral red 
shift of QD emission.2 Between 5 d and 10 d after treatment, the aggregates continued to 
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grow until the QDs precipitated out of solution, as seen in Figure 5.3e where the QD 
solution no longer fluoresced. Rather than confirming this quenching of the QY by 
completely flattening, the fluorescence peak blue-shifted to a wavelength of 450 nm (see 
purple peak in Figure 5.3). 
As seen in the CdSe (oleylamine) treatments, the same peak was observed at 
450 nm (see section 4.2). After performing fluorescence spectroscopy on a solution of 
each oleylamine, chloroform, and reducing/oxidizing agent combination, the peak was 
determined to represent the precursor solution, not the QDs. To verify that the peak 
measured 10 d after treatment of CdS (oleylamine) QDs with CaH2 was also 
representative of the precursor solution, fluorescence spectroscopy was performed on a 
solution consisting of oleylamine, chloroform, and CaH2. This normalized fluorescence 
spectrum can be seen in Figure 5.4 below. A peak centered at 450 nm was clearly 
measured, therefore confirming that the blue fluorescence peak centered at 510 nm was 
representative of the QDs. For this reason, it can be confirmed that the CdS (oleylamine) 
QDs stopped fluorescing 10 d after treatment with CaH2 due to precipitation of the QDs. 
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Figure 5.3. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 
d (red), 5 d (green), and 10 d (purple) after treatment with CaH2 (2.01 x 10-5 molar ratio of QDs to CaH2). 
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
 
Table 5.3. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and CaH2 solution dissolved in chloroform at a 2.01 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.087 197 2.42 
Initial 0.012 194 2.41 
1 d 0.032 158 2.42 
5 d 0.049 181 2.43 
10 d 0.037 63.9 2.51 
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Figure 5.4. Normalized fluorescence spectrum of a solution composed of chloroform, oleylamine, and 
CaH2. 
 
5.1.4 Treatment with Calcium Hydride (CaH2) in Toluene 
Figure 5.5 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and calcium hydride (CaH2) solution dissolved in toluene at a 1.38 x  
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 5.4 
below, show that the QY of the QDs decreased after treatment with CaH2. This decrease 
in QY was confirmed by both the fluorescence spectrum and pictures included in Figure 
5.5 as the treated sample (right) is less bright than the untreated sample (left). 
Additionally, no notable change in FWHM or Eg was observed therefore ruling out a 
significant broadening of the QD size distribution or change in QD size after treatment. 
In conclusion, treatment of CdS (oleylamine) QDs dissolved in toluene with CaH2 
resulted in a decrease in the QY of the QDs. 
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Figure 5.5. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with CaH2 (1.38 x 10-5 molar ratio of QDs to CaH2). 
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
 
Table 5.4. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and CaH2 solution dissolved in toluene at a 1.38 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.471 174 2.40 
Initial 0.193 174 2.42 
1 d 0.210 170 2.42 
5 d 0.442 183 2.40 
10 d 0.212 187 2.41 
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5.1.5 Treatment with Hydrazine (N2H4) in Chloroform 
Figure 5.6 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and hydrazine (N2H4) solution dissolved in chloroform at a 1.02 x 10-7 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 5.5 
below. From these values, it can be seen that the QY of the QDs decreased after treatment 
with N2H4. Similar to treatment of CdSe (oleylamine) QDs in chloroform (as described in 
section 4.1.5), the addition of N2H4 resulted in an emulsion. Oleylamine was again 
identified as the surfactant, as its surface tension (31.4 mN/m3) was in between that of 
N2H4 (66.39 mN/m3) and chloroform (27.5 mN/m3).  
Immediately after treatment, a small amount of soluble N2H4 reacted with the 
QDs and reduced their surface to etch and destroy the QDs thereby quenching the QD 
fluorescence. The remainder of the N2H4 formed large, unevenly dispersed N2H4 droplets 
stabilized by the residual oleylamine. Because the large droplets could clearly be seen in 
the solution, similar to the corresponding CdSe case, I shook the solution. Agitation 
enabled the large N2H4 droplets to break up and disperse in the solution temporarily, 
thereby scattering the 365 nm UV light and causing the solution to appear purple (see 
Figure 5.6c). Five days after treatment, the N2H4 droplets returned to their original size 
and again were clearly separated from the chloroform. Figure 5.6d confirms this 
observation as large, poorly dispersed N2H4 droplets were again visible. After 10 d a 
visible layer formed at the top of the chloroform solution, presumably due to instability 
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of the emulsion (see Figure 5.6e). The solution appeared blue-green when excited by a 
365 nm UV lamp because the oleylamine emits light at 450 nm upon excitation (see 
Figure 4.6 in Chapter 4). In conclusion, the fluorescence of CdS (oleylamine) QDs 
dissolved in chloroform died immediately after treatment with N2H4. 
 
Figure 5.6. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 
d (red), 5 d (green), and 10 d (purple) after treatment with N2H4 (1.02 x 10-7 molar ratio of QDs to N2H4). 
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
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Table 5.5. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and N2H4 solution dissolved in chloroform at a 1.02 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.071 197 2.42 
Initial 0.008 --- 2.55 
1 d 0.005 --- --- 
5 d 0.011 75.0 2.56 
10 d 0.029 66.2 2.57 
 
5.1.6 Treatment with Hydrazine (N2H4) in Toluene 
Figure 5.7 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and hydrazine (N2H4) solution dissolved in toluene at a 6.96 x 10-8 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 5.6 
below, show that the QY of the QDs was quenched immediately after treatment with 
N2H4. This decrease in QY was confirmed by the pictures included in Figure 5.3 as the 
treated sample (right) is less bright than the untreated sample (left). Similar to several of 
the treatments described previously, the fluorescence peak centered at 510 nm in Figure 
5.7b represents the emission of the QDs. The peaks measured 5 d (green) and 10 d 
(purple) after treatment, on the other hand, are centered at approximately 440 nm and are 
therefore representative of the mixture of toluene, oleylamine, and N2H4, not the QDs 
(see Figure 5.8 below). Focusing on the peak representing the QDs, it can therefore be 
seen that the fluorescence of the QDs was quenched immediately after treatment. 
Hydrazine is soluble in toluene, therefore it was assumed that all of the reducing agent 
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reacted with the QDs immediately after treatment and the concerns discussed in section 
5.1.5 above were not applicable. In conclusion, treatment of CdS (oleylamine) QDs 
dissolved in toluene with N2H4 resulted in a quenching of the fluorescence of the QDs. 
 
Figure 5.7. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with N2H4 (6.96 x 10-8 molar ratio of QDs to N2H4). 
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 
5 d, and (e) 10 d after treatment. 
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Table 5.6. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and N2H4 solution dissolved in toluene at a 6.96 x 10-8 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.458 174 2.40 
Initial 0.026 150 --- 
1 d 0.003 --- --- 
5 d 0.082 90.0 2.57 
10 d 0.074 96.0 2.57 
 
 
Figure 5.8. Normalized fluorescence spectrum of a solution composed of toluene, oleylamine, and N2H4. 
 
5.1.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform 
Figure 5.9 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 
1.21 x 10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 
5.7 below. From these values, it can be seen that the QY of the QDs steadily decreased 
with time after treatment with C14H10O4. Additionally, the Eg increased 5 d and 10 d after 
176 
 
 
 
treatment, indicating a blue-shift in emission. Rather than confirming this expected blue-
shift, however, pictures d and e in Figure 5.9 illustrate that the QDs fluoresced pink after 
treatment.  
A possible explanation for these conflicting results may be explained by a change 
in the QD size distribution after treatment. More specifically, prior to treatment, the 
solution of QDs contained a very broad size distribution as illustrated by the wide 
fluorescence peak (blue) centered at 510 nm (see Figure 5.9b) as well as the high FWHM 
value. Five (green) and ten (purple) days after treatment, however, the fluorescence peaks 
transformed from a wide peak to a bimodal peak. This bimodal peak indicates that the 
QD solution was comprised of two distinct populations of QDs: one set of smaller QDs 
centered at 440 nm and one larger set of QDs centered at 650 nm. Additionally, 5 d and 
10 d after treatment, a slight increase in absorbance was observed representing an 
increase in concentration. In a study by Kagan et al.4, it was concluded that in a system 
composed of small and large QDs, electronic energy transfer from the small to the large 
QDs is observed as fluorescence quenching of the small dots, and fluorescence 
enhancement of the large QDs. In other words, electronic energy transfer in close-packed 
QD systems arises from dipole-dipole interactions between proximal QDs resulting in an 
observed red-shift in emission.4 In conclusion, treatment of CdS (oleylamine) QDs 
dissolved in chloroform with C14H10O4 resulted in a red-shift in emission as well as a 
decrease in the QY of the QDs.  
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Figure 5.9. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 
d (red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.21 x 10-4 molar ratio of QDs to 
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 5.7. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and C14H10O4 solution dissolved in chloroform at a 1.21 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.075 197 2.40 
Initial 0.063 201 2.42 
1 d 0.058 196 2.42 
5 d 0.041 75.7 2.52 
10 d 0.043 80.9 2.51 
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5.1.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene 
 Figure 5.10 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at an 
8.25 x 10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.8 below, show that the QY of the QDs decreased immediately after treatment with 
C14H10O4 before increasing to above that of the untreated QY 10 d later. This increase in 
QY 10 d after treatment is illustrated in Figure 5.10e where the treated QDs (right) are 
brighter than the untreated cores (left). Additionally, the FWHM decreased and Eg 
increased 10 d after treatment, indicating a narrowing of the size distribution and blue-
shift in emission. In conclusion, treatment of CdS (oleylamine) QDs dissolved in toluene 
with C14H10O4 resulted in a 25.0 % increase in the QY of the QDs 10 d after treatment. 
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Figure 5.10. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (8.25 x 10-5 molar ratio of QDs to 
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 5.8. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and C14H10O4 solution dissolved in toluene at a 8.25 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.404 174 2.42 
Initial 0.338 194 2.41 
1 d 0.078 98.5 2.54 
5 d 0.293 99.1 2.50 
10 d 0.505 71.0 2.49 
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5.1.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform 
Figure 5.11 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in 
chloroform at a 3.09 x 10-7 molar ratio. From these spectra, quantum yield (QY), full-
width half-maximum (FWHM), and bandgap energy (Eg) were calculated before 
treatment, as well as immediately, 1 d, 5 d, and 10 d after treatment. These results are 
summarized in Table 5.9 below. From these values, it can be seen that the QY of the QDs 
decreased immediately after treatment with C4H10O2 before ceasing to fluoresce 1 d later. 
This quenching of the QD fluorescence was confirmed by the pictures in Figure 5.11 
where the treated QDs (right) were not fluorescent. Similar to treatment of CdSe 
(oleylamine) QDs in chloroform with C4H10O2 (as described in section 4.1.9), the wide 
fluorescence peak centered at 540 nm in Figure 5.11 represents the emission of the QDs. 
The peaks measured after treatment, on the other hand, are centered at 450 nm and are 
therefore representative of the mixture of chloroform, oleylamine, and C4H10O2, not the 
QDs. For this reason, the quenching of the fluorescence of the QDs 1 d after treatment 
was confirmed. In conclusion, treatment of CdS (oleylamine) QDs dissolved in 
chloroform with C4H10O2 resulted in a quenching of the QD fluorescence 1 d after 
treatment. 
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Figure 5.11. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 
d (red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (3.09 x 10-7 molar ratio of QDs to 
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 5.9. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and C4H10O2 solution dissolved in chloroform at a 3.09 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.085 188 2.42 
Initial 0.037 140 2.52 
1 d 0.021 97.8 2.53 
5 d 0.079 50.8 2.56 
10 d 0.024 68.1 2.54 
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5.1.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene 
Figure 5.12 displays the absorbance and fluorescence spectra of a CdS 
(oleylamine) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at 
a 2.12 x 10-7 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.10 below, show that the QY of the QDs decreased immediately after treatment with 
C4H10O2. This decrease in QY was confirmed by the pictures included in Figure 5.12 as 
the treated sample (right) is less bright than the untreated sample (left). Similar to 
treatment in chloroform, as explained in the previous section, the fluorescence peaks 
measured after treatment were centered at 440 nm and were therefore representative of 
the mixture of toluene, oleylamine, and C4H10O2, not the QDs (see Figure 4.15 in Chapter 
4). For this reason, the quenching of the fluorescence of the QDs immediately after 
treatment was confirmed. In conclusion, treatment of CdS (oleylamine) QDs dissolved in 
toluene with C4H10O2 resulted in a quenching of the QD fluorescence immediately after 
treatment. 
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Figure 5.12. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS 
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d 
(red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (2.12 x 10-7 molar ratio of QDs to 
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV 
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
 
Table 5.10. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(oleylamine) QD and C4H10O2 solution dissolved in toluene at a 2.12 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.384 162 2.40 
Initial 0.030 91.0 2.55 
1 d 0.019 98.2 2.55 
5 d 0.104 96.6 2.53 
10 d 0.064 89.9 2.54 
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5.1.11 Summary of CdS/Oleylamine Treatments 
 Figure 5.13 compares the effect of treating CdS (oleylamine) QDs with various 
reducing and oxidizing agents in chloroform versus toluene. From these photographs, it 
can be seen that the QDs dissolved in toluene were visibly brighter than those in 
chloroform. This observation was confirmed as the QY of the QDs before treatment in 
chloroform was approximately 0.085 while the QY in toluene was approximately 0.475. 
Because both sets of QDs came from the same master batch of cores, this difference in 
QY may be due to the solubility of oleylamine in the various solvents. Thuy et al. have 
shown that the QY is higher when the capping ligand is less soluble in a given solvent.13 
Because the QY was higher in toluene than chloroform, we therefore hypothesize that 
oleylamine is less soluble in toluene than chloroform. This result is consistent with the 
results summarized in section 4.1.11 regarding the QY of CdSe (oleylamine) QDs in each 
solvent. The Eg of the untreated QDs in chloroform and toluene were 2.42 eV and 
2.40 eV, respectively, which suggests the solvent does not have an effect on QD size and 
therefore color emitted.  
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Figure 5.13. Photos of CdS (oleylamine) QDs that are from left to right: untreated, treated with NaBH4, 
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were 
suspended and treated in chloroform while those in the right column were suspended and treated in toluene. 
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment. 
 
The effect of reducing and oxidizing agents on the QY of CdS (oleylamine) QDs 
was found to be independent of solvent for 4 of the 5 treatments. More specifically, it was 
found that the QY of the QDs declined after treatment with CaH2, N2H4, and C4H10O2 and 
improved after treatment with NaBH4 in both chloroform and toluene. Treatment with 
C14H10O4, on the other hand, increased the QY of the QDs when dissolved in toluene, but 
not in chloroform. These exact trends were observed when treating CdSe (oleylamine) 
QDs as discussed in detail in section 4.1. For this reason, we hypothesize that the effect 
of treating QDs capped with oleylamine with various reducing/oxidizing agents is 
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independent of chalcogenide (Se or S). Furthermore, the theory proposed to explain the 
dependence on solvent is applicable to this batch of QDs as well. 
 Treatment of QDs with a reducing/oxidizing agent is expected to reduce the 
surface ligands thereby causing them to lose their coordinating properties and detach 
from the QD surface.6 Oxygen from atmospheric air is then able to diffuse to the exposed 
cadmium on the QD surface to form a cadmium oxide (CdO) layer around the QDs.6 This 
CdO layer serves to passivate defects on the QD surface, thereby enhancing the QY of 
the QDs.6 A possible explanation for the observed decrease of the QY after treatment 
with C14H10O4 in chloroform is that the oxidizing agent reacted with the QDs at a rate so 
fast that oxygen was not able to diffuse to the QD surface and form a CdO layer. Instead, 
C14H10O4 caused the oleylamine ligands to quickly detach from the QD surface and 
therefore caused aggregation in chloroform (as measured by the increase in absorbance), 
and resulted in a quenched QY.2 In toluene, however, the reaction rate was slowed down 
significantly because C14H10O4 is less soluble in toluene than chloroform.7 Because the 
reaction rate was slowed, after the C14H10O4 reduced the oleylamine on the QD surface, 
oxygen was able to form the CdO layer and therefore passivate the defect sites on the QD 
surface. To confirm this theory, additional testing is required. A possible experiment 
involves treating the QDs with a lower concentration of C14H10O4 in chloroform to see if 
the reaction rate slows enough to allow for the formation of a CdO layer and therefore 
increased QY. 
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 As mentioned above, treatment of CdS (oleylamine) QDs with NaBH4 resulted in 
an enhanced QY, while treatment with CaH2 decreased the QY of the QDs. We 
hypothesize that this result can be explained by a difference in the reducing agents 
reactivity with water. Specifically, we hypothesize that the reducing agents react with the 
residual water present in each of the solvents to form hydrogen. The hydrogen then reacts 
with the surface ligands, causing them to detach from the QD surface, and allowing 
oxygen from the atmospheric air to diffuse to the exposed cadmium. The resulting CdO 
layer around the QDs serves to passivate the defect sites located on the QD surface and 
therefore improves the QY of the QDs. If the reducing agent reacts too fast with the 
residual water, the QDs will aggregate and the QY will be quenched. In a study by Kong 
et al., the reaction rate of NaBH4 with water vapor was found to be ten times slower than 
that of CaH2.8 For this reason, it is hypothesized that CaH2 reacted very fast with the 
residual water present in the QD solution, causing the QDs to aggregate, and the QY to 
be quenched. This aggregation was confirmed by an increase in the measured absorbance. 
NaBH4, on the other hand, reacted with the water at a slow enough rate that the hydrogen 
produced was able to effectively detach ligands on the QD surface and allow for the 
formation of the CdO layer. 
 In several of the 10 preceding subsections, a fluorescence peak centered at 
approximately 440 nm was observed. To account for this peak, fluorescence spectroscopy 
was performed on solutions consisting of each oleylamine, solvent, and 
reducing/oxidizing agent combination. Several of these spectra are included in the above 
section. From these spectra, the peak at 440 nm was consistently found to represent the 
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ligand, solvent, and reducing/oxidizing agent combination, not the QDs. Often, an 
increase in this peak was observed with time. A possible explanation for this increase is 
that the solvent evaporated over time, as seen by the decrease in solution volume in the 
pictures included in the figures above. As the solvent evaporated, the concentration of the 
precursor solution increased, and an increase in fluorescence was therefore observed. 
This observation is consistent with the results obtained for the treatment of CdSe 
(oleylamine) QDs. 
 
5.2 CdS (OA and ODE) Quantum Dot Cores  
The following 11 sections discuss the effect of treating CdS (OA & ODE) QDs 
with each of the investigated reducing/oxidizing agents. This batch of QDs was different 
from the previous 4 batches of QDs in two ways: (1) the untreated QDs yielded a bimodal 
fluorescence peak in both solvents, and (2) a different batch of QDs was used in 
chloroform than toluene. These two differences make this set of results unique and help 
to explain the results obtained. 
A bimodal fluorescence peak indicates that either there are two separate size 
populations of QDs in the solution or that the peaks represent multiple things present in 
the QD solution. For example, if there is residual ligand present in the solution, one peak 
may correspond to the combination of solvent and ligand while the other represents the 
QDs. Similar to in previous sections, fluorescence spectroscopy was performed on 
solutions of each ligand, solvent, and reducing/oxidizing agent combination to account 
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for their influence on the measured fluorescence spectra. Figure 5.14 below illustrates the 
fluorescence spectra of the combination of OA, ODE, and chloroform as well as the 
combination of OA, ODE, and toluene. From these fluorescence spectra, it can clearly be 
seen that a peak centered at 450 nm was measured in both solvents that represents the 
mixture of the ligand, non-coordinating solvent, and dispersion solvent. We therefore 
hypothesize that because the bimodal fluorescence peaks representing the untreated QD 
solution contain one peak centered at 450 nm and one centered at approximately 620 nm, 
the latter peak is representative of the QDs. For this reason, the 620 nm peak will be the 
focus of the following sections to evaluate the effect of each surface treatment. 
Furthermore, the QYs calculated for each treatment only accounted for the area under the 
peak corresponding to the QDs. The reported Eg and FWHM values are also only 
representative of the QD peak. 
 
Figure 5.14. Normalized fluorescence spectrum of a solution composed of chloroform, OA, and ODE 
(solid) and a solution composed of toluene, OA, and ODE (dashed). 
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5.2.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform 
Figure 5.15 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 5.62 x 
10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.11 below, show that the QY of the QDs increased slightly after treatment with NaBH4 
and reached a maximum 1 d after treatment before decreasing to below that of the 
untreated QY 5 d later. Additionally, the absorbance value increased significantly 5 d and 
10 d after treatment. In a study by Mandal et al., an increase in absorbance was found to 
be indicative of aggregation because absorbance measurements are sensitive to scattering 
from colloidal suspensions that form as QD aggregates grow in size.1 Furthermore, they 
found that a decrease in QD fluorescence also resulted from aggregation.1 The observed 
increase in absorbance and decrease of the fluorescence peak measured 5 d and 10 d after 
treatment therefore imply that the QDs began to aggregate 5 d after treatment. Lastly, no 
notable change in FWHM or Eg was observed therefore ruling out a significant 
broadening of the QD size distribution or change in QD size after treatment. In 
conclusion, treatment of CdS (OA & ODE) QDs dissolved in chloroform with NaBH4 
resulted in a 45.8 % increase in QY of the QDs 1 d after treatment. 
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Figure 5.15. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA & 
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with NaBH4 (5.62 x 10-6 molar ratio of QDs to NaBH4). 
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 5.11. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and NaBH4 solution dissolved in chloroform at a 5.62 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.024 122 2.65 
Initial 0.030 131 2.65 
1 d 0.035 144 2.65 
5 d 0.019 185 2.65 
10 d 0.017 188 2.66 
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5.2.2 Treatment with Sodium Borohydride (NaBH4) in Toluene 
 Figure 5.16 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a 7.69 x 10-6 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.12 below, show that the QY of the QDs decreased after treatment with NaBH4. 
Furthermore, 5 d and 10 d after treatment, the peak centered at 450 nm that was 
representative of the combination of OA, ODE, toluene, and NaBH4 increased 
significantly. The normalized fluorescence peak of this solution as well as a picture of the 
solution excited by a 365 nm UV light is shown in Figure 5.17 below. As seen in the 
picture, this solution fluoresces bright blue. Because the fluorescence of the QD solution 
decreased and the fluorescence of the precursor solution increased, a blue-shift in 
emission is expected. Figure 5.16d and e illustrate this expected blue-shift as the treated 
QDs (right) appear more blue than the untreated QDs (left). In conclusion, treatment of 
CdS (OA & ODE) QDs dissolved in toluene with NaBH4 resulted in a decrease in the QY 
of the QDs. 
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Figure 5.16. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA & 
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with NaBH4 (7.69 x 10-6 molar ratio of QDs to NaBH4). Photos of 
untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 5.12. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and NaBH4 solution dissolved in toluene at a 7.69 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.117 152 2.60 
Initial 0.099 151 2.60 
1 d 0.103 151 2.60 
5 d 0.051 --- 2.62 
10 d 0.062 --- 2.62 
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Figure 5.17. Normalized fluorescence spectrum and picture (inset) of a solution composed of chloroform, 
OA, ODE, and NaBH4. 
 
5.2.3 Treatment with Calcium Hydride (CaH2) in Chloroform 
Figure 5.18 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 1.87 x 10-5 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.13 below, show that the QY of the QDs decreased immediately after treatment with 
CaH2. An increase in absorbance was also observed after treatment (see Figure 5.18a). In 
a study by Mandal et al., an increase in absorbance was found to be indicative of 
aggregation because absorbance measurements are sensitive to scattering from colloidal 
suspensions that form as QD aggregates grow in size.1 Furthermore, they found that a 
significant decrease in QD fluorescence also resulted from aggregation.1 It can therefore 
be concluded that the flattening of the fluorescence peak coupled with the significant 
increase in absorbance observed immediately after treatment with CaH2, indicates that the 
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QDs began to aggregate at this time. The aggregates grew to a size that allowed them to 
be clearly visible in the solution, causing the solution to appear cloudy in visible light. 
When excited with a 365 nm UV light, as seen in the pictures in Figure 5.18, the 
aggregates scattered the incident light and caused the solution to appear pink. With time, 
the aggregates continued to grow which explains why the absorbance continued to 
increase and fluorescence peak continued to flatten with time. In conclusion, treatment of 
CdS (OA & ODE) QDs dissolved in chloroform with CaH2 resulted in aggregation and a 
decrease in the QY of the QDs. 
 
Figure 5.18. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA & 
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with CaH2 (1.87 x 10-5 molar ratio of QDs to CaH2). Photos of 
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
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Table 5.13. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and CaH2 solution dissolved in chloroform at a 1.87 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.024 122 2.65 
Initial 0.005 188 2.66 
1 d 0.007 190 2.66 
5 d 0.002 --- 2.66 
10 d 0.001 --- 2.66 
 
5.2.4 Treatment with Calcium Hydride (CaH2) in Toluene 
Figure 5.19 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and calcium hydride (CaH2) solution dissolved in toluene at a 2.56 x 10-5 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.14 below, show that the QY of the QDs decreased after treatment with CaH2. 
Furthermore, 5 d and 10 d after treatment, the peak centered at 450 nm that was 
representative of the combination of OA, ODE, toluene, and CaH2 increased 
significantly. The normalized fluorescence peak of this solution as well as a picture of the 
solution excited by a 365 nm UV light is shown in Figure 5.20 below. As seen in the 
picture, this solution fluoresces bright blue. Because the fluorescence of the QD solution 
decreased and the fluorescence of the precursor solution increased, a blue-shift in 
emission is expected. Figure 5.19d and e illustrate this expected blue-shift as the treated 
QDs (right) appear more blue than the untreated QDs (left). This same result was 
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observed after treatment with NaBH4, as detailed in section 5.2.2 above. In conclusion, 
treatment of CdS (OA & ODE) QDs dissolved in toluene with CaH2 resulted in a 
decrease in the QY of the QDs. 
 
Figure 5.19. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA & 
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with CaH2 (2.56 x 10-5 molar ratio of QDs to CaH2). Photos of 
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
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Table 5.14. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and CaH2 solution dissolved in toluene at a 2.56 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.084 152 2.60 
Initial 0.032 --- 2.60 
1 d 0.063 --- 2.60 
5 d 0.039 --- 2.59 
10 d 0.032 --- 2.59 
 
 
Figure 5.20. Normalized fluorescence spectrum and picture (inset) of a solution composed of chloroform, 
OA, ODE, and CaH2. 
 
5.2.5 Treatment with Hydrazine (N2H4) in Chloroform 
Figure 5.21 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and hydrazine (N2H4) solution dissolved in chloroform at a 2.84 x 10-7 molar 
ratio. Because the fluorescence of the QDs was quenched immediately after treatment, it 
was not possible to calculate the quantum yield (QY), full-width half-maximum (FWHM) 
or bandgap energy (Eg) of the QDs. Similar to treatment of CdSe (OA & ODE) QDs in 
chloroform (as described in section 4.2.5), the addition of N2H4 resulted in an emulsion. 
We hypothesize that OA was able to act as a surfactant and stabilize the hydrazine 
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droplets, as its surface tension (32.5 mN/m3) was in between that of N2H4 (66.39 mN/m3) 
and chloroform (27.5 mN/m3). The hydrophilic-lipophilic balance (HLB) of OA was 
found to be 19, indicating that it is a hydrophobic surfactant.10 Chloroform is a 
hydrophobic solvent, therefore OA was found to be a good surfactant that yielded a stable 
emulsion with small, evenly dispersed droplets of N2H4. 
Immediately after adding N2H4 to the chloroform, a small amount of soluble N2H4 
reacted with the QDs and reduced their surface to etch and destroy the QDs thereby 
quenching the QD fluorescence. The fluorescence spectrum included in Figure 5.21b 
confirms this quenching of the fluorescence as the peak completely flattened immediately 
after treatment. The residual OA in the solution then stabilized the remaining N2H4 into 
small, evenly dispersed N2H4 droplets. These droplets scattered the light, causing the 
solution to appear cloudy in visible light. When a 365 nm UV lamp was used as the 
incident light, the evenly dispersed droplets of N2H4 in the QD solution scattered the light 
causing the solution to appear purple (see pictures in Figure 5.21). In conclusion, 
treatment of CdS (OA & ODE) QDs dissolved in chloroform with N2H4 caused the QDs 
to stop fluorescing immediately after treatment. 
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Figure 5.21. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA & 
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with N2H4 (2.84 x 10-7 molar ratio of QDs to N2H4). Photos of 
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 5.15. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and N2H4 solution dissolved in chloroform at a 2.84 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.024 122 2.65 
Initial --- --- --- 
1 d --- --- --- 
5 d --- --- --- 
10 d --- --- --- 
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5.2.6 Treatment with Hydrazine (N2H4) in Toluene 
Figure 5.22 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and hydrazine (N2H4) solution dissolved in toluene at a 3.89 x 10-7 molar ratio. 
From these spectra, quantum yield (QY), full-width half-maximum (FWHM), and 
bandgap energy (Eg) were calculated before treatment, as well as immediately, 1 d, 5 d, 
and 10 d after treatment. These results are summarized in Table 5.16 below. As 
illustrated in Figure 5.22b, immediately after treatment with N2H4, the fluorescence peak 
corresponding to the QDs flattened completely. The peak corresponding to the solution of 
toluene, OA, ODE, andN2H4, on the other hand, was still measured. We therefore 
hypothesize that immediately after treatment the fluorescence of the QD solution was 
quenched. The blue color observed in the pictures included in Figure 5.22 is therefore 
representative of the precursor solution, not the QDs. Because N2H4 is soluble in toluene, 
the issues explained in section 5.2.5 above are not applicable to this system. Lastly, these 
results are consistent with those observed in the treatment of CdSe (OA & ODE) QDs 
with N2H4 as detailed in section 4.2.6. In conclusion, treatment of CdS (OA & ODE) QDs 
dissolved in toluene with N2H4 resulted in the quenching of the QD fluorescence 
immediately after treatment. 
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Figure 5.22. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA & 
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with N2H4 (3.89 x 10-7 molar ratio of QDs to N2H4). Photos of 
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 5.16. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and N2H4 solution dissolved in toluene at a 3.89 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.062 152 2.60 
Initial --- --- --- 
1 d --- --- --- 
5 d --- --- --- 
10 d --- --- --- 
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5.2.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform 
Figure 5.23 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 3.75 x 
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.17 below, show that the QY of the QDs increased after treatment with C14H10O4 and 
reached a maximum 10 d after treatment. Figure 5.23e illustrates this increase in QY 10 d 
after treatment as the treated sample (right) is significantly brighter than the untreated 
sample (left). Additionally, the FWHM decreased slightly and the absorbance peak 
became more sharp (see Figure 5.23a) 10 d after treatment, indicating a significant 
narrowing of the QD size distribution. In conclusion, treatment of CdS (OA & ODE) 
QDs dissolved in chloroform with C14H10O4 resulted in a 62.5 % increase in the QY of 
the QDs 10 d after treatment. 
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Figure 5.23. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA & 
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with C14H10O4 (3.75 x 10-5 molar ratio of QDs to C14H10O4). 
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 5.17. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and C14H10O4 solution dissolved in chloroform at a 3.75 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.024 122 2.65 
Initial 0.025 124 2.65 
1 d 0.030 125 2.66 
5 d 0.019 139 2.65 
10 d 0.039 146 2.63 
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5.2.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene 
Figure 5.24 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 5.13 x 10-5 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.18 below, show that the QY of the QDs reached a maximum 10 d after treatment with 
C14H10O4. Figure 5.24e illustrates this increase in QY 10 d after treatment as the treated 
sample (right) is significantly brighter than the untreated sample (left). In conclusion, 
treatment of CdS (OA & ODE) QDs dissolved in toluene with C14H10O4 resulted in a 
6.84 % increase in the QY of the QDs 10 d after treatment. 
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Figure 5.24. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA & 
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with C14H10O4 (5.13 x 10-5 molar ratio of QDs to C14H10O4). 
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 5.18. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and C14H10O4 solution dissolved in toluene at a 5.13 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.117 152 2.60 
Initial 0.117 153 2.60 
1 d 0.099 155 2.60 
5 d 0.089 155 2.60 
10 d 0.125 --- 2.60 
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5.2.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform 
Figure 5.25 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in chloroform at a 
4.32 x 10-7 molar ratio. From these spectra, quantum yield (QY), full-width half-
maximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well 
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.19 below, show that the QY of the QDs decreased immediately after treatment with 
C4H10O2. An increase in absorbance was also observed immediately after treatment (see 
Figure 5.25a). In a study by Mandal et al., an increase in absorbance was found to be 
indicative of aggregation because absorbance measurements are sensitive to scattering 
from colloidal suspensions that form as QD aggregates grow in size.1 Furthermore, they 
found that a significant decrease in QD fluorescence also resulted from aggregation.1 It 
can therefore be concluded that the flattening of the fluorescence peak coupled with the 
significant increase in absorbance observed immediately after treatment with C4H10O2, 
indicates that the QDs began to aggregate at this time. One day after treatment, the 
aggregates grew to a size that allowed them to be clearly visible in the solution, causing 
the solution to appear cloudy in visible light. When excited with a 365 nm UV light, as 
seen in Figure 5.25c, the aggregates scattered the incident light and caused the solution to 
appear pink.  
In previous cases of aggregation, the aggregates grew to a large enough size that 
they precipitated out of solution and caused the fluorescence of the QD solution to 
quench. In this case, however, a fluorescence peak centered at 510 nm increased 5 d and 
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10 d after treatment. Additionally, the QDs blue-shifted in color and increased in 
brightness, as illustrated in Figure 5.25d and e. These observations are unlike any of the 
others and have no obvious explanation.  
 
Figure 5.25. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA & 
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with C4H10O2 (4.32 x 10-7 molar ratio of QDs to C4H10O2). 
Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
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Table 5.19. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and C4H10O2 solution dissolved in chloroform at a 4.32 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.024 122 2.65 
Initial --- --- --- 
1 d --- --- --- 
5 d 0.008 149 2.71 
10 d 0.015 141 2.72 
 
5.2.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene 
Figure 5.26 displays the absorbance and fluorescence spectra of a CdS (OA & 
ODE) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at a 5.91 
x 10-7 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.20 below, show that the QY of the QDs decreased after treatment with C4H10O2. This 
decrease in QY was confirmed as the fluorescence peak corresponding to the QDs 
decreased after treatment. Furthermore, the pictures in Figure 5.26 illustrate that the 
treated sample (right) is less bright than the untreated sample (left). In conclusion, 
treatment of CdS (OA & ODE) QDs dissolved in toluene with C4H10O2 resulted in a 
decline in the QY of the QDs. 
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Figure 5.26. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA & 
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with C4H10O2 (5.91 x 10-7 molar ratio of QDs to C4H10O2). Photos 
of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, 
and (e) 10 d after treatment. 
 
Table 5.20. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & ODE) QD and N2H4 solution dissolved in toluene at a 5.91 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.086 152 2.60 
Initial 0.020 --- 2.61 
1 d 0.026 --- 2.61 
5 d 0.021 --- 2.61 
10 d 0.028 --- 2.60 
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5.2.11 Summary of CdS/OA & ODE Treatments 
 Figure 5.27 compares the effect of treating CdS (OA & ODE) QDs with various 
reducing and oxidizing agents in chloroform and toluene. From these photographs, it can 
be seen that the QDs dissolved in toluene were visibly brighter than those in chloroform. 
This observation was confirmed as the QY of the QDs before treatment in chloroform 
was approximately 0.024 while the QY in toluene was approximately 0.085. A different 
batch of QDs was used for treatments in chloroform than toluene due to low yield 
therefore it is unclear if this difference in QY is attributed to differences in the batch 
quality or to QD solubility in each solvent. In each of the other 2 batches of QDs capped 
with OA, it was hypothesized that the QDs exhibited a higher QY in toluene over 
chloroform because of the difference in dissolved oxygen concentration in each solvent.5 
The Eg of the untreated QDs in chloroform and toluene were 2.65 eV and 2.60 eV, 
respectively, which suggests the solvent does not have a significant effect on QD size and 
therefore color emitted. 
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Figure 5.27. Photos of CdS (OA & ODE) QDs that are from left to right: untreated, treated with NaBH4, 
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were 
suspended and treated in chloroform while those in the right column were suspended and treated in toluene. 
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment. 
 
The effect of reducing and oxidizing agents on the QY of CdS (OA & ODE) QDs 
was found to be independent of solvent for 3 of the 5 treatments. More specifically, it was 
found that the quality of the QDs worsened after treatment with N2H4 and CaH2, and 
improved after treatment with C14H10O4 in both chloroform and toluene. Treatment with 
NaBH4 and C4H10O2, on the other hand, increased the quality of the QDs when dissolved 
in chloroform, but not toluene. Even though the QY of the QDs increased after treatment 
with C14H10O4 in both chloroform and toluene, the percent increase in QY in chloroform 
was significantly higher than in toluene, 62.5 % compared to 6.84 %, respectively. These 
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results clearly illustrate that the surface treatment of CdS (OA & ODE) QDs was more 
effective in chloroform than toluene. This is consistent with the CdSe (OA & ODE) case 
where surface treatment was also more effective in chloroform than toluene. 
 The reason for this dependence on solvent is not known, however, a possible 
explanation focuses on the solubility of the ligand (OA) in the dispersion solvent. In a 
study by Bullen et al., it was concluded that desorption of the surface ligands may occur 
if the ligand is more soluble in a given solvent, therefore resulting in decreased QY.11 
Oleic acid is more soluble in toluene than chloroform as confirmed by comparing 
Hildebrand solubility parameters. Specifically, the Hildebrand solubility parameter (δ) 
provides a good estimation of the solubility of two substances as it is a numerical 
estimate of the degree of interaction between materials. The closer the δ of two 
substances, the better the degree of solubility. Furthermore, δOA = 15.95, δtoluene = 17.8, 
and δchloroform = 19.012, therefore confirming that OA is more soluble in toluene than 
chloroform. For this reason, it can be hypothesized that OA ligands will desorb from the 
QD surface at a faster rate in toluene than chloroform, thereby explaining why surface 
treatment is more effective in chloroform than toluene. 
 A second possible explanation for the observed results focuses on the solubility of 
the reducing agent in the dispersion solvent. It is hypothesized that NaBH4 is more 
soluble in toluene than chloroform. For this reason, the reducing agent reacts with the 
QDs at a faster rate when dissolved in toluene than chloroform. It is therefore 
hypothesized that when dispersed and treated in toluene, oxygen was not able to diffuse 
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to the QD surface to form a CdO layer and therefore was not able to passivate the surface 
defect sites. Instead, NaBH4 caused the OA ligands to detach from the QD surface and 
destroyed the QDs dispersibility in toluene, thereby resulting in a decreased QY.2 
Unfortunately, information is not currently available regarding the solubility of NaBH4 in 
toluene versus chloroform. For this reason, it is recommended that future work include a 
solubility study to determine the solubility of NaBH4 in both chloroform and toluene to 
confirm this theory.   
 Treatment with C4H10O2 also resulted in an enhanced QY when the QDs were 
dispersed and treated in chloroform but not in toluene. As detailed in section 5.2.9 above, 
the observed increase in QY was unlike any other C4H10O2 treatment. Furthermore, the 
measured fluorescence and absorbance spectra indicate that the QDs aggregated 
immediately after treatment before increasing significantly in brightness. Due to the 
uniqueness of this result, it is recommended that the treatment be redone to validate 
accuracy.  
In each of the 10 preceding sections, a bimodal fluorescence peak was measured 
to represent the untreated QDs. As previously explained, the fluorescence peak centered 
at 450 nm was believed to be representative of the mixture of OA, ODE, and solvent, 
whereas the peak centered at 620 nm was representative of the QDs. We hypothesize that 
measurement of a fluorescence peak at 450 nm indicates that residual ligand is present in 
the QD solution after washing. As explained in section 4.2.11 where the treatment of 
CdSe (OA & ODE) QDs is summarized, no peak at 450 nm was measured. It is unclear 
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why residual OA and ODE were found to be present in the case of CdS QDs but not 
CdSe QDs. Furthermore, in previous cases where residual ligand was present in solution 
after washing, a peak centered at 450 nm was only observed after treatment. This leads to 
another interesting difference between CdS (OA & ODE) QDs and the other batches: a 
peak representing the precursor solution was measured prior to treatment. A reason for 
this observation is not readily known.  
 
5.3 CdS (OA and TOA) Quantum Dot Cores  
 Each of the previous 5 QD batches were treated with various reducing and 
oxidizing agents at an initial absorbance between 0.08 a.u. and 0.10 a.u.. This starting 
absorbance value was chosen to ensure accurate QY calculations. CdS (OA & TOA) QD 
solutions with this same concentration did not fluoresce. Furthermore, treatment of these 
poor quality QDs with each of the reducing and oxidizing agents failed to improve the 
quality. Appendix B illustrates these results. Jang et al.6 report an increase in QY of CdS 
(OA & TOA) QDs after treatment with NaBH4. For their study, a starting absorbance of 
0.35 a.u. was reported. For this reason, the CdS (OA & TOA) QD treatments described in 
the following section had an initial absorbance of 0.35 a.u..  
Similar to CdS (OA & ODE) QDs, the untreated CdS (OA & TOA) QDs yielded 
a bimodal fluorescence peak in both solvents. As explained in section 5.2 above, we 
hypothesize that this bimodal fluorescence peak indicates that there is residual ligand 
present in the solution. Similar to in previous sections, fluorescence spectroscopy was 
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performed on solutions of each ligand, solvent, and reducing/oxidizing agent combination 
to account for their influence on the measured fluorescence spectra. Figure 5.28 below 
illustrates the fluorescence spectra of the combination of OA, TOA, and chloroform as 
well as the combination of OA, TOA, and toluene. From these fluorescence spectra, it 
can clearly be seen that a peak centered at 460 nm was measured in both solvents that 
represents the mixture of the ligand, non-coordinating solvent, and dispersion solvent. 
We therefore hypothesize that because the bimodal fluorescence peaks representing the 
untreated QD solution contain one peak centered at 460 nm and one centered at 
approximately 650 nm, the latter peak is representative of the QDs. For this reason, the 
650 nm peak will be the focus of the following sections to evaluate the effect of each 
surface treatment. Furthermore, the QYs calculated for each treatment only accounted for 
the area under the peak corresponding to the QDs. The reported Eg and FWHM values are 
also only representative of the QD peak. 
 
Figure 5.28. Normalized fluorescence spectrum of a solution composed of chloroform, OA, and TOA 
(solid) and a solution composed of toluene, OA, and TOA (dashed). 
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5.3.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform 
Figure 5.29 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 9.19 x 
10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.21 below, show that the QY of the QDs decreased after treatment with NaBH4. 
Additionally, the absorbance value increased 1 d after treatment. In a study by Mandal et 
al., an increase in absorbance was found to be indicative of aggregation because 
absorbance measurements are sensitive to scattering from colloidal suspensions that form 
as QD aggregates grow in size.1 Furthermore, they found that a decrease in QD 
fluorescence also resulted from aggregation.1 The observed increase in absorbance and 
flattening of the fluorescence peak (see Figure 5.29) therefore indicate that the QDs 
began to aggregate 1 d after treatment.  
Similar to in the fluorescence spectra of CdSe (OA & TOA) QDs dissolved in 
chloroform as described in section 4.3, a negative peak was measured after treatment (see 
Figure 5.29b). This peak was found to represent the combination of OA, TOA, 
chloroform, and NaBH4 (see Figure 4.27 in Chapter 4), however it is unclear why the 
peak is negative. An explanation for this negative peak is therefore not known and will be 
explored further in future work. In conclusion, treatment of CdS (OA & TOA) QDs 
dissolved in chloroform with NaBH4 resulted in a decrease in the QY of the QDs. 
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Figure 5.29. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with NaBH4 (9.19 x 10-6 molar ratio of QDs to NaBH4). 
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 5.21. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and NaBH4 solution dissolved in chloroform at a 9.19 x 10-6 molar ratio. 
 QY x 10-3 FWHM (nm) Eg (eV) 
Untreated 1.00 198 2.45 
Initial 1.00 198 2.45 
1 d 0.80 196 2.45 
5 d 0.30 --- 2.45 
10 d 0.50 195 2.45 
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5.3.2 Treatment with Sodium Borohydride (NaBH4) in Toluene 
 Figure 5.30 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and sodium borohydride (NaBH4) solution dissolved in toluene at an 8.16 x 
10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.22 below, show that the QY of the QDs increased immediately after treatment with 
NaBH4. Additionally, a significant increase in the fluorescence peak corresponding to the 
precursor solution was seen over time (see Figure 5.30b). In conclusion, treatment of CdS 
(OA & TOA) QDs dissolved in toluene with NaBH4 resulted in a 200 % increase in the 
QY of the QDs immediately after treatment. 
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Figure 5.30. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with NaBH4 (8.16 x 10-6 molar ratio of QDs to NaBH4). Photos of 
untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 5.22. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and NaBH4 solution dissolved in toluene at a 8.16 x 10-6 molar ratio. 
 QY  FWHM (nm) Eg (eV) 
Untreated 0.002 198 2.45 
Initial 0.006 150 2.46 
1 d 0.003 197 2.47 
5 d 0.001 --- 2.47 
10 d 0.003 195 2.47 
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5.3.3 Treatment with Calcium Hydride (CaH2) in Chloroform 
Figure 5.31 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 2.10 x 10-5 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.23 below, show that the QY of the QDs decreased after treatment with CaH2. 
Additionally, the absorbance value increased after treatment. In a study by Mandal et al., 
an increase in absorbance was found to be indicative of aggregation because absorbance 
measurements are sensitive to scattering from colloidal suspensions that form as QD 
aggregates grow in size.1 Furthermore, they found that a decrease in QD fluorescence 
also resulted from aggregation.1 Similar to treatment of CdSe (OA & TOA) QDs with 
CaH2 as described in section 4.3.3, the observed increase in absorbance and flattening of 
the fluorescence peak (see Figure 5.31) therefore indicate that the QDs began to 
aggregate after treatment. 
The absorbance continued to increase 10 d after treatment (see purple line in 
Figure 5.31a) which indicates that the QD aggregates continued to grow with time. Ten 
days after treatment, the aggregates grew to a size that allowed them to be clearly visible 
in the solution, causing the solution to appear cloudy in visible light. When a 365 nm UV 
lamp was used as the incident light (as in the case in Figure 5.31e) the QD aggregates 
scattered the incident light causing the solution to appear pink. In conclusion, treatment 
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of CdS (OA & TOA) QDs dissolved in chloroform with CaH2 resulted in a decrease in 
the QY of the QDs due to aggregation.  
 
Figure 5.31. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with CaH2 (2.10 x 10-5 molar ratio of QDs to CaH2). Photos of 
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 5.23. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and CaH2 solution dissolved in chloroform at a 2.10 x 10-5 molar ratio. 
 QY x 10-3 FWHM (nm) Eg (eV) 
Untreated 0.70 198 2.45 
Initial 0.50 --- 2.45 
1 d 0.50 --- 2.45 
5 d 0.20 --- --- 
10 d 0.20 --- --- 
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5.4.4 Treatment with Calcium Hydride (CaH2) in Toluene 
 Figure 5.32 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and calcium hydride (CaH2) solution dissolved in toluene at a 1.86 x 10-5 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.24 below, show that the QY of the QDs decreased after treatment with CaH2. 
Additionally, a significant increase in the fluorescence peak corresponding to the 
precursor solution was seen over time (see Figure 5.32b). In conclusion, treatment of CdS 
(OA & TOA) QDs dissolved in toluene with CaH2 resulted in a decrease in the QY of the 
QDs. 
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Figure 5.32. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with CaH2 (1.86 x 10-5 molar ratio of QDs to CaH2). Photos of 
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 5.24. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and CaH2 solution dissolved in toluene at a 1.86 x 10-5 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.006 197 2.45 
Initial 0.002 191 2.45 
1 d 0.004 193 2.45 
5 d 0.002 192 2.45 
10 d 0.005 180 2.45 
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5.3.5 Treatment with Hydrazine (N2H4) in Chloroform 
Figure 5.33 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and hydrazine (N2H4) solution dissolved in chloroform at a 9.30 x 10-7 molar 
ratio. Because the fluorescence of the QDs was quenched immediately after treatment, it 
was not possible to calculate the quantum yield (QY), full-width half-maximum (FWHM) 
or bandgap energy (Eg) of the QDs. Similar to treatment of CdSe (OA & TOA) QDs with 
N2H4, the fluorescence of the QDs was quenched and an emulsion resulted immediately 
after treatment due to the near insolubility of N2H4 in chloroform. Figure 5.33c illustrates 
this emulsion 1 d after treatment as an uneven distribution of N2H4 droplets can clearly be 
seen in the solution. Immediately after adding N2H4 to the chloroform, a small amount of 
N2H4 reacted with the QDs and reduced their surface to etch and destroy the QDs thereby 
quenching the QD fluorescence. The fluorescence spectrum included in Figure 5.33b 
confirms this quenching of the fluorescence as the peak completely flattened immediately 
after treatment. The remainder of the N2H4 formed large, unevenly dispersed N2H4 
droplets stabilized by the residual OA and TOA. The solution appeared blue-green when 
excited by a 365 nm UV lamp because the mixture of toluene, OA, and TOA emits light 
at 450 nm upon excitation (see Figure 4.36 in Chapter 4). By 10 d after treatment, two 
distinct layers were clearly visible presumably due to instability of the emulsion, so I 
shook the vial. Agitation enabled the N2H4 layer to break up and disperse in the solution 
temporarily, thereby causing the solution to appear bright (see Figure 5.33e) even though 
the fluorescence of the QDs had been quenched prior. 
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Similar to in the fluorescence spectra of the same batch of QDs dissolved in 
chloroform after treatment with NaBH4, the peak fell negative at 450 nm. This peak was 
found to represent the combination of OA, TOA, chloroform, and N2H4 (see Figure 4.36 
in Chapter 4), however it is unclear why the peak is negative. An explanation for this 
negative peak is therefore not known and will be explored further in future work. In 
conclusion, the fluorescence of CdS (OA & TOA) QDs dissolved in chloroform died 
immediately after treatment with N2H4.  
 
Figure 5.33. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with N2H4 (9.30 x 10-7 molar ratio of QDs to N2H4). Photos of 
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
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Table 5.25. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and N2H4 solution dissolved in chloroform at a 9.30 x 10-7 molar ratio. 
 QY x 10-3 FWHM (nm) Eg (eV) 
Untreated 1.00 195 2.45 
Initial --- --- --- 
1 d --- --- --- 
5 d --- --- --- 
10 d --- --- --- 
 
5.3.6 Treatment with Hydrazine (N2H4) in Toluene 
Figure 5.34 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and hydrazine (N2H4) solution dissolved in toluene at an 8.26 x 10-7 molar 
ratio. Because the fluorescence of the QDs was quenched immediately after treatment, it 
was not possible to calculate the quantum yield (QY), full-width half-maximum (FWHM) 
or bandgap energy (Eg) of the QDs. Although N2H4 is soluble in toluene, residual TOA in 
the QD solution prevented all of the reducing agent from reacting immediately with the 
QDs, similar to treatment in chloroform, as detailed in section 5.3.5 above. Instead, 
immediately after adding N2H4 to the toluene, a small amount of N2H4 reacted with the 
QDs and reduced their surface to etch and destroy the QDs thereby quenching the QD 
fluorescence. The fluorescence spectrum included in Figure 5.34b confirms this 
quenching of the fluorescence as the peak corresponded to the QDs completely flattened 
immediately after treatment. The remainder of the N2H4 formed two clearly separate 
phases in the solution stabilized by the residual OA and TOA (see pictures in Figure 
5.34). The solution appeared blue-green when excited by a 365 nm UV lamp because the 
mixture of toluene, OA, and TOA emits light at 450 nm upon excitation (see Figure 4.38 
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in Chapter 4). In conclusion, the fluorescence of CdS (OA & TOA) QDs dissolved in 
toluene died immediately after treatment with N2H4.  
 
Figure 5.34. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with N2H4 (8.26 x 10-7 molar ratio of QDs to N2H4). Photos of 
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and 
(e) 10 d after treatment. 
 
Table 5.26. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and N2H4 solution dissolved in toluene at a 8.26 x 10-7 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.006 195 2.45 
Initial --- --- --- 
1 d --- --- --- 
5 d --- --- --- 
10 d --- --- --- 
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5.3.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform 
Figure 5.35 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 3.68 x 
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.27 below, show that the QY of the QDs decreased after treatment with C14H10O4. 
Additionally, the fluorescence peak corresponding to the QDs (centered at 650 nm) 
flattened completely 5 d and 10 d after treatment, indicating that the fluorescence of the 
QDs was quenched at this time. Furthermore, the absorbance value increased 5 d and 
10 d after treatment. In a study by Mandal et al., an increase in absorbance was found to 
be indicative of aggregation because absorbance measurements are sensitive to scattering 
from colloidal suspensions that form as QD aggregates grow in size.1 Furthermore, they 
found that a decrease in QD fluorescence also resulted from aggregation.1 The observed 
increase in absorbance and flattening of the fluorescence peak (see Figure 5.35) therefore 
indicate that the QDs began to aggregate 5 d after treatment.  
The absorbance continued to increase 10 d after treatment (see purple line in 
Figure 5.35a) which indicates that the QD aggregates continued to grow with time. Ten 
days after treatment, the aggregates grew to a size that allowed them to be clearly visible 
in the solution, causing the solution to appear cloudy in visible light. When a 365 nm UV 
lamp was used as the incident light (as in the case in Figure 5.35e) the QD aggregates 
scattered the incident light causing the solution to appear pink. Lastly, 5 d and 10 d after 
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treatment, a measurable fluorescence peak centered at 450 nm was observed. This peak 
was found to represent the combination of OA, TOA, chloroform, and C14H10O4 (see 
Figure 5.36 below). In conclusion, treatment of CdS (OA & TOA) QDs dissolved in 
chloroform with C14H10O4 resulted in a quenching of the fluorescence of the QDs 5 d 
after treatment. 
 
Figure 5.35. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with C14H10O4 (3.68 x 10-4 molar ratio of QDs to C14H10O4). 
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
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Table 5.27. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and C14H10O4 solution dissolved in chloroform at a 3.68 x 10-4 molar ratio. 
 QY x 10-3 FWHM (nm) Eg (eV) 
Untreated 1.00 198 2.45 
Initial 0.90 198 2.45 
1 d 0.90 198 2.45 
5 d --- --- --- 
10 d --- --- --- 
 
 
Figure 5.36. Normalized fluorescence spectrum of a solution composed of chloroform, OA, TOA, and 
C14H10O4. 
 
5.3.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene 
Figure 5.37 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 3.26 x 10-4 
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum 
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as 
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 
5.28 below, show that the QY of the QDs decreased immediately after treatment with 
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C14H10O4. The peak corresponding to the QDs (centered at 650nm) flattened completely 
1 d after treatment, indicating that the fluorescence of the QDs was quenched at this time 
(see Figure 5.37b). Additionally, a significant increase in the fluorescence peak 
corresponding to the precursor solution was seen over time (centered at 450 nm). In 
conclusion, treatment of CdS (OA & TOA) QDs dissolved in toluene with C14H10O4 
resulted in a quenching of the QD fluorescence 1 d after treatment. 
 
Figure 5.37. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with C14H10O4 (3.26 x 10-4 molar ratio of QDs to C14H10O4). 
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
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Table 5.28. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and C14H10O4 solution dissolved in toluene at a 3.26 x 10-4 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.005 198 2.45 
Initial 0.004 197 2.45 
1 d --- --- --- 
5 d --- --- --- 
10 d --- --- --- 
 
5.3.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform 
Figure 5.38 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in chloroform at a 
1.41 x 10-6 molar ratio. Because the fluorescence of the QDs was quenched immediately 
after treatment, it was not possible to calculate the quantum yield (QY), full-width half-
maximum (FWHM) or bandgap energy (Eg) of the QDs. The fluorescence peak 
corresponding to the QDs (centered at 650nm) flattened immediately after treatment, 
indicating that the fluorescence of the QDs was quenched at this time (see Figure 5.38b). 
The fluorescence peak corresponding to the precursor solution (centered at 450 nm), on 
the other hand, increased significantly 5 d and 10 d after treatment. In conclusion, 
treatment of CdS (OA & TOA) QDs dissolved in chloroform with C4H10O2 resulted in a 
quenching of the QD fluorescence immediately after treatment. 
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Figure 5.38. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 
5 d (green), and 10 d (purple) after treatment with C4H10O2 (1.41 x 10-6 molar ratio of QDs to C4H10O2). 
Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d, 
(d) 5 d, and (e) 10 d after treatment. 
 
Table 5.29. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and C4H10O2 solution dissolved in chloroform at a 1.41 x 10-6 molar ratio. 
 QY x 10-3 FWHM (nm) Eg (eV) 
Untreated 0.70 198 2.45 
Initial --- --- --- 
1 d --- --- --- 
5 d --- --- --- 
10 d --- --- --- 
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5.3.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene 
Figure 5.39 displays the absorbance and fluorescence spectra of a CdS (OA & 
TOA) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at a 1.25 
x 10-6 molar ratio. Because the fluorescence of the QDs was quenched immediately after 
treatment, it was not possible to calculate the quantum yield (QY), full-width half-
maximum (FWHM) or bandgap energy (Eg) of the QDs. The fluorescence peak 
corresponding to the QDs (centered at 650 nm) flattened immediately after treatment, 
indicating that the fluorescence of the QDs was quenched at this time (see Figure 5.39b). 
The fluorescence peak corresponding to the precursor solution (centered at 450 nm), on 
the other hand, increased significantly 5 d and 10 d after treatment. In conclusion, 
treatment of CdS (OA & TOA) QDs dissolved in toluene with C4H10O2 resulted in a 
quenching of the QD fluorescence immediately after treatment. 
 
236 
 
 
 
 
Figure 5.39. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA & 
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d 
(green), and 10 d (purple) after treatment with C4H10O2 (1.25 x 10-6 molar ratio of QDs to C4H10O2). Photos 
of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, 
and (e) 10 d after treatment. 
 
Table 5.30. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS 
(OA & TOA) QD and C4H10O2 solution dissolved in toluene at a 1.25 x 10-6 molar ratio. 
 QY FWHM (nm) Eg (eV) 
Untreated 0.005 198 2.45 
Initial --- --- --- 
1 d --- --- --- 
5 d --- --- --- 
10 d --- --- --- 
 
 
 
237 
 
 
 
5.3.11 Summary of CdS/OA & TOA Treatments 
 Figure 5.40 compares the effect of treating CdS (OA & TOA) QDs with various 
reducing and oxidizing agents in chloroform and toluene. From these photographs, it can 
be seen that the initial quality of these QDs were not as high as the other batches 
described in the preceding sections. This observation was confirmed as the QY of the 
QDs before treatment was only 0.001 in chloroform and 0.005 in toluene. This batch, 
therefore, did not have a strong dependence on solvent as seen in the other QD batches. 
The Eg of the untreated QDs in chloroform and toluene were both 2.45 eV, which 
suggests the solvent does not have a significant effect on QD size and therefore color 
emitted. 
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Figure 5.40. Photos of CdS (OA & TOA) QDs that are from left to right: untreated, treated with NaBH4, 
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were 
suspended and treated in chloroform while those in the right column were suspended and treated in toluene. 
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment. 
 
The effect of reducing and oxidizing agents on the QY of CdS (OA & TOA) QDs 
was found to be independent of solvent for 4 of the 5 treatments. More specifically, the 
QY of the QDs decreased after treatment with CaH2, N2H4, C14H10O4, and C4H10O2 in 
both chloroform and toluene. The latter three treatments resulted in a quenched 
fluorescence after treatment. Sodium borohydride, on the other hand, resulted in an 
increased QY immediately after treatment in toluene, however the QY decreased after 
treatment in chloroform. Although treatment with NaBH4 seems to have a dependence on 
solvent, the initial quality of the QDs was so poor that it is difficult to form a concrete 
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conclusion to explain these results. Furthermore, due to the difference in starting 
concentration for this set of treatments, laterally comparing these results to the other 5 
systems is not consistent. For these reasons, a recommendation for the future work of this 
thesis is to develop a more robust procedure to synthesize higher quality CdS (OA & 
TOA) QDs. Once this procedure is developed, it is recommended that the QDs be treated 
with each of the reducing/oxidizing agents discussed in this thesis.  
An important result stemming from the above results is consistent with the CdS 
(OA & ODE) QD results (see section 5.2.11 above). Specifically, in each of the 10 
preceding sections, a bimodal fluorescence peak was measured to represent the untreated 
QDs. As previously explained, the fluorescence peak centered at 450 nm was believed to 
be representative of the mixture of OA, TOA, and solvent, whereas the peak centered at 
650 nm was representative of the QDs. We hypothesize that measurement of a 
fluorescence peak at 450 nm indicates that residual ligand is present in the QD solution 
after washing. A reason for this observation is not readily known. 
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Chapter 6. Results and Discussion: Concentration Dependence on QY 
The previous 2 chapters thoroughly present and discuss the effect of various 
reducing/oxidizing agents on the optical properties of QDs after treatment. Treatment of 
QDs with a reducing/oxidizing agent is expected to reduce the surface ligands thereby 
causing them to lose their coordinating properties and detach from the QD surface.1 
Oxygen from atmospheric air is then able to diffuse to the exposed cadmium on the QD 
surface to form a cadmium oxide (CdO) layer around the QDs.1 This CdO layer serves to 
passivate defects on the QD surface, thereby enhancing the QY of the QDs.1 As 
explained in the previous results chapters, however, only 18 of the 50 investigated 
treatments resulted in an enhanced QY of the QDs. Two possible explanations for the 
observed decrease of the QY after the majority of the surface treatments involve the 
reaction rate. Specifically, we hypothesize that when a reducing/oxidizing agent it too 
soluble in a given solvent, it will lead to the formation of QD aggregates and an eventual 
decrease in the QY of the QDs. Instead, the reducing/oxidizing agent will cause the 
ligands to quickly detach from the QD surface and destroy the QDs dispersibility in the 
solvent, and result in a quenched QY.2 
A second possible hypothesis to explain the observed decrease in QY of the QDs 
after several treatments also focuses on the reaction rate. Specifically, we hypothesize 
that the reducing/oxidizing agents react with the residual water present in each of the 
solvents to form hydrogen. The hydrogen then reacts with the surface ligands, causing 
them to detach from the QD surface, and allowing oxygen from the atmospheric air to 
diffuse to the exposed cadmium. The resulting CdO layer around the QDs serves to 
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passivate the defect sites located on the QD surface and therefore improves the QY of the 
QDs. If the reducing/oxidizing agents react too fast with the residual water, the QDs will 
aggregate and the QY will be quenched. Based on this hypothesis, the amount of water 
present in each of the solvents may be responsible for the dependence of solvent on the 
effectiveness of the various surface treatments. 
These theories can also be applied to explain why specific treatments were 
successful in improving the QY of the QDs. For example, 10 of the 18 observed increases 
in QY resulted after surface treatment with sodium borohydride (NaBH4). Consistent 
with the theory presented above, it is believed that NaBH4 was effective as a reducing 
agent because it is only slightly soluble in the two dispersion solvents. Because NaBH4 is 
only slightly soluble in chloroform and toluene, we hypothesize that the reducing agent 
diffused through the solvent to react with the QDs at a slow enough reaction rate that the 
QDs surface was effectively reduced. In the case of reducing/oxidizing agents that were 
completely soluble in the dispersion solvents, the reaction often happened so fast that the 
QDs aggregated and the fluorescence of the QD solution was completely quenched. A 
second possible explanation involves the reactivity of NaBH4 with water. In a study by 
Kong et al., the reaction rate of NaBH4 with water vapor was found to be ten times 
slower than that of CaH2.3 For this reason, we hypothesize that NaBH4 reacted with the 
residual water in each solvent at a slow enough rate that the hydrogen produced was able 
to effectively detach ligands on the QD surface and allow for the formation of the CdO 
layer.  
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Unlike NaBH4, surface treatment with tert-butyl hydroperoxide (C4H10O2) 
resulted in a decline in the QY of the QDs in 11 of the 12 treatments. Eight of those 
treatments led to a total quenching of the QD fluorescence. It is hypothesized that 
because C4H10O2 is a liquid that was miscible in both solvents, all of the oxidizing agent 
was able to react with each batch of QDs immediately after addition. Consistent with the 
theory explained above, we hypothesize that because all of the C4H10O2 was able to react 
with the QDs, the reaction rate was too fast for the formation of the CdO layer due to 
either its solubility in the solvents or its reactivity with water. Regardless of explanation, 
the fast reaction rate led to a decrease in QY. To test this theory, an additional set of 
experiments was performed to investigate whether treatment with a lower concentration 
of C4H10O2 would slow the reaction rate down enough to allow for proper passivation of 
surface defects and therefore enhancement of the QY. 
 
6.1 Effect of tert-Butyl Hydroperoxide (C4H10O2) Concentration on QY of QDs 
Appendix C contains the results from treating each of the 6 batches of QDs with 
lower concentrations of C4H10O2 in both chloroform and toluene. The new concentrations 
investigated were: 0.006 M, 0.010 M, and 0.015 M. It is important to note that these 
concentrations were significantly lower than those evaluated in determining the optimum 
reducing/oxidizing agent concentration (as summarized in Appendix A). In Appendix A, 
results for treatment with 0.104 M, 0.208 M, and 0.312 M C4H10O2 are presented. 
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From these results, a clear dependence on C4H10O2 concentration was observed on 
the QY of the QDs. Specifically, the fluorescence of the QDs was never quenched 
immediately after treatment with lower concentrations of C4H10O2, as was seen after 
treatment with higher concentrations. Instead, the fluorescence often decreased gradually 
over the 10 d period, indicating a significantly slower reaction rate. Figure 6.1 below 
illustrates this dependence on concentration as the fluorescence of the CdSe (oleylamine) 
QDs dissolved in chloroform was quenched immediately after treatment with 0.1038 M 
C4H10O2 (6.14 x 10-6 molar ratio of QDs to C4H10O2), but not after treatment with 
0.0062 M C4H10O2 (1.37 x 10-4 molar ratio of QDs to C4H10O2). The same trend was 
observed when the QDs were dispersed and treated in toluene, as illustrated in Figure 6.2. 
Each of the photos was taken 1 d after the respective treatments. 
 
Figure 6.1. Photos of a (a) 6.39 x 10-7 M solution of CdSe (oleylamine) QDs dissolved in chloroform before 
treatment (left) and 1 d after treatment with C4H10O2 (6.14 x 10-6 molar ratio of QDs to C4H10O2) (right), 
and (b) 8.51 x 10-7 M solution of CdSe (oleylamine) QDs dissolved in chloroform before treatment (left) 
and 1 d after treatment with C4H10O2 (1.37 x 10-4 molar ratio of QDs to C4H10O2) (right). 
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Figure 6.2. Photos of a (a) 1.04 x 10-6 M solution of CdSe (oleylamine) QDs dissolved in toluene before 
treatment (left) and 1 d after treatment with C4H10O2 (1.00 x 10-5 molar ratio of QDs to C4H10O2) (right), 
and (b) 1.04 x 10-6 M solution of CdSe (oleylamine) QDs dissolved in toluene before treatment (left) and 
1 d after treatment with C4H10O2 (1.68 x 10-4 molar ratio of QDs to C4H10O2) (right). 
 
Although only 1 of the 5 reducing/oxidizing agents investigated in this thesis was 
evaluated as a function of concentration, it is expected that the lower the concentration of 
reducing/oxidizing agent, the slower the rate of reaction and therefore the better the 
treatment. Future work based on this thesis will investigate the effect of concentration of 
the other 4 reducing/oxidizing agents on the QY of the QDs after treatment. 
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Chapter 7. Conclusions 
 Quantum dots are nanoscale semiconductors that exhibit fascinating optical and 
electrical properties not observed in bulk semiconductors. Specifically, the size and shape 
of QDs can be tuned by varying reaction conditions therefore making QDs advantageous 
for a variety of applications ranging from electronics to the medical field.   
 This thesis focused on producing QDs with a high quantum yield (QY) by 
investigating the effect of treating QDs with either reducing or oxidizing agents to 
enhance the QY. The reducing agents investigated include: sodium borohydride (NaBH4), 
calcium hydride (CaH2), and hydrazine (N2H4); and the oxidizing agents investigated are: 
benzoyl peroxide (C14H10O4) and tert-butylhydroperoxide (C4H10O2). To correlate what 
effect the reducing and oxidizing agents were having on the optical properties of the 
QDs, we investigated these treatments on the following factors: chalcogenide (Se vs. S), 
ligand (oleylamine vs. OA), coordinating solvent (ODE vs. TOA), and dispersant solvent 
(chloroform vs. toluene) on the overall optical properties of the QDs.  The main 
conclusions from the work of this thesis are presented below. 
 
• The ability of the various reducing/oxidizing agents to enhance the QY of the 
QDs was independent of the chalcogenide. No clear trend was observed to indicate 
that the surface treatments were more effective in treating CdSe QDs versus CdS 
QDs. In fact, the exact same results were obtained when oleylamine was used as the 
capping ligand. The initial QY of CdSe QDs, however, was higher than that of CdS 
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QDs when capped with oleylamine. Conversely, the initial QY of CdS QDs was 
higher than that of CdSe QDs when capped with oleic acid (regardless of non-
coordinating solvent used). A reason for this difference is not known, however, we 
hypothesize that a possible explanation involves the coverage of ligands on the 
surface of the QDs. To estimate ligand surface coverage, thermogravimetric analysis 
(TGA) data coupled with data regarding the geometry of the QD can be used. 
Specifically, TGA measures the weight change of a sample as it is heated to the 
temperature at which it degrades. After performing TGA on the QD samples, it is 
believed that the mass remaining after heating is that of the metal core without the 
ligands. TGA was performed on each batch of QDs used in this thesis (see Appendix 
D). Coupling this TGA data with information regarding the size and shape of the QDs 
would allow for the estimate of ligand surface coverage and therefore provide an 
explanation as to why the QY of the untreated QDs was higher when CdSe QDs were 
capped with oleylamine and CdS QDs were capped with OA. To estimate the size and 
shape of the QDs, it is recommended that transmission electron microscopy (TEM) or 
dynamic light scattering (DLS) be performed in the future work of this thesis. 
  
• The QY of the QDs was calculated to be higher when octadecene (ODE) was 
used as the non-coordinating solvent versus trioctylamine (TOA). The QY of the 
QDs synthesized with OA as the ligand and ODE as the non-coordinating solvent 
were visibly brighter and yielded a higher QY than those with TOA as the non-
coordinating solvent. This was observed regardless of chalcogenide or dispersion 
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solvent. The primary difference between the two investigated solvents is that ODE is 
a non-coordinating solvent whereas TOA is a weakly-coordinated solvent. Because 
TOA has both polar and non-polar groups, it may have coordinated to the QD surface 
and interfered with the OA coverage of the QD surface, therefore leading to a reduced 
QY. Further characterization of the QDs is required before a definitive conclusion can 
be made.  
In terms of surface treatment, the QY of the QDs was enhanced after treatment 
with the various reducing/oxidizing agents more often when ODE was used as the 
non-coordinating solvent than TOA. More specifically, 8 of the 20 treatments 
performed on QDs with ODE as the non-coordinating solvent resulted in an increased 
QY, whereas only 4 of the 20 treatments increased in the presence of TOA. Similar to 
the effect of the chalcogenide, it is believed that the difference in coverage of the 
ligands on the QD surface is responsible for this observation. As mentioned above, it 
is possible that the TOA may have interfered with the OA coverage of the QD 
surface, therefore preventing the reducing/oxidizing agents from effectively 
passivating the surface defects on the QDs surface. To determine the effect the non-
coordinating solvent has on the ability of OA to bind to the QD surface, it is 
recommended that further characterization techniques be performed. Specifically, 
TEM or DLS should be performed to determine the size and shape of the QDs. 
Coupling this geometry data with the TGA data summarized in Appendix D of this 
thesis would allow for the estimate of OA coverage in the presence of the 2 non-
coordinating solvents. Furthermore, this data would provide an explanation about 
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why the surface treatment of the QDs was more effective at increasing the QY of the 
QDs when ODE was used instead of TOA. 
 
• The QY of the QDs was calculated to be higher when the QDs were dispersed in 
toluene versus chloroform. Regardless of chalcogenide, ligand, non-coordinating 
solvent, or treatment, QDs were visibly brighter and yielded a higher QY when 
dissolved in toluene than chloroform. This result is consistent with the work of Bullen 
et al. who concluded that when capping ligands are very soluble in a solvent, the 
ligands detach from the QD surface, therefore resulting in a quenched QY.1 
Conversely, if the ligands are less soluble in a solvent, they will tend to adsorb onto 
the surface of the QDs from solution which may enhance the QY even further.1 
Because oleylamine is more soluble in chloroform than toluene, the higher QY of 
QDs capped with oleylamine in toluene than chloroform was therefore justified. Oleic 
acid, on the other hand, is more soluble in toluene than chloroform therefore the 
dependence of solvent is hypothesized to be due to the difference in dissolved oxygen 
concentration in each solvent. 
In terms of surface treatment, the QY of the QDs capped with OA was enhanced 
after treatment with the various reducing/oxidizing agents more often when the QDs 
were dispersed and treated in chloroform than toluene. When oleylamine was used as 
the capping ligand, no difference in solvent was observed. To explain the dependence 
on solvent in the presence of OA, we present 2 possible explanations. First, we 
251 
 
 
 
hypothesize that if the reducing/oxidizing agent is more soluble in a given solvent it 
will react at a significantly faster rate than in a poor solvent. If the reaction happens 
too fast, the QDs will begin to aggregate, and the QY will be quenched. To test this 
theory, a solubility study to determine the solubility of each reducing/oxidizing agent 
in both chloroform and toluene should be conducted. Based on the results presented 
in this thesis, we expect that the reducing/oxidizing agents will be more soluble in 
toluene than chloroform, therefore explaining our results. 
A second possible explanation for the observed results also focuses on the 
reaction rate. Specifically, we hypothesize that the reducing/oxidizing agents react 
with the residual water present in each of the solvents to form hydrogen. The 
hydrogen then reacts with the surface ligands, causing them to detach from the QD 
surface, and allowing oxygen from the atmospheric air to diffuse to the exposed 
cadmium. The resulting CdO layer around the QDs serves to passivate the defect sites 
located on the QD surface and therefore improves the QY of the QDs. If the 
reducing/oxidizing agents react too fast with the residual water, the QDs will 
aggregate and the QY will be quenched. Based on this hypothesis, the amount of 
water present in each of the solvents may be responsible for the dependence of 
solvent on the effectiveness of the various surface treatments. To test this theory, the 
hydrogen concentration emitted from the reaction of each reducing/oxidizing agent 
with both chloroform and toluene should be measured and compared. 
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• Surface treatment of QDs with sodium borohydride (NaBH4) resulted in an 
enhanced QY in 10 of the 12 treatments. Sodium borohydride (NaBH4) was found 
to be the most effective reducing agent at improving the QY of the as-synthesized 
QDs. Of the 12 batches of QDs investigated, NaBH4 effectively improved the QY of 
all but 2 after treatment (including CdS (OA & TOA) in chloroform, and CdS (OA & 
ODE) in toluene). One potential explanation for the success of NaBH4 in enhancing 
the QY of the QDs is due to the slight solubility of NaBH4 in the two dispersion 
solvents. Because NaBH4 is only slightly soluble in chloroform and toluene, we 
hypothesize that the reducing agent diffused through the solvent to react with the QDs 
at a slow enough reaction rate that the QDs surface was effectively reduced. In the 
case of reducing/oxidizing agents that were completely soluble in the dispersion 
solvents, the reaction often happened so fast that the QDs aggregated and the 
fluorescence of the QD solution was completely quenched.  
A second possible explanation involves the reactivity of NaBH4 with water. In a 
study by Kong et al., the reaction rate of NaBH4 with water vapor was found to be ten 
times slower than that of CaH2.2 For this reason, we hypothesize that NaBH4 reacted 
with the residual water in each solvent at a slow enough rate that the hydrogen 
produced was able to effectively detach ligands on the QD surface and allow for the 
formation of the CdO layer. As explained above, if a reducing/oxidizing agent reacts 
too fast with the residual water, the QDs will aggregate and the QY will be quenched. 
It is therefore hypothesized that CaH2 reacted with the residual water at too fast a rate, 
therefore explaining the observed aggregation and decrease in QY. 
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• Surface treatment of QDs with hydrazine (N2H4) in chloroform resulted in poor 
dispersion of the hydrazine which quenched the QY. Hydrazine is a liquid that is 
nearly insoluble in chloroform. When hydrazine was added to the QD solution an 
emulsion formed. We hypothesize that OA and oleylamine were able to act as 
surfactants and stabilize the N2H4 droplets in their respective emulsions. In the 
presence of oleylamine, large, poorly dispersed droplets of N2H4 formed, indicating 
that oleylamine is not a good surfactant for N2H4 in chloroform. However, OA 
seemed to be a better surfactant for N2H4 in chloroform because small, evenly 
dispersed droplets of N2H4 could be seen in the chloroform. Figure 7.2 illustrates this 
difference in droplet suspension when oleylamine was used as opposed to OA. 
We hypothesized the emulsions had two effects on the QD solutions. For the 
oleylamine QDs, a small amount of soluble N2H4 reacts with the QDs and reduces 
their surface to etch and destroy the QDs thereby quenching the QD fluorescence. 
The remainder of the N2H4 forms large, unevenly dispersed N2H4 droplets stabilized 
by the residual oleylamine. The solution appears blue-green when excited by a 
365 nm UV lamp because the oleylamine emits light at 450 nm upon excitation. After 
10 d a visible layer forms at the top of the chloroform solution, presumably due to 
instability of the emulsion. A similar effect was observed with the OA/TOA QDs 
presumably because residual TOA is a poor surfactant for N2H4 in chloroform. 
In the case of the OA QDs, when the N2H4 is added to the chloroform a small 
amount of soluble N2H4 reacts with the QDs and reduces their surface to etch and 
destroy the QDs thereby quenching the QD fluorescence. The residual OA then 
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stabilized the remaining N2H4 into small, evenly dispersed N2H4 droplets. These 
droplets scatter light, causing the solution to appear cloudy in visible light. When a 
365 nm UV lamp was used as the incident light, the evenly dispersed droplets of 
N2H4 in the QD solution scattered the light causing the solution to appear purple (see 
Figure 7.1).  
 
Figure 7.1. Schematic illustrating effect of ligand on N2H4 dispersion in chloroform.  
 
Regardless of ligand, the fluorescence of the OA/TOA QDs was quenched 
immediately after treatment with N2H4. 
 
• The effectiveness of QD surface treatment with various reducing/oxidizing 
agents is dependent on concentration. As explained above, often the 
reduction/oxidation of the QD surface happened so fast that the fluorescence of the 
QD solution was quenched after treatment. We hypothesize that when a 
reducing/oxidizing agent it highly soluble in a given solvent or very reactive with 
water, it reacts with the QDs at a rate so fast desorption of the ligands and 
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aggregation occur before forming a stable QD with a CdO layer.3 The net result is an 
increase in the UV absorbance and a quenching of the fluorescence resulting in a 
decrease in QY. This theory was investigated by treating each of the 6 batches of QDs 
with tert-butylhydroperoxide (C4H10O2) in both chloroform and toluene at several 
concentrations. From this set of treatments, a clear dependence on the oxidizing 
agent’s concentration was observed. Specifically, at lower concentrations of the 
oxidizing agent, the reaction rate slowed significantly, and the fluorescence was not 
quenched. Although this theory was only tested for 1 of the 5 reducing/oxidizing 
agents, it is expected the concentration dependence on the reactivity effect the other 4 
treatments as well. 
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Chapter 8. Future Work 
 The work detailed in this thesis was aimed at surveying the effect of oxidizing and 
reducing agents on the quantum yield of CdSe and CdS QDs. Future work focuses on 
expanding on these results to include additional characterization methods to gather more 
information about the effect of the reducing and oxidizing agents on the structure of the 
QDs. Additional future work involves investigating the solubility and reactivity of each 
reducing/oxidizing agent to support the conclusion that the effectiveness of each agent 
was dependent on reaction rate. Specific recommendations for future work of this thesis 
are presented below. 
 
• Characterization methods should be performed to quantify the size and shape of 
the QDs. Specifically, transmission electron microscopy (TEM), atomic force 
microscopy (AFM) or dynamic light scattering (DLS) should be performed to 
measure the size and shape of the QDs before and after treatment. Knowledge of the 
morphology of the QDs would help to quantitatively determine what effect the 
oxidizing and reducing agents have on the size of the QDs due to etching or 
aggregation. For example, increases in absorbance and flattening of the fluorescence 
peak seem to indicate aggregation had occurred after treating several of the QD 
batches with calcium hydride (CaH2). Information regarding the size of the QDs 
before treatment and at each time interval after treatment with CaH2 could quantify 
what fraction of the QDs aggregated with time. TEM images would also provide 
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information about the shape of the QDs. The size and shape of the QDs could be used 
in conjunction with thermogravitational analysis (TGA) results to determine the 
ligand surface coverage of the various QD batches. The ligand surface coverage could 
be used to determine if there is a correlation between coverage of the ligands on the 
QDs surface and effectiveness of a reducing/oxidizing agent. 
 
• The dependence of concentration on the effectiveness of QD surface treatment 
should be investigated for each reducing/oxidizing agent. One of the main 
conclusions of this thesis is that the effectiveness of QD surface treatments on the QY 
of the QDs is dependent on concentration. This conclusion was explored by retreating 
each of the 6 batches of QDs with a lower concentration of tert-butylhydroperoxide 
(C4H10O2) in both chloroform and toluene. From this set of treatments, a clear 
dependence on the oxidizing agent’s concentration was observed. Specifically, lower 
oxidizing agent concentrations resulted in slower reaction rates and greater increases 
in QY. Given these results, the concentration dependence of the remaining surface 
treatments (sodium borohydride (NaBH4), hydrazine (N2H4), calcium hydride (CaH2), 
and benzoyl peroxide (C14H10O2)) on the QY should be explored.  
 
• A solubility study should be performed to determine the solubility of each 
reducing/oxidizing agent in chloroform and toluene. As explained in the results 
sections of this thesis, little information is available regarding the solubility of each 
reducing/oxidizing agent in toluene versus chloroform. We hypothesize that if a given 
259 
 
 
 
reducing/oxidizing agent is more soluble is a particular solvent, it will react at a much 
faster rate than in a poor solvent. The result of the faster reaction rate leads to the 
ligands detaching from the QD surface at a rate that favors aggregation of the QDs. 
For this reason, information concerning the solubility of each agent in the dispersion 
solvents is crucial to confirming this hypothesis. It is therefore recommended that a 
solubility study be conducted on each of the 5 reducing/oxidizing agents in both 
toluene and chloroform.  
 
• Additional testing should be performed to test the hypothesis that water 
contained in the solvents reacted with each reducing/oxidizing agent to 
reduce/oxidize the QD surface. As explained in Chapter 7, we hypothesize that 
water contained in the solvents reacted with each reducing/oxidizing agent to produce 
hydrogen. This hydrogen then reacted with the surface ligands, causing them to 
detach from the QD surface, and allowing oxygen from the atmospheric air to diffuse 
to the exposed cadmium. The resulting CdO layer around the QDs served to passivate 
the defect sites located on the QD surface and resulted in an enhanced QY. To test 
this hypothesis, it is recommended that each of the QDs be dispersed and treated in 
dried chloroform and toluene. If our hypothesis is correct, the QDs will not be 
reduced/oxidized and no change in the QY of the QDs will be observed.  
This hypothesis was also applied as a possible explanation as to why NaBH4 
was an effective reducing agent but CaH2 was not. Specifically, CaH2 reacts with 
water vapor at a significantly faster rate (10 X) than NaBH4.1 For this reason, it is 
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believed that because the reduction of the QDs happened so fast when treated with 
CaH2, the QDs often aggregated, resulting in reduced QY. To further test this 
hypothesis, the hydrogen concentration emitted from the reaction of each solvent, 
ligand, and CaH2 reaction can be compared to that of each solvent, ligand, and 
NaBH4 reaction. If our hypothesis is correct, the amount of hydrogen produced from 
the reaction with CaH2 will be significantly higher than the amount produced from the 
NaBH4 reaction. 
 
• It is recommended that techniques to synthesize better quality CdS (OA & TOA) 
QDs be investigated. Of the 6 batches of QDs synthesized in the work of this thesis, 
CdS (OA & TOA) QDs had the lowest initial QY. It is therefore recommended that 
techniques to synthesize better quality CdS (OA & TOA) QDs be investigated. A 
potential modification to the existing procedure involves heating the precursor 
solution to a higher temperature prior to injection into the reaction solution. 
Currently, the precursor solution is heated to 120 °C prior to injection into the 
reaction solution which is then heated to 175 °C. It is recommended that the precursor 
solution be preheated to temperatures between 120 °C and 175 °C to determine the 
influence, if any, that this temperature has on the QY of the synthesized QDs. 
Another potential modification involves exploring other cadmium sources. In this 
thesis, cadmium acetate was used as the cadmium source for each of the batches, 
however, several research groups report the use of cadmium oxide (CdO) to produce 
high quality CdS QDs.2 It is therefore recommended that CdO be investigated.  
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• Methods to quench the QD synthesis reaction should be explored. The procedure 
followed to synthesize QDs in this thesis involved heating the reaction mixture in a 
microwave to a specific temperature. After the reaction was complete, the reaction 
solution slowly cooled to room temperature. As seen from the fluorescence spectra 
included in the results of this thesis, the as-synthesized QDs yielded a broad 
fluorescence peak indicating a wide size distribution of particles. Specifically, an 
average full-width half-maximum (FWHM) of 90 nm was reported for CdSe QDs and 
170 nm for CdS QDs. The literature, on the other hand, reports CdSe FWHM values 
as low as 25 nm3,4, and CdS values of 18 nm.3 A recommendation for future work 
involves quenching the reaction immediately after heating to prevent any further 
reaction. It is expected that by quenching the reaction, a more uniform size 
distribution of particles will be achieved. A possible technique to explore involves 
adding a small amount of ethanol to the reaction solution immediately after the 
reaction is complete.5  
 
• It is recommended that the negative fluorescence peak observed in the 
fluorescence spectra of CdSe (OA & TOA) and CdS (OA & TOA) QDs dissolved 
in chloroform be investigated further. Fluorescence spectroscopy was performed 
on solutions consisting of each ligand, non-coordinating solvent, dispersion solvent, 
and reducing/oxidizing agent combination to account for the potential influence of the 
various reaction materials on QD fluorescence. Each spectra yielded a similar peak at 
450 nm, therefore this peak was said to be representative of the reaction materials. 
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Although this peak was observed in several of the QD batches, in the case of both 
CdSe (OA & TOA) and CdS (OA & TOA) QDs dissolved in chloroform, this 
fluorescence peak was negative. Because a positive peak centered at 450 nm was 
observed in the fluorescence spectra of OA, TOA, and chloroform (no negative peak), 
it is unclear why this negative peak was seen. The final recommendation for future 
work of this thesis is that additional batches of CdSe (OA & TOA) and CdS (OA & 
TOA) QDs dissolved in chloroform be tested to confirm this result. If the negative 
peak is observed in these new batches, it is recommended that further 
characterizations be performed to determine its cause. 
 
• A method to purify the QDs after treatment should be explored. As explained in 
Chapter 4, the measured absorbance and fluorescence spectra presented in this thesis 
(and therefore calculated quantum yield values) were representative of the QD 
mixture, not just the QDs. For this reason, it is unclear what led to the quenching of 
the QD solutions. Developing a method to purify the QDs after treatment may remove 
the quenching agent and enable us to measure the absorbance and fluorescence of just 
the QDs. Furthermore, if the quenching is reversible, purification may allow for the 
restoration of the QD fluorescence after quenching. For example, if excess free ligand 
led to the quenching of the fluorescence, purifying the QDs would remove the 
residual ligand, and, if the quenching is reversible, restore the fluorescence. Future 
work should also focus on determining the specific effect of the ligands on QD 
quenching as well as determining the extinction coefficient of the QD mixture. 
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Appendix A . Determining the Optimum Concentration of 
Reducing/Oxidizing Agents for Experiments 
 
Included in this appendix are plots and pictures that led to the determination of the 
optimal concentration of each the 5 reducing/oxidizing agents used in this thesis. The 
agents investigated include: (1) sodium borohydride (NaBH4), (2) calcium hydride 
(CaH2), (3) hydrazine (N2H4), (4) benzoyl peroxide (C14H10O4), and (5) tert-butyl 
hydroperoxide (C4H10O2). Preliminary results showed that QDs fluoresced brighter in 
chloroform than toluene, therefore, chloroform was used as the solvent when determining 
each reducing/oxidizing agent concentration. 
 
A.1 CdSe Quantum Dot Cores Synthesized with Oleylamine  
A.1.1 Sodium Borohydride (NaBH4) 
 Cadmium selenide QD cores synthesized with oleylamine were treated with 0.001 
g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to determine 
which concentration yielded the highest fluorescence peak. Figure A1 below shows the 
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The 
optimal concentration of NaBH4 for this batch type was found to be 0.006 g (0.159 
mmol) as represented by the green line. 
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Figure A.1. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g NaBH4 excited with 365 nm UV light. 
 
A.1.2 Calcium Hydride (CaH2) 
 Cadmium selenide QD cores synthesized with oleylamine were treated with 0.001 
g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to determine 
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which concentration yielded the highest fluorescence peak. Figure A2 below shows the 
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The 
optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024 mmol) 
as represented by the orange line. 
 
Figure A.2. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g CaH2 excited with 365 nm UV light. 
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A.1.3 Hydrazine (N2H4) 
 Cadmium selenide QD cores synthesized with oleylamine were treated with 
0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to 
determine which concentration yielded the highest fluorescence peak. Figure A3 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of N2H4 for this batch type was found to be 0.15 mL (4.74 
mmol) as represented by the green line. 
 
Figure A.3. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and 
0.15 mL N2H4 excited with 365 nm UV light. 
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A.1.4 Benzoyl Peroxide (C14H10O4) 
 Cadmium selenide QD cores synthesized with oleylamine were treated with 0.001 
g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4 to determine 
which concentration yielded the highest fluorescence peak. Figure A4 below shows the 
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The 
optimal concentration of C14H10O4 for this batch type was found to be 0.001 g (0.004 
mmol) as represented by the orange line. 
 
Figure A.4. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g C14H10O4 excited with 365 nm UV light. 
A6 
 
A.1.5 tert-Butyl Hydroperoxide (C4H10O2) 
 Cadmium selenide QD cores synthesized with oleylamine were treated with 
0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to 
determine which concentration yielded the highest fluorescence peak. Figure A5 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
Although the QDs stopped fluorescing after the addition of C4H10O2 as seen in Figure 
A5c, the optimal concentration of C4H10O2 for this batch type was assumed to be 0.05 
mL (orange line). 
 
Figure A.5. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, 
and 0.15 mL C4H10O2 excited with 365 nm UV light. 
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A.2 CdSe Quantum Dot Cores Synthesized with Oleic Acid and ODE  
A.2.1 Sodium Borohydride (NaBH4) 
 Cadmium selenide QD cores synthesized with oleic acid and ODE were treated 
with 0.001 g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to 
determine which concentration yielded the highest fluorescence peak. Figure A6 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of NaBH4 for this batch type was found to be 0.006 g (0.159 
mmol) as represented by the green line. 
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Figure A.6. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g NaBH4 excited with 365 nm UV light. 
 
A.2.2 Calcium Hydride (CaH2) 
 Cadmium selenide QD cores synthesized with oleic acid and ODE were treated 
with 0.001 g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to 
determine which concentration yielded the highest fluorescence peak. Figure A7 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
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The optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024 
mmol) as represented by the orange line. 
 
Figure A.7. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g CaH2 excited with 365 nm UV light. 
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A.2.3 Hydrazine (N2H4) 
 Cadmium selenide QD cores synthesized with oleic acid and ODE were treated 
with 0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to 
determine which concentration yielded the highest fluorescence peak. Figure A8 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
Although the QDs stopped fluorescing after the addition of N2H4, the optimal 
concentration of N2H4 for this batch type was assumed to be 0.05 mL (orange line).  
 
Figure A.8. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and 
0.15 mL N2H4 excited with 365 nm UV light. 
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A.2.4 Benzoyl Peroxide (C14H10O4) 
 Cadmium selenide QD cores synthesized with oleic acid and ODE were treated 
with 0.001 g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4 
to determine which concentration yielded the highest fluorescence peak. Figure A9 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of C14H10O4 for this batch type was found to be 0.006 g (0.025 
mmol) as represented by the green line. 
 
Figure A.9. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g C14H10O4 excited with 365 nm UV light. 
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A.2.5 tert-Butyl Hydroperoxide (C4H10O2) 
 Cadmium selenide QD cores synthesized with oleic acid and ODE were treated 
with 0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to 
determine which concentration yielded the highest fluorescence peak. Figure A10 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of C4H10O2 for this batch type was found to be 0.15 mL (1.56 
mmol) as represented by the green line. 
 
Figure A.10. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, 
and 0.15 mL C4H10O2 excited with 365 nm UV light. 
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A.3 CdSe Quantum Dot Cores Synthesized with Oleic Acid and TOA  
A.3.1 Sodium Borohydride (NaBH4) 
 Cadmium selenide QD cores synthesized with oleic acid and TOA were treated 
with 0.001 g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to 
determine which concentration yielded the highest fluorescence peak. Figure A11 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of NaBH4 for this batch type was found to be 0.001 g (0.026 
mmol) as represented by the orange line. 
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Figure A.11. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g NaBH4 excited with 365 nm UV light. 
 
A.3.2 Calcium Hydride (CaH2) 
 Cadmium selenide QD cores synthesized with oleic acid and TOA were treated 
with 0.001 g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to 
determine which concentration yielded the highest fluorescence peak. Figure A12 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
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The optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024 
mmol) as represented by the orange line. 
 
Figure A.12. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g CaH2 excited with 365 nm UV light. 
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A.3.3 Hydrazine (N2H4) 
 Cadmium selenide QD cores synthesized with oleic acid and TOA were treated 
with 0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to 
determine which concentration yielded the highest fluorescence peak. Figure A13 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
Although the QDs stopped fluorescing after the addition of N2H4, the optimal 
concentration of N2H4 for this batch type was assumed to be 0.15 mL (green line).  
 
Figure A.13. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and 
0.15 mL N2H4 excited with 365 nm UV light. 
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A.3.4 Benzoyl Peroxide (C14H10O4) 
 Cadmium selenide QD cores synthesized with oleic acid and TOA were treated 
with 0.001 g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4 
to determine which concentration yielded the highest fluorescence peak. Figure A14 
below shows the absorbance spectrum, the fluorescence spectrum, and a picture of the 
samples. The optimal concentration of C14H10O4 for this batch type was found to be 0.003 
g (0.012 mmol) as represented by the red line. 
 
Figure A.14. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g C14H10O4 excited with 365 nm UV light. 
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A.3.5 tert-Butyl Hydroperoxide (C4H10O2) 
 Cadmium selenide QD cores synthesized with oleic acid and TOA were treated 
with 0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to 
determine which concentration yielded the highest fluorescence peak. Figure A15 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of C4H10O2 for this batch type was found to be 0.10 mL (1.04 
mmol) as represented by the red line. 
 
Figure A.15. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, 
and 0.15 mL C4H10O2 excited with 365 nm UV light. 
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A.4 CdS Quantum Dot Cores Synthesized with Oleylamine  
A.4.1 Sodium Borohydride (NaBH4) 
 Cadmium sulfide QD cores synthesized with oleylamine were treated with 0.001 
g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to determine 
which concentration yielded the highest fluorescence peak. Figure A16 below shows the 
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The 
optimal concentration of NaBH4 for this batch type was found to be 0.003 g (0.079 
mmol) as represented by the red line. 
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Figure A.16. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g NaBH4 excited with 365 nm UV light. 
 
A.4.2 Calcium Hydride (CaH2) 
 Cadmium sulfide QD cores synthesized with oleylamine were treated with 0.001 
g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to determine 
A21 
 
which concentration yielded the highest fluorescence peak. Figure A17 below shows the 
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The 
optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024 mmol) 
as represented by the orange line. 
 
Figure A.17. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g CaH2 excited with 365 nm UV light. 
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A.4.3 Hydrazine (N2H4) 
 Cadmium sulfide QD cores synthesized with oleylamine were treated with 
0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to 
determine which concentration yielded the highest fluorescence peak. Figure A52 below 
shows the absorbance spectrum, Figure A53 shows the fluorescence spectrum, and Figure 
A54 includes a picture of the samples. The optimal concentration of N2H4 for this batch 
type was found to be 0.15 mL (4.74 mmol) in Figure A53 (green line). 
 
Figure A.18. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and 
0.15 mL N2H4 excited with 365 nm UV light. 
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A.4.4 Benzoyl Peroxide (C14H10O4) 
 Cadmium sulfide QD cores synthesized with oleylamine were treated with 0.001 
g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4 to determine 
which concentration yielded the highest fluorescence peak. Figure A19 below shows the 
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The 
optimal concentration of C14H10O4 for this batch type was found to be 0.001 g (0.004 
mmol) as represented by the orange line. 
 
Figure A.19. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g C14H10O4 excited with 365 nm UV light. 
A24 
 
A.4.5 tert-Butyl Hydroperoxide (C4H10O2) 
 Cadmium sulfide QD cores synthesized with oleylamine were treated with 
0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to 
determine which concentration yielded the highest fluorescence peak. Figure A20 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of C4H10O2 for this batch type was found to be 0.15 mL (1.56 
mmol) as represented by the green line. 
 
Figure A.20. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, 
and 0.15 mL C4H10O2 excited with 365 nm UV light. 
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A.5 CdSe Quantum Dot Cores Synthesized with Oleic Acid and ODE  
A.5.1 Sodium Borohydride (NaBH4) 
 Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated 
with 0.001 g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to 
determine which concentration yielded the highest fluorescence peak. Figure A21 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of NaBH4 for this batch type was found to be 0.003 g (0.079 
mmol) as represented by the red line. 
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Figure A.21. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g NaBH4 excited with 365 nm UV light. 
 
A.5.2 Calcium Hydride (CaH2) 
 Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated 
with 0.001 g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to 
determine which concentration yielded the highest fluorescence peak. Figure A22 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
A27 
 
The optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024 
mmol) as represented by the orange line. 
 
Figure A.22. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g CaH2 excited with 365 nm UV light. 
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A.5.3 Hydrazine (N2H4) 
 Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated 
with 0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to 
determine which concentration yielded the highest fluorescence peak. Figure A23 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
Although the QDs stopped fluorescing after the addition of N2H4, the optimal 
concentration of N2H4 for this batch type was assumed to be 0.05 mL (orange line).  
 
Figure A.23. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and 
0.15 mL N2H4 excited with 365 nm UV light. 
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A.5.4 Benzoyl Peroxide (C14H10O4) 
 Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated 
with 0.001 g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4 
to determine which concentration yielded the highest fluorescence peak. Figure A24 
below shows the absorbance spectrum, the fluorescence spectrum, and a picture of the 
samples. The optimal concentration of C14H10O4 for this batch type was found to be 0.003 
g (0.012 mmol) as represented by the red line. 
 
Figure A.24. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g C14H10O4 excited with 365 nm UV light. 
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A.5.5 tert-Butyl Hydroperoxide (C4H10O2) 
 Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated 
with 0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to 
determine which concentration yielded the highest fluorescence peak. Figure A25 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of C4H10O2 for this batch type was found to be 0.10 mL (1.04 
mmol) as represented by the red line. 
 
Figure A.25. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, 
and 0.15 mL C4H10O2 excited with 365 nm UV light. 
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A.6 CdS Quantum Dot Cores Synthesized with Oleic Acid and TOA  
A.6.1 Sodium Borohydride (NaBH4) 
 Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated 
with 0.001 g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to 
determine which concentration yielded the highest fluorescence peak. Figure A26 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of NaBH4 for this batch type was found to be 0.006 g (0.159 
mmol) as represented by the green line. 
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Figure A.26. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g NaBH4 excited with 365 nm UV light. 
 
A.6.2 Calcium Hydride (CaH2) 
 Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated 
with 0.001 g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to 
determine which concentration yielded the highest fluorescence peak. Figure A27 below 
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shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of CaH2 for this batch type was found to be 0.003 g (0.071 
mmol) as represented by the red line. 
 
Figure A.27. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g CaH2 excited with 365 nm UV light. 
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A.6.3 Hydrazine (N2H4) 
 Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated 
with 0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to 
determine which concentration yielded the highest fluorescence peak. Figure A28 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of N2H4 for this batch type was found to be 0.05 mL (1.58 
mmol) as represented by the orange line.  
 
Figure A.28. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and 
0.15 mL N2H4 excited with 365 nm UV light. 
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A.6.4 Benzoyl Peroxide (C14H10O4) 
 Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated 
with 0.001 g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4 
to determine which concentration yielded the highest fluorescence peak. Figure A29 
below shows the absorbance spectrum, the fluorescence spectrum, and a picture of the 
samples. The optimal concentration of C14H10O4 for this batch type was found to be 0.001 
g (0.004 mmol) as represented by the orange line. 
 
Figure A.29. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and 
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and 
0.006 g C14H10O4 excited with 365 nm UV light. 
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A.5.5 tert-Butyl Hydroperoxide (C4H10O2) 
 Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated 
with 0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to 
determine which concentration yielded the highest fluorescence peak. Figure A30 below 
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples. 
The optimal concentration of C4H10O2 for this batch type was found to be 0.10 mL (1.04 
mmol) as represented by the red line. 
 
Figure A.30. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs 
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and 
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, 
and 0.15 mL C4H10O2 excited with 365 nm UV light. 
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Appendix B . Determining the Effect of Reducing/Oxidizing Agents on 
CdS (OA & TOA) QDs 
 
Included in this appendix are plots and pictures that illustrate the effect of treating 
CdS (OA & TOA) QDs with various reducing and oxidizing agents. The agents 
investigated include: (1) sodium borohydride (NaBH4), (2) calcium hydride (CaH2), (3) 
hydrazine (N2H4), (4) benzoyl peroxide (C14H10O4), and (5) tert-butyl hydroperoxide 
(C4H10O2). The absorbance of the QD solution prior to treatment was ~ 0.08 a.u. 
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B.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform 
 
Figure B.1. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.159 mmol NaBH4. Photos of untreated QDs (left) and QDs treated with 
NaBH4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.2 Treatment with Sodium Borohydride (NaBH4) in Toluene 
 
Figure B.2. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.159 mmol NaBH4. Photos of untreated QDs (left) and QDs treated with 
NaBH4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.3 Treatment with Calcium Hydride (CaH2) in Chloroform 
 
Figure B.3. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.071 mmol CaH2. Photos of untreated QDs (left) and QDs treated with CaH2 
(right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.4 Treatment with Calcium Hydride (CaH2) in Toluene 
 
Figure B.4. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.071 mmol CaH2. Photos of untreated QDs (left) and QDs treated with CaH2 
(right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.5 Treatment with Hydrazine (N2H4) in Chloroform 
 
Figure B.5. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 1.58 mmol N2H4. Photos of untreated QDs (left) and QDs treated with N2H4 
(right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.6 Treatment with Hydrazine (N2H4) in Toluene 
 
Figure B.6. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 1.58 mmol N2H4. Photos of untreated QDs (left) and QDs treated with N2H4 
(right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform 
 
Figure B.7. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.004 mmol C14H10O4. Photos of untreated QDs (left) and QDs treated with 
C14H10O4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene 
 
Figure B.8. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.004 mmol C14H10O4. Photos of untreated QDs (left) and QDs treated with 
C14H10O4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform 
 
Figure B.9. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 1.04 mmol C4H10O2. Photos of untreated QDs (left) and QDs treated with 
C4H10O2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene 
 
Figure B.10. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 1.04 mmol C4H10O2. Photos of untreated QDs (left) and QDs treated with 
C4H10O2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment. 
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B.11 Summary of CdSe/OA & ODE Treatments 
 
Figure B.11. Photos of CdS (OA & TOA) QDs that are from left to right: untreated, treated with 0.159 
mmol NaBH4, 0.004 mmol C14H10O4, 0.071 mmol CaH2, 1.58 mmol N2H4, and 1.04 mmol C4H10O2 excited 
with 365 nm UV light. The QDs in the left column were suspended and treated in chloroform while those 
in the right column were in toluene. Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom 
row) after treatment. 
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Appendix C . Determining the Effect of Concentration on the Surface 
Treatment of QDs with tert-Butyl Hydroperoxide (C4H10O2) 
 
Included in this appendix are plots and pictures that illustrate the effect of treating 
each batch of QDs with varying concentrations of tert-butyl hydroperoxide (C4H10O2).  
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C.1 CdSe/Oleylamine Quantum Dot Cores  
C.1.1 Chloroform 
 
Figure C1. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
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Figure C2. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
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Figure C3. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
 
Figure C4. Photos of CdSe (oleylamine) QDs dissolved in chloroform that are from left to right: untreated, 
treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, (b) 
5 d, and (c) 10 d after treatment.. 
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C.1.2 Toluene 
 
Figure C5. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
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Figure C6. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
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Figure C7. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
 
Figure C8. Photos of CdSe (oleylamine) QDs dissolved in toluene that are from left to right: untreated, 
treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, (b) 
5 d, and (c) 10 d after treatment. 
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C.2 CdSe/OA & ODE Quantum Dot Cores  
C.2.1 Chloroform 
 
Figure C9. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
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Figure C10. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
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Figure C11. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
Figure C12. Photos of CdSe (OA & ODE) QDs dissolved in chloroform that are from left to right: 
untreated, treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light 
(a) 1 d, (b) 5 d, and (c) 10 d after treatment.. 
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C.2.2 Toluene 
 
Figure C13. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
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Figure C14. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
C13 
 
 
Figure C15. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
 
Figure C16. Photos of CdSe (OA & ODE) QDs dissolved in toluene that are from left to right: untreated, 
treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, (b) 
5 d, and (c) 10 d after treatment. 
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C.3 CdSe/OA & TOA Quantum Dot Cores  
C.3.1 Chloroform 
 
Figure C17. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
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Figure C18. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
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Figure C19. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
Figure C20. Photos of CdSe (OA & TOA) QDs dissolved in chloroform that are from left to right: 
untreated, treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light 
(a) 1 d, (b) 5 d, and (c) 10 d after treatment. 
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C.3.2 Toluene 
 
Figure C21. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
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Figure C22. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
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Figure C23. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
Figure C24. Photos of CdSe (OA & TOA) QDs dissolved in toluene that are from left to right: untreated, 
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, 
(b) 5 d, and (c) 10 d after treatment. 
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C.4 CdS/Oleylamine Quantum Dot Cores  
C.4.1 Chloroform 
 
Figure C25. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
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Figure C26. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
C22 
 
 
Figure C27. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
 
Figure C28. Photos of CdS (oleylamine) QDs dissolved in chloroform that are from left to right: untreated, 
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, 
(b) 5 d, and (c) 10 d after treatment. 
C23 
 
C.4.2 Toluene 
 
Figure C29. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
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Figure C30. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
C25 
 
 
Figure C31. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
 
Figure C32. Photos of CdS (oleylamine) QDs dissolved in toluene that are from left to right: untreated, 
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, 
(b) 5 d, and (c) 10 d after treatment. 
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C.5 CdS/OA & ODE Quantum Dot Cores  
C.5.1 Chloroform 
 
Figure C33. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
C27 
 
 
Figure C34. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
C28 
 
 
Figure C35. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
Figure 
C36. Photos of CdS (OA & ODE) QDs dissolved in chloroform that are from left to right: untreated, treated 
with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, (b) 5 d, 
and (c) 10 d after treatment. 
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C.5.2 Toluene 
 
Figure C37. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
C30 
 
 
Figure C38. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
C31 
 
 
Figure C39. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
Figure C40. Photos of CdS (OA & ODE) QDs dissolved in toluene that are from left to right: untreated, 
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, 
(b) 5 d, and (c) 10 d after treatment. 
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C.6 CdS/OA & TOA Quantum Dot Cores  
C.6.1 Chloroform 
 
Figure C41. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
C33 
 
 
Figure C42. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
C34 
 
 
Figure C43. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
 
Figure C44. Photos of CdS (OA & TOA) QDs dissolved in chloroform that are from left to right: untreated, 
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, 
(b) 5 d, and (c) 10 d after treatment. 
C35 
 
C.6.2 Toluene 
 
Figure C45. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0311 mmol C4H10O2. 
C36 
 
 
Figure C46. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0519 mmol C4H10O2. 
C37 
 
 
Figure C47. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in 
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d 
(purple) after treatment with 0.0726 mmol C4H10O2. 
 
 
Figure C48. Photos of CdS (OA & TOA) QDs dissolved in toluene that are from left to right: untreated, 
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, 
(b) 5 d, and (c) 10 d after treatment. 
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Appendix D . Thermogravimetric Analysis (TGA) 
 
 
 
Figure D.1. TGA of CdSe (oleylamine) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min 
under nitrogen. 
 
 
 
Figure D.2. TGA of CdSe (OA & ODE) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min 
under nitrogen. 
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Figure D.3. TGA of CdSe (OA & TOA) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min 
under nitrogen. 
 
 
 
Figure D.4. TGA of CdS (oleylamine) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min 
under nitrogen. 
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Figure D.5. TGA of CdS (OA & ODE) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min 
under nitrogen. 
 
 
 
Figure D.6. TGA of CdS (OA & TOA) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min 
under nitrogen. 
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